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Language encompasses an ability to acquire and integrate complex cognitive systems in order to 
communicate with others, and inherited factors are thought to play a key role in modulating these 
emergent skills. In recent years, the role of genetics in language has gained focus and attention, 
based on accumulating empirical knowledge about the genes, proteins, and cellular machinery 
involved. In particular, disruption to various mechanisms has been shown to relate to 
impairments in language -- as seen in neurodevelopmental disorders such as autism, dyslexia and 
SLI. Mouse models can serve as a useful tool in studying the genetic modulators of related 
neural circuitry. The central over-arching aim of the current series of studies was to examine 
behavioral and neuroanatomic profiles of transgenic mice modeled on several established 
neurodevelopmental disorders (NDDs). We focused on five transgenic murine preparations 
exhibiting mutations derived from NDD populations characterized by atypical language. These 
include NDDs with language disability as a core feature of the disorder (e.g., specific language 
impairment (SLI), dyslexia), or as a sub-type (i.e., only some individuals affected; autism 
spectrum disorders (ASD)). The transgenic models assessed include: (1) Cntnap2 knock-out 
(KO; implicated in ASD and SLI); (2) Dyx1c1 conditional forebrain KO (implicated in dyslexia); 
(3) Ts2-neo model (a mutation associated with ASD); (4) Dcdc2 KO (implicated in dyslexia); 
and (5) Shank3b KO (associated with ASD). Using these models, we assessed specific links 
between: (a) genetically driven alterations in neurodevelopment; and (b) anomalies in 
fundamental non-verbal behaviors subserving aspects of language-learning. Our novel behavioral 
paradigms were able to tap “intermediate” language-related behavioral phenotypes in mice.  
 
  
Amanda Rose Rendall – University of Connecticut, 2017 
Measures included acoustic processing of rapid and complex stimuli, visual motion perception, 
sensorimotor functions, social/communicative interactions, and working memory. We also 
quantified gross neuroanatomy to assess whether neural anomalies correlate with any atypical 
behaviors. Cumulative findings provide insight about the role of genes critical in the polygenic 
developmental cascade supporting emergent language, as well as the consequences of disruption 
to those pathways. Ongoing research may promote enhanced early screening of infants, as well 
as individualized treatment techniques for neurodevelopmental disorders that include language 
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1.1     Background -- Neurogenetics of developmental language disabilities 
Language use is an enormously complex process, yet surprisingly, most children acquire 
these skills with little to no initial instruction. By the late toddler/early pre-school years, most 
children have acquired a large number of words, and can assemble them into sentences following 
complex grammatical rules. However, not all children acquire language so effortlessly. In fact, 
substantial variability exists in the speed and proficiency of language acquisition, reflecting both 
environmental and genetic factors. Although some children grow out of their language 
impairments, many others have persistent difficulties with language expression and 
comprehension throughout life. These difficulties appear to be common, with developmental 
disorder of speech, language and communication accounting for 40% of referrals to pediatric 
services (Harel et al., 1996).  
In recent years, the role of genetics in language has gained particular attention, given 
accumulating empirical knowledge about the genes, proteins, and cellular machinery involved in 
both brain development and cognitive outcomes. Disruptions to various neurodevelopmental 
mechanisms (e.g. neuronal migration and synaptic plasticity) have been related to impairments in 
language as seen in neurodevelopmental disorders (NDDs) such as dyslexia, specific language 
impairment (SLI), and autism spectrum disorders (ASDs). Developmental dyslexia is a learning 
disability characterized by unexpected difficulties in learning to read and write (Shaywitz & 
Shaywitz, 2005), while SLI is diagnosed when children exhibit significant delays in spoken 
language acquisition (Leonard, 2000). Both dyslexia and SLI employ a diagnosis of “exclusion”, 
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meaning that observed dysfunctions cannot be explained by concomitant factors such as 
intellectual impairment, lack of educational opportunity, or other co-morbid neurological 
disorders (e.g., epilepsy, or primary sensory impairments (blindness, deafness); Leonard, 2000; 
Shaywitz &Shaywitz, 2005). Language impairment is also a core feature of ASD, affecting 
approximately 50% of all children diagnosed with autism, and can manifest in varying degrees 
that range from a complete absence of language to hyperlexic skills (Alarcón et al., 2008).  
Although these clinical populations are diverse, they do share overlapping symptomatology that 
is thought to contribute to the similar language deficits observed. 
The language-related NDDs described above have shown to be highly heritable 
(indicating a strong genetic basis), with familial rates ranging from 40 to 90% (Bailey et al., 
1995; Steffenburg et al., 1989; Rosenberg et al., 2009; Schumacher, Hoffmann, Schmal, Schulte-
Korne, & Nothen, 2007). However, many different genes have been implicated in these 
language-based developmental disabilities, leading investigators to postulate a complex 
polygenic and environmental array of “risk factors” that may contribute to developmental 
disruption. This puzzling identification of hundreds of gene pathways leading to a small number 
of common and/or overlapping language-related phenotypes is not unprecedented, and has been 
seen for other genetically-mediated non-syndromic disorders such as schizophrenia and bipolar 
disorder (Gelernter, 2015).  
1.2     Genetics of language-related disorders 
 The first gene identified to have an influence on speech and language was the 
transcription factor, forkhead box protein P2 (FOXP2). In 2001, FOXP2 was discovered to be 
the cause of a monogenic verbal dyspraxia in the KE family (Lai et al., 2001). Not only did these 
family members have difficulty producing speech, they also displayed an array of linguistic 
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deficits affecting expressive and written language (Watkins, Dronkers & Vargha-Khadem, 
2002). Although FOXP2 is popularly designated the “language gene,” this is not completely 
accurate, since evidence clearly shows that one gene does not mediate all aspects of language 
abilities. Moreover, FOXP2 is not the only risk gene of language-related disorders. For instance, 
FOXP2 directly downregulates contactin-associated-like-protein 2 (CNTNAP2), which has also 
been linked to specific language impairment, autism and dyslexia (Alarcón et al., 2008; Arking 
et al., 2008; Bakkaloglu et al., 2008; Peter et al., 2013; Vernes et al., 2008). CNTNAP2 variants 
have also been specifically associated with non-word repetition as well as age at first word and 
phrase (Alarcon et al., 2008; Anney et al., 2012; Peter et al., 2011; Vernes et al., 2008). 
Developmental dyslexia has been known to have familial clustering for well over 100 
years (Hinshelwood 1902, Stephenson 1907; Thomas 1905). Specifically, a child with an 
affected parent has a risk of 40-60% of developing dyslexia, and this risk is increased to 76-78% 
when both parents are affected (Gilger et al., 1996; Olson, Forsberg & Wise, 1994; Schulte-
Körne et al., 1996; Ziegler et al., 2005). To date, at least nine loci for dyslexia have been mapped 
(DYX1 to DYX9), which include candidate risk genes DYX1C1, DCDC2, KIAA0319 and ROBO1. 
DYX1C1 (dyslexia susceptibility 1 candidate 1) was the first dyslexia candidate risk gene 
identified, specifically in two Finnish families with a history of dyslexia (Nopola-Hemmi et al., 
2000). Of the more recently identified candidate genes, DCDC2 (doublecortin domain containing 
protein 2) and K1AA0319 seem to be of most significance for dyslexia, with multiple reports 
from well-established independent samples, and including severely affected individuals with 
dyslexia (Schumacher et al., 2007). By contrast, DYX1C1 and ROBO1 have seen inconsistent 
findings of involvement in the development of dyslexia across various populations. 
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Although the genetic etiology of dyslexia is complex, understanding the genetic 
mechanisms underlying ASD has been one of the most puzzling biological questions of the past 
decade. The genetic influence in ASD is strong, with heritability rates consistently ranging from 
70-80% (Bailey et al., 1995; Rosenberg et al., 2009). However, contrary to the several candidate 
risk genes identified for dyslexia, it is suggested that over 1,000 genes may be involved in ASD, 
reflecting a tremendously complex genetic architecture (De Rubeis & Buxbaum, 2015). 
Additionally, no one of these known genetic contributors accounts for more than 1-2% of the 
phenotypic variance seen in ASD, despite having strong inheritance patterns (Abrahams & 
Geschwind, 2008). Several dozen ASD susceptibility genes have been identified in the past 
decade, collectively accounting for 10–20% of ASD cases (Geschwind, 2011). Considerable 
insight into potential risk genes has been discovered by the molecular study of defined 
syndromes related to ASD, such as fragile X syndrome (FMR1), Rett syndrome (MECP2), 
Angelman syndrome (UBE3A, GARBRB3), Timothy syndrome (CACNA1C) and Phelan-
McDermid syndrome (SHANK3). Culminating evidence is starting to link these syndromes and 
idiopathic autism. For instance, levels of UBE3A and GABRB3 are reduced in each of Angelman 
syndrome, Rett syndrome and idiopathic autism (Samaco, Hogart, & LaSalle, 2005). This is also 
seen for other candidate genes such as CACNA1C and SHANK3, which associate with both 
syndromic and non-syndromic forms of ASD.  Although these ASD-associated syndromes 
involve genes with multiple molecular functions, it seems increasingly plausible that they 
converge on common biological pathways and neural circuits that generate ASD phenotypes. 
These candidate genes provide an opportunity for insight into the biological pathways that 
underpin normal language acquisition. However, it is difficult to understand how a mutation in 
just one gene could have a profound and specific effect on the development of language (leaving 
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many other neural functions relatively intact), as well as how mutations in so many different 
genes with distinct functions could lead to a common phenotype of atypical language skill. An 
integrative approach across disciplines examining genetic contribution at multiple levels is 
necessary to bridge this gap between genes and language. 
1.3     Neurobiological themes of language-related disorders 
 Language development is a biologically complicated process that involves the 
development and recruitment of multiple neural systems needed to process auditory, visual, 
sensorimotor, and memory functions in an integrated fashion for the individual to perceive, 
comprehend and produce language. Early disturbances in neurodevelopment may consequently 
disrupt fundamental processes necessary to acquire typical language abilities, and ultimately lead 
to language disability. To date, several neurobiological themes have been established that may 
account for the language impairments observed in these clinical populations.  
1.3.1    Neural mechanisms underlying dyslexia  
The neurobiological mechanisms underlying dyslexia/reading disability are not yet fully 
understood, however, most of the risk genes identified appear to converge on similar biological 
mechanisms (i.e., neuronal migration and cilia function; Kere, 2014). Early studies of post-
mortem dyslexic brains revealed anomalies of neuronal migration (molecular layer ectopias and 
focal microgyri) predominantly in the left hemisphere (Galaburda et al., 1985; Galaburda & 
Kemper, 1979; Humphreys et al., 1990; Kaufmann & Galaburda, 1989). In parallel, neuronal 
migration defects have also been observed in animal models that express a downregulation of 
dyslexia candidate risk genes. Specifically, rat models using RNA interference to knock-down 
Dcdc2, Dyx1c1 and Kiaa0319 resulted in disruption of the typical neuronal migration trajectory 
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from the ventricular zone to the cortex, leaving cells in subcortical localizations (Meng et al., 
2005; Peschansky et al., 2010; Wang et al., 2006). Furthermore, Robo1 knockout mice display 
neuronal migration defects in the forebrain. Interestingly,, these neuronal migration anomalies 
have not yet been observed in other knockout mouse models targeting dyslexia risk genes, 
although signaling of primary cilia in neurons has been also associated with DCDC2, DYX1C1, 
and KIAA0319 (Chandrasekar et al., 2013; Ivliev et al., 2012; Massienen et al., 2011; Tarkar et 
al., 2013). Overall findings are consistent with aberrant neuronal migration, since primary cilia 
have a critical role in cortical morphogenesis of the developing forebrain (Willaredt et al., 2008). 
These deviant neurodevelopmental processes could lead to abnormal cortico-cortical and cortico-
thalamic circuits that affect sensorimotor, perceptual and cognitive processes critical for learning 
and language processing. 
1.3.2    Magnocellular theory of dyslexia 
Cytoarchitectonic anomalies have also been observed in the thalamus of human dyslexic 
brains, particularly in the lateral geniculate nucleus (LGN), where magnocellular layers were 
seen to be more disorganized and characterized by smaller cell bodies (Livingstone et al., 1991). 
This reduction in the distribution of large cells (“magnocells”) versus small cells (“parvocells”) 
was seen in both the lateral geniculate (visual), and also the medial geniculate (auditory) nuclei 
of dyslexic subjects (note there is no distinctive layering in the MGN; Galaburda et al., 1994). 
These findings, along with related neuroanatomical evidence and findings of atypical sensory 
processing for magnocellular-dependent tasks, led to the magnocellular theory of dyslexia. This 
theory posits that both visual and auditory processing dysfunction associated with reading 
disability can be attributed to low-level processing deficits resulting from specific disruption to 
the magnocellular sub-systems of thalamic nuclei, and potentially elsewhere in sub-cortical 
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sensory structures (Galaburda et al., 1994; Livingstone et al., 1991; see Stein, 2001, for review). 
It is well established that the magnocellular component of the visual system is specialized for 
processing rapidly-changing temporal information (e.g., motion). Further support of this theory 
has come from animal models displaying similar thalamic anomalies within the MGN (more 
small and fewer large neurons), along with rapid auditory processing deficits consistent with 
magnocellular processes (Fitch et al., 1994; Fitch et al., 1997; Herman et al., 1997; Peiffer et al., 
2001; Peiffer et al., 2002a; Peiffer et al., 2002b). It is thought that a resulting disruption in 
temporal processing in both visual and auditory domains might make it difficult for individuals 
with dyslexia to process rapidly changing sensory input crucial to the initial establishment of 
critical speech sounds, as well as the later visual processing of letters (Stein & Walsh, 1997).  
1.3.3    Synaptic dysfunction in ASD 
 Due to the numerous autism candidate susceptibility genes that are associated with 
synaptic structure, function and regulation, ASD is in fact referred to as a “synaptopathy” 
(Zoghbi, 2003; Geschwind & Levitt, 2007; Zoghbi & Bear, 2012). Many identified ASD risk 
genes encode synaptic scaffolding proteins, receptors, cell adhesion molecules or proteins that 
are involved in chromatin remodeling, transcription, protein synthesis or degradation, or actin 
cytoskeleton dynamics -- all which are key regulators of synaptic plasticity (see Bourgeron 2015 
for review). The possibility that alteration of synaptic functions could lead to ASD was first 
indicated by the phenotypic overlap between autism, fragile X syndrome, and Rett syndrome 
(Belmonte & Bourgeron, 2006; Zoghbi, 2003). Moreover, an imbalance between inhibitory and 
excitatory currents in ASD was further supported by the observation that 10-30% of affected 
individuals have epilepsy (Canitano, 2007). Synaptic dysfunction was further implicated in ASD 
when mutations affecting postsynaptic cell adhesion molecules, Neuroligins (NLGN), were 
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identified in a subset of individuals with ASD (Jamain et al., 2003; Laumonnier et al., 2004). 
Mutations were also reported in other synaptic proteins such as SHANK3, NRXN1, CNTNAP2, 
CNTN3/4, and PCDH9/10 (Alarcon et al., 2008; Arking et al., 2008; Bakkaloglu et al., 2008; 
Durand et al., 2007; Kim et al., 2008; Marshall et al., 2008; Morrow et al., 2008; Szatmari et al., 
2007).  Atypical voltage-gated calcium channel subunits (CACNA1C, CACNB2, CACNA1I) have 
also been identified in ASD populations, and these subunits are crucial for establishing synaptic 
homeostasis (Turrigiano, 2011). Mice carrying various mutations in these genes display ASD-
like behaviors, such as repetitive grooming and deficits in social interaction and communication 
(see Ey, Leblond & Bourgeron, 2010 for review). Disruption of these proteins alters synaptic 
homeostasis and may ultimately induce atypical brain connectivity. 
1.3.4    Abnormal connectivity observed in ASD 
Abnormal brain growth and connectivity have also been a hypothesized cause of ASD 
(Courchesne & Pierce, 2005; Just et al., 2007).   It is suggested that connectivity within the 
frontal lobe is excessive, disorganized, and inadequately selective, whereas connectivity between 
frontal cortex and other systems is poorly synchronized and weakly responsive (Courchesne & 
Peirce, 2005).  In addition to these findings, evidence has shown that connections across cortical 
regions are often diminished in general in ASD. Conversely, functional whole-brain connectivity 
analyses have revealed that individuals with ASD show subcortical areas that exhibit 
hyperconnectivity, even though cortiocortical areas in the same subjects are predominantly 
hypoconnected (Di Martino et al., 2014). This developmental “disconnection” may account for 
clinical heterogeneity, as well as the frequent late emergence during development (around 2 yrs) 
seen in ASD (Belmonte et al., 2004). This is consistent with the notion that people with ASD 
suffer from a lack of “central coherence” -- the cognitive ability to bind together a jumble of 
9 
 
separate features to form a single coherent concept (Frith, 1989).  Impairments in the integration 
of sensory information could in turn reflect diminished cross-modal white matter connectivity, as 
reported in some DTI/MRI studies (Maximo et al., 2013; Travers et al., 2012). The purported 
hypoconnectivity and multisensory integration issue may be further disrupting higher-order 
cognitive abilities, such as learning and social communication that are heavily dependent on 
multi-modal and trans-cortical integration. 
1.4     Intermediate language phenotypes 
Given the enormous number of identified gene risk factors underlying language-related 
disorders, it is crucial that we try to deconstruct complex diagnostic outcomes into simpler 
behavioral endophenotypes or “intermediate phenotypes” that can more easily be associated with 
individual genetic and neurobiological mechanisms, particularly where these features are shared 
across disorders. Language-related endophenotypes employed in more recent human gene wide 
association studies (GWAS) include scores on specific language-based tasks thought to tap 
specific sub-skills or domains. This contrasts more traditional gene association studies that rely 
on broad diagnostic categorization (i.e., GWAS using “affected” versus “unaffected” groups). 
More novel language-related intermediate phenotypes include measures of impairment in 
phonological processing (Alcántara et al., 2012; Benasich et al., 2006; Bhatara et al., 2013; 
Boscariol et al., 2010; McArthur &Bishop, 2005; Kovelman et al., 2012; Melby-Lervag, Lyster 
& Hulme, 2012; Peyrin et al., 2012), short-term and/or working memory (Beneventi et al., 2010; 
Gathercole et al., 2006; Menghini et al., 2010; Barendse et al., 2013) rapid auditory processing 
(Cohen-Mimran & Sapir, 2007; Fitch & Szalkowski, 2012; Hamalainen, Salminen & Leppanen, 
2013; Bonnel et al., 2003; Järvinen-Palsey, Peppé, King-Smith & Heaton, 2008; O'Riordan & 
Passetti, 2006; Tomchek, & Dunn, 2007 ), visuospatial attention (Franceschini, 2012; Gabrieli & 
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Norton, 2012), and/or visual attention/perception (Galaburda and Livingstone, 1993; Stein and 
Walsh, 1997; Vidyasagar and Pammer, 2010; Townsend, Harris &Courchesne, 1996; Frischen, 
Bayliss & Tipper, 2007). Use of these more fine-grained functional measures to link genetic risks 
with specific behavioral traits (rather than global and highly variable diagnostic categories) 
permits a much more focused analysis of how genes are specifically contributing to behavioral or 
functional components within a broader clinical domain.  
1.4.1    Intermediate language phenotypes - Auditory processing  
Deficits in auditory temporal processing are commonly shared across SLI, dyslexia, and 
autism, suggesting that auditory processing may be a core skill for the development of language, 
as well as subsequent reading ability. For example, work has shown that language impaired 
populations exhibit difficulties in detecting and discriminating rapidly changing acoustic stimuli 
(i.e., in the range of tens of milliseconds), regardless of whether stimuli comprise verbal or 
nonverbal information (Cohen-Mimran & Sapir, 2007; Tallal & Piercy, 1973; Tallal et al., 1993; 
Tallal & Newcombe, 1978; Vandermosten et al., 2011). Most of these studies have reported that 
when stimulus durations were longer, language impaired individuals were comparable to typical 
controls in effectively detecting differences in auditory information. Therefore the deficits appear 
to be specific to rapidly changing sounds, and not whether stimuli are verbal or nonverbal in 
nature (Tallal, 1980; Vandermosten et al., 2011). Related research has described evidence of 
longitudinal prediction for future language impairments, based on evidence of abnormal non-
lingual rapid auditory processing measured during infancy (Benasich & Tallal, 2002; Benasich et 
al., 2006; Choudhury et al., 2007). Interestingly, these same studies showed that early acoustic 
processing indices were effective predictors of long-term language outcomes not only in at-risk 
samples (i.e., infants with affected family members), but also in typically developing infants. 
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Thus overall evidence strongly supports the view that intact auditory processing ability is crucial 
to early language development, including the ability to discriminate and categorize sounds for 
the formation of phonological categories, which in turn become the building blocks for words. 
In the context of autism, anomalies in auditory processing can also relate to deficits in 
language abilities, but in this case it appears that enhancements in processing low-level detailed 
acoustic information (e.g., frequency information) may also undermine subsequent global 
processing required for effective language skills (e.g., formation of phoneme categories, 
processing of words and sentences; Eigsti & Fein, 2013; Bonnel et al. 2010, 2003; Heaton and 
Heaton 2003, 2005; Jones et al. 2009; O’Riordan & Plaisted 2001; Stewart, Griffiths, Grube, 
2015). These theories are supported by robust evidence that individuals with ASD display 
superior pitch discrimination, and enhanced ability to detect and discriminate low-level auditory 
information (Hyde et al., 2011; Hertrich et al., 2013). Moreover, the incidence of low-level 
acoustic enhancements appears to relate specifically to the incidence of speech onset delays, 
meaning that acoustic superiorities may be specifically associated with -- not merely co-
occurring with -- language deficits in ASD populations (Eigsti & Fein, 2013; Mottron et al., 
2014). 
1.4.2    Intermediate language phenotypes - Visual processing  
Visual attention and perception have also shown to impact language development. 
Specifically, atypical or impaired visual perception of motion has been strongly implicated in 
dyslexia, and may be a one causal factor underlying slow reading speeds (Lyon et al., 2003; 
Nicholson and Fawcett, 2007). Children with dyslexia are reported to have some combination of 
spatial (Lovegrove et al., 1980; Cornelissen et al., 1995; Stein and Walsh, 1997; Lawton, 2000, 
2007, 2008, 2011; Talcott et al., 2000; Hansen et al., 2001; Stein, 2001) and/or temporal (Stanley 
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and Hall, 1973; Bradley and Bryant, 1983; Tallal et al., 1993; Temple et al., 2003) visual 
sequencing deficits. These impairments could relate to reports from dyslexics that letters in 
words and/or words on a page appear distorted, displaced, or crowded together (Atkinson, 1991). 
Moreover, visual processing deficits are prominent in dyslexic samples when images are rapidly 
presented or moving – findings that support speculation about neural timing deficits associated 
with sluggish magnocellular neurons in dyslexia (Livingstone et al., 1991; Stein and Walsh, 
1997; Vidyasagar, 1999, 2001, 2012; Lawton, 2000, 2007, 2008, 2011; Stein, 2001; Vidyasagar 
and Pammer, 2010; Boets et al., 2011). In fact, early evidence pointed to a selective deficit of the 
magnocellular-dorsal system as measured both by atypical cellular morphology in thalamic 
nuclei (Galaburda and Kemper, 1979; Galabur 
da et al., 1985; Livingstone et al., 1991), as well as electrophysiological profiles during 
motion-related magnocellular processing tasks (Lovegrove et al., 1980; Cornelissen et al., 1995; 
Stein and Walsh, 1997; Demb et al., 1998; Slaghuis and Ryan, 1999, 2006). Importantly, these 
deficits in motion perception can be detected earlier than language impairments, and are also 
predictive of language outcome, making motion perception another useful “intermediate” and 
pre-lingual phenotype for early diagnosis and intervention (Boets et al., 2011). 
1.4.3    Intermediate language phenotypes – Working memory  
It has also been suggested that working memory may be disrupted in autism, as well as 
dyslexia (Barendse et al., 2013; Williams et al., 2005; Jeffries & Everatt, 2004; Smith-Spark & 
Fisk, 2007). Working memory involves the temporary storage and manipulation of information 
that is required for a wide range of complex cognitive tasks, including language. Therefore, 
disruptions in working memory may consequently constrain language development in children 
(Gathercole & Baddeley, 1993; Bishop et al., 1996; Baddeley, 2003). It has been postulated that 
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impairments in phonological memory in particular may influence the efficiency and accuracy 
with which stable long-term memory phonological representations can be established. Such 
deficits would negatively impact the ability to acquire grammatical constructs, as well as new 
words (Speidel and Herreshoff, 1989; Baddeley et al., 1998; Gathercole and Baddeley, 1990). 
Therefore, disruptions in working memory could also fundamentally alter language development.  
Overall, language requires stability and integration from multiple systems that depend on 
intact auditory processing, visual attention/perception, and working memory. Importantly, all of 
these fundamental processes can be measured during early development -- well before the onset 
of language and reading. Yet, these indices also appear to be predictive of later language 
outcomes, and may provide particularly useful screening tools for at-risk infants. Additionally, 
auditory processing, visual perception, and working memory can be reliably assessed in mouse 
models, using various carefully designed behavioral paradigms. Finally, a focus on intermediate 
processing skills crucial to language development opens a dramatic new domain for the use of 
animal models in studying NDDs. 
1.5     Dissertation Purpose 
The purpose of the current thesis was to target specific genes that have been implicated in 
language disorders, and assess the behavioral and neuroanatomical consequences of 
manipulating the protein products associated with the genes. To accomplish this, we used a 
variety of transgenic mouse models that capitalize on recent developments in the capacity to turn 
genes down or off (“knock-outs”), turn genes “up” (using over-expressive mutations such as 
copy number variants), or alter the functionality of gene protein products through insertion of 
more precise mutations (e.g., SNP and point mutation “knock-ins”). Using such manipulations, 
we can further explore gene-brain-behavior relationships to examine how each targeted gene 
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mediates core behavioral endophenotypes associated with language and reading-related 
dysfunction. In the current dissertation, we focused on five transgenic preparations exhibiting 
mutations derived from NDD populations with atypical language. These include NDDs with 
language disability as a core feature of the disorder (specific language impairment (SLI), 
dyslexia), or as a sub-type (some individuals affected; autism spectrum disorders (ASD)). 
Transgenic strains assessed include: (1) Cntnap2 knock-out (KO; implicated in ASD and SLI); 
(2) Dyx1c1 conditional forebrain KO (implicated in dyslexia); (3) Ts2-neo model (a mutation 
associated with ASD); (4) Dcdc2 KO (implicated in dyslexia); and (5) Shank3b KO (associated 
with ASD). In all cases, mutants were compared to same-sex and age wild-type (WT) mice. 
Using these models, we assessed specific links between: (a) genetically driven alterations in 
neurodevelopment; and (b) anomalies in fundamental non-verbal behaviors subserving aspects of 
language-learning. Our novel behavioral paradigms were able to tap into “intermediate” 
language-related behavioral phenotypes in these mice. Behavioral measures included acoustic 
processing of rapid and complex stimuli, visual motion perception, sensorimotor functions, 
social/communicative interactions, and working memory. We also quantified gross 
neuroanatomy to assess whether neural anomalies correlate with any atypical behaviors. In 
closing, ongoing research can provide valuable insight to our understanding of the biological 
substrates of atypical language development. Future applications of data could allow for more 
precise diagnosis, and advanced early screening tools as well as more targeted interventions 
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2.1       Abstract 
 
Autism Spectrum Disorder (ASD) is a heterogeneous neurodevelopmental disorder with core 
symptoms of atypical social interactions and repetitive behaviors. It has also been reported that 
individuals with ASD have difficulty with multisensory integration, and this may disrupt higher-
order cognitive abilities such as learning and social communication. Impairments in the 
integration of sensory information could in turn reflect diminished cross-modal white matter 
connectivity. Moreover, the genetic contribution in ASD appears to be strong, with heritability 
estimates as high as 90%. However, no single gene has been identified, and over 1,000 risk genes 
have been reported. One of these genes -- contactin-associated-like-protein 2 (CNTNAP2) -- was 
first associated with Specific Language Impairment, and more recently has been linked to ASD. 
CNTNAP2 encodes a cell adhesion protein regulating synaptic signal transmission. To better 
understand the behavioral and biological underlying mechanisms of ASD, a transgenic mouse 
model was created with a genetic knockout (KO) of the rodent homolog Cntnap2. Initial studies 
on this mouse revealed poor social interactions, behavioral perseveration, and reduced 
vocalizations -- all strongly resembling human ASD symptoms. Cntnap2 KO mice also show 
abnormalities in myelin formation, consistent with a hypo-connectivity model of ASD. The 
current study was designed to further assess the behavioral phenotype of this mouse model, with 
a focus on learning and memory. Cntnap2 KO and wild-type mice were tested on a 4/8 radial 
arm water maze for 14 consecutive days. Error scores (total, working memory, reference 
memory, initial and repeated reference memory), latency and average turn angle were 
independently assessed using a 2 x 14 repeated measures ANOVA. Results showed that Cntnap2 
KO mice exhibited significant deficits in working and reference memory during the acquisition 
period of the task. During the retention period (i.e., after asymptote in errors), Cntnap2 KO mice 
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performed comparably to wild-type mice. These findings suggest that CNTNAP2 may influence 
the development of neural systems important to learning and cross-modal integration, and that 
disruption of this function could be associated with delayed learning in ASD.  
 
2.2       Introduction 
 
Autism Spectrum Disorder (ASD) is a set of neurodevelopmental disorders characterized 
by a complex behavioral phenotype, encompassing deficits in both social and cognitive domains. 
Accepted core symptoms are heterogeneous ranging from atypical social interactions and 
language impairments to repetitive behaviors. Accordingly, individual cases vary substantially in 
severity and presentation of symptoms. The current estimated prevalence for ASD in the United 
States is 1 in 68, and is consistently more prevalent in boys than girls (1 in 42 boys versus 1 in 
189 girls) (Baio, 2012; Elsabbagh et al., 2012). To date, causal mechanisms underlying ASD 
remain poorly understood, but likely include a complex combination of polygenic and 
environmental risk factors (Moreno-De-Luca, 2013). 
 Ongoing ASD research has focused on the genetic and neurobiological mechanisms of 
ASD, based on the notion that characterization of the varied neurogenetic features of ASD could 
provide insight to the diverse behavioral symptoms. The genetic contribution in ASD appears to 
be strong; for example, monozygotic twin studies estimate the concordance rates are as high as 
70% - 90% (Bailey et al., 1995; Steffenburg et al., 1989; Rosenberg et al., 2009). However, the 
relative proportion of ASD that can be accounted for by either rare or common genetic variation 
remains to be determined, and no single gene has been identified as a major cause. In fact, over 
1,000 risk genes have been reported, pointing to a very complex genetic etiology (De Rubeis & 
Buxbaum, 2015).  
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One of the autism susceptibility candidate genes -- contactin-associated-like-protein 2 
(CNTNAP2) -- was first linked to Specific Language Impairment, and more recently has been 
linked to ASD (Alarcón et al., 2008; Arking et al., 2008). CNTNAP2 has also been linked to 
other complex neurological disorders such as schizophrenia, dyslexia and depression in genome-
wide association studies (Vernes et al., 2008; Newbury et al., 2011; Peter et al., 2011; Ji et al., 
2013). Thus CNTNAP2 mutations could underlie similar endophenotypes across various 
disorders. In clinically language-impaired populations, CNTNAP2 variants have been associated 
with difficulties with non-word repetition -- a measure of working memory that critically 
underlies language and social cognition (Vernes et al., 2008; Peter et al., 2011). Further studies 
have highlighted significant association between specific SNPs in CNTNAP2 and language 
endophenotypes of ASD including age at first word (Alarcon et al., 2008) and age at first phrase 
(Anney et al., 2012). 
CNTNAP2 is located on chromosome 7, and is responsible for encoding a cell adhesion 
protein regulating synaptic signal transmission (Alarcón et al., 2008).To better understand the 
behavioral and biological underlying mechanisms of ASD, a transgenic mouse model was 
created with a genetic knockout (KO) of the rodent homolog Cntnap2 (Poliak et al., 2003). Initial 
behavioral studies of this mouse revealed poor social interactions, perseveration, and reduced 
pup vocalizations -- all strongly resembling human ASD symptoms (Peñagarikano et al., 2011; 
Penagarikano & Geschwind 2012). CNTNAP2’s role in neurodevelopment has been further 
studied using this mouse model, revealing that Cntnap2 KO mice show abnormalities in myelin 
formation -- consistent with a hypo-connectivity model of ASD (Poliak et al., 2003). These mice 
also exhibit abnormal cortical neural synchrony (i.e., enhanced asynchrony), fewer inter-neurons 
(which are mostly inhibitory), and atypical neuronal migration (Peñagarikano et al., 2011). All of 
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these cellular anomalies can be linked to current biological theories for mechanisms of ASD. 
More recent studies from our lab revealed that the KO mice exhibit unexpected enhancements in 
acoustic frequency processing, despite impairments on more complex silent gap detection tasks 
(Truong et al., 2015). The latter results have been linked with anomalies at the level of the 
thalamus, and also could also reflect atypical patterns of cortical connectivity. 
The current study was designed to further assess the behavioral phenotype of the Cntnap2 
KO mouse model, with a focus on putative anomalies in spatial learning and memory. 
Specifically, impairments in working memory have been noted in individuals with ASD, and 
these deficits are more pronounced when the task load is high (Barendse et al., 2013). It is also 
important to note that although most of these working memory impairments in ASD are found in 
the spatial domain (e.g. Lind et al., 2013), they have also been observed in complex verbal 
working memory tasks  (Schuh & Eigsti, 2012; Steele et al., 2007; Luna et al., 2007; Williams, 
Goldstein, & Minshew, 2005; Willims et al., 2005). Previous studies investigating the Cntnap2 
KO mice, however, found similar learning rates on the Morris Water maze task for KOs versus 
WT controls. This result suggests a lack of spatial learning and memory impairments 
(Peñagarikano et al., 2011). However, when presented with a maze reversal task, Cntnap2 KOs 
did show significant impairments in learning the new platform location (Peñagarikano et al., 
2011). These results reinforce the notion that difficulty of task may play a role in inconsistent 
findings for memory deficits associated with ASD. Our goal was to further assess Cntnap2 KOs 
spatial memory ability utilizing a more difficult 4/8 arm radial water maze task. This task also 
allows for the analysis of both reference and working memory, while introducing a higher 
cognitive load (compared to Morris Water maze, with only one platform). Finally, this task 
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generates a more extended learning curve, allowing us to adequately evaluate performance 
during acquisition and retention periods separately. 
2.3       Methods and Materials 
2.3.1     Subjects 
10 Cntnap2 KO mice (B6.129(Cg)-Cntnap2tm1Pele/J; stock number 017482) and 11 wild 
type (WT) controls (C57BL/6J; stock number 000664) were obtained from The Jackson 
Laboratory (Bar Harbor, ME)1. 1Subjects were delivered to the University of Connecticut, 
Department of Psychology at 7 weeks of age. Upon arrival, subjects were single housed in 
standard plexiglass laboratory cages (12:12 light/dark cycle) with food and water available ad 
lib. Only male subjects were used for testing, based on evidence of a higher incidence of ASD 
and developmental language impairments in males as compared to females (Baio, 2012). Maze 
testing began when the animals were around 24 weeks of age, and occurred during the subjects’ 
light cycle. All procedures were performed blind to subject genotype and were conducted in 
compliance with the National Institutes of Health and approved by the University of 
Connecticut’s Institutional Animal Care and Use Committee (IACUC).  
2.3.2     Water maze assessment – Visible platform and 4/8 radial water maze 
 Subjects were initially tested on a visible platform control task (also known as “water 
escape”) prior to the 4/8 radial water maze task, to evaluate any underlying impairments that 
might confound further maze testing (i.e., deficits in motivation, swimming, or visual acuity). 
Subjects were placed in the far end of an oval tub (103 cm x 55.5 cm) filled with room 
temperature water, and given 45 seconds to swim to a visible escape platform (8.5 cm in 
diameter; 1 cm above water surface) located at the opposite end of the tub. Latencies to the 
                                                          
1 Jax guarantees “rigorous genetic quality control and mutant gene genotyping programs” for 
mouse strains with identified molecular mutations (see Terms of Sale). 
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visual platform were recorded for assessment. None of the subjects displayed any impairments, 
and there were no observed differences between genotypes on this task. We therefore proceeded 
to testing on the water version of the 4/8 radial arm maze (adapted from Hyde, Hoplight & 
Denenberg, 1998).  
The 4/8 radial arm water maze assesses spatial reference and working memory abilities 
simultaneously, using a standard 8 arm radial maze with 4 arms containing a submerged goal 
(escape) platform, and 4 open arms that never contain a platform (Fig. 2.1). Configuration of 
goal arms were counterbalanced between subjects, but remained fixed for each subject across all 
test sessions. Additionally, high contrast extra maze cues were present in the room, and the 
locations of these remained static for the entire experiment. 
 The day prior to testing (Day 1), subjects were given a training session where all arms 
that would never contain a platform were blocked, forcing the animals to only enter arms 
containing a platform. Subjects were placed in the middle of the maze and were given 120 
seconds to locate a platform. Every subject completed 4 training trials. Each time they found a 
platform, the recently located platform was removed, and the entrance to that arm was blocked. 
This ensured that the subject could no longer enter this arm for the remainder of the training 
session. If the subject failed to find a platform in this time-period, they were guided to the 
nearest available goal. Once on the platform, subjects remained for 20 seconds and then were 
removed to their home cage (30 second inter-trial interval; ITI). 
 Testing began on Day 2 and continued for 14 consecutive days. The testing session 
followed training procedures, except instead of blocking the goal arm of the most recently 
located platform, the platform was simply removed during the 30 second ITI. This arm remained 
open for the remainder of the test session, but contained no escape. Test sessions were recorded 
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using a Sony camera, integrated with the SMART video-tracking program (Panlab, Barcelona, 
Spain). An arm entry was counted for a subject when all four paws entered an arm. Three types 
of errors were quantified for analysis: 1) Working memory errors (the number of initial and 
repeat entries into arms from which a platform had been removed during a testing session on a 
given day); 2) Initial reference memory errors (the total number of first entries into arms that 
never contained a goal platform) and; 3) Repeat reference memory incorrect errors (the total 
number of repeat entries (following the initial entry) into arms that never contained escape 
platforms). Total errors per test session in each category were tabulated, averaged within 
Genotype, and used for analysis across days of testing.  
 Finally, in order to determine whether subjects utilized a spatial or chaining (swimming 
to successive adjacent arms) strategy to solve the water maze, angles of arm choices were 
derived and analyzed. Specifically, video tracking data obtained from the SMART system was 
reviewed, and turn angle entry was calculated to determine the average turn angle utilized across 
sessions. Lower turn-angle averages (closer to 45°) suggest that subjects preferred adjacent arm 
choices to solve the maze. Alternatively, higher averages (around 90° and greater) suggest a 
preference for more spatial strategies to solve the maze. 
2.3.3     Statistical Analysis 
 A univariate ANOVA was conducted to compare latencies as a function of Genotype. 
Average total, working memory, total reference memory, initial reference memory, and repeated 
reference memory errors, and average turn angle, were independently assessed using a 2 x 14 
repeated measures ANOVA. Genotype (2 levels: WT and Cntnap2 KO) as the between measure, 
and Days (14 levels) served as the within measure. A one-way ANOVA was also conducted to 
assess significance between genotypes of each day of testing for all error types. Some analyses 
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also were performed as a function of test periods, as defined by Acquisition (days 1-7) and 
Retention (days 8-14) portions of the learning curve.  
2.4       Results 
2.4.1    Water maze assessment 
2.4.1.1             Water Escape 
 A univariate ANOVA found no main effect of Genotype [F(1,19)=.915, N.S.]. Thus no 
subjects showed any impairment that might confound a swim-task, and all 10 Cntnap2 KO and 
11 WT mice advanced to the testing sessions (Fig. 2.2). 
2.4.1.2             Total errors 
 The 4/8 radial arm water maze was used to simultaneously measure spatial working and 
reference memory performance. Analysis of the average number of total errors (working 
memory, initial reference, and repeated reference memory errors) revealed a significant 
difference between WT and Cntnap2 KO groups [F(1,19)=4.791, p<0.05] via repeated measures 
ANOVA, with Cntnap2 KOs making significantly more errors than WTs. A main effect of Day 
[F(13,247)=4.036, p<.001] was also observed, confirming that both groups reduced errors across 
days (i.e., showed learning). Within test session an analysis of total errors across days revealed a 
Day × Genotype interaction [F(13,247)=1.886, p<0.05], with Cntnap2 KOs making significantly 
more errors during the Acquisition period of testing (days 1-7 of testing) [F(1,19)=5.332, p<.05], 
but performing comparably to WTs during the Retention period (days 8 – 14 of testing) 
[F(1,19)=1.846, N.S.] (Fig. 2.3a). A one-way ANOVA was conducted to look at differences 
between genotypes at each day [Day 1: F(1,19)=.001, p>0.05; Day 2: F(1,19)=1.620, p>0.05;  
Day 3: F(1,19)=4.374, p<0.05; Day 4: F(1,19)=.056, p>0.05;  Day 5: F(1,19)=5.498, p<0.05;  
Day 6: F(1,19)=9.537, p<0.05;  Day 7: F(1,19)=1.372, p>0.05;  Day 8: F(1,19)=7.374, p<0.05;  
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Day 9: F(1,19)=.003, p>0.05;  Day 10: F(1,19)=.177, p>0.05;  Day 11: F(1,19)=.118 , p>0.05;  
Day 12: F(1,19)=1.276, p>0.05;  Day 13: F(1,19)=.074, p>0.05; Day 14: F(1,19)=.588, p>0.05]. 
2.4.1.3             Reference Memory Errors 
We examined the group differences for four different performance error types including 
working memory, initial reference memory, repeated reference memory, and total repeated 
reference memories (METHODS, Fig. 2.1). A repeated measures ANOVA on total reference 
memory errors (across Days) revealed that Cntnap2 KOs did in fact make significantly more 
errors than WT subjects [F(1,19)=4.514, p<0.05]. As seen with total errors, there was also a Day 
x Genotype interaction [F(1,19)=4.514, p<.05], wherein the Cntnap2 KOs made significantly 
more errors during the Acquisition period [F(1,19) = 3.305, p<0.05], but performed comparably 
to the WTs during the Retention period [F(1,19)=2.902, p>0.05] (Fig. 2.3b). A one-way 
ANOVA was conducted to look at differences between genotypes at each day [Day 1: 
F(1,19)=.139 , p>0.05; Day 2: F(1,19)=1.878, p>0.05;  Day 3: F(1,19)=1.451 , p>0.05; Day 4: 
F(1,19)=.160 , p>0.05;  Day 5: F(1,19)=6.713, p<0.05;  Day 6: F(1,19)=7.680, p<0.05;  Day 7: 
F(1,19)=1.421, p>0.05;  Day 8: F(1,19)=8.352, p<0.05;  Day 9: F(1,19)=.003, p >0.05;  Day 10: 
F(1,19)=.003, p>0.05;  Day 11: F(1,19)=.318, p>0.05;  Day 12: F(1,19)=4.494, p<0.05;  Day 13: 
F(1,19)=.048, p>0.05; Day 14: F(1,19)=.880, p>0.05]. 
Further analysis of reference memory error type also revealed that Cntnap2 KOs made 
significantly more initial reference memory errors [F(1,19)=5.522, p<.05] (Fig. 2.3c). A one-way 
ANOVA revealed the following statistics at each day [Day 1: F(1,19)=.158 , p>0.05; Day 2: 
F(1,19)=5.600, p<0.05;  Day 3: F(1,19)=1.947, p >0.05; Day 4: F(1,19)=.033, p>0.05;  Day 5: 
F(1,19)=8.913, p<0.05;  Day 6: F(1,19)=7.902, p<0.05;  Day 7: F(1,19)=2.533, p>0.05;  Day 8: 
F(1,19) = 18.736, p<0.05;  Day 9: F(1,19)=.195, p>0.05;  Day 10: F(1,19)=.032, p >0.05;  Day 
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11: F(1,19)=.068, p >0.05;  Day 12: F(1,19)=2.987, p>0.05;  Day 13: F(1,19)=.051, p>0.05; Day 
14: F(1,19)=.766, p>0.05].  
Cntnap2 KOs also made more repeated reference memory errors across the 14 days of 
testing, but there was no significant main effect of Genotype [F(1,19) = 3.040, N.S] (Fig. 2.3d).  
A one-way ANOVA was conducted to look at differences between genotypes at each day [Day 
1: F(1,19)=.102, p>0.05; Day 2: F(1,19)=.793, p>0.05;  Day 3: F(1,19)=.820, p>0.05; Day 4: 
F(1,19)=.287, p>0.05;  Day 5: F(1,19)=4.131, p<0.10 ;  Day 6: F(1,19)=4.935, p<0.05;  Day 7: 
F(1,19)=.635, p>0.05;  Day 8: F(1,19)=2.327, p>0.05;  Day 9: F(1,19)=.248, p>0.05;  Day 10: 
F(1,19)=.002, p>0.05;  Day 11: F(1,19)=.554, p>0.05;  Day 12: F(1,19)=3.822, p<0.10;  Day 13: 
F(1,19)=.022, p>0.05; Day 14: F(1,19)=.529, p>0.05]. 
2.4.1.4             Working memory errors 
 A repeated measures ANOVA on working memory errors revealed that Cntnap2 KOs 
made significantly more working memory errors, specifically during the Acquisition period 
[F(1,19)=4.560, p<.05]. However, they performed comparably to WTs during the Retention 
period of the task [F(1,19)=.257, p>0.05] (Fig. 2.3e). Another one-way ANOVA was conducted 
to look at differences between genotypes at each day [Day 1: F(1,19)=.249, p>0.05; Day 2: 
F(1,19)=.573, p>0.05;  Day 3: F(1,19)=2.556, p>0.05; Day 4: F(1,19)=.782, p>0.05;  Day 5: 
F(1,19)=3.243, p<0.10;  Day 6: F(1,19)=5.202, p<0.05;  Day 7: F(1,19)=1.003, p>0.05;  Day 8: 
F(1,19)=3.403, p<0.10;  Day 9: F(1,19)=.019, p>0.05;  Day 10: F(1,19)=.417, p>0.05;  Day 11: 
F(1,19)=.860, p>0.05;  Day 12: F(1,19)=.001, p>0.05;  Day 13: F(1,19)=.310, p>0.05; Day 14: 
F(1,19)=.139, p>0.05]. 




 Total latency across the 4 trials was computed, and a repeated measures ANOVA was 
performed to analyze Genotype and Day differences (as above).  This revealed no significant 
difference of total latency to the platform during testing sessions, when comparing Cntnap2 KOs 
and WTs [F(1,19) = 2.842, p>0.05]. There was, however, a main effect of Day, indicating both 
groups were completing the task more quickly as testing progressed (Fig. 2.4a).  
2.4.1.6             Average turn angle 
 Average turn angle per testing session was recorded and analyzed to assess possible 
differences in strategies used to complete the task. A repeated measures ANOVA revealed no 
main effect of Genotype [F(1,19)=.343, p>0.05], but did reveal a significant Day effect 
[F(13,246)=2.856, p<.05]. Overall, subjects used shorter turn angles during the beginning of 
testing, but as testing continued, subjects used wider turn angles (indicating more selective arm 
choices; Fig. 2.4b).   
2.5     Discussion 
Cntnap2 KO and wild-type mice were tested on a 4/8 radial arm water maze for 14 
consecutive days. Results showed that Cntnap2 KO mice exhibited significant deficits in spatial 
working and reference memory as indicated by higher numbers of errors, specifically during the 
acquisition period of the task. However, during the retention period (i.e., after an asymptote in 
errors), Cntnap2 KO mice performed comparably to wild-type mice. These findings indicate that 
the mutant animals are able to learn, but exhibit delayed learning -- resulting in a different 
learning curve. It is important to note the differences between Cntnap2 KOs and WTs are 
particularly robust on days 5 through 8. This likely reflects the floor effect that occurs the first 
few days of testing, when none of the animals perform substantially better than chance. During 
day 5-8, however (when WTs begin to learn and improve on the task), Cntnap2 KOs do not 
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appear to learn as quickly as WTs, and continue to exhibit relatively high number of errors 
during this time period. Importantly, KOs do display some improvement, but not as robust as 
WTs. This would suggest that once the Cntnap2 KOs begin to learn the platform location they 
are perseverating on these locations within a testing session. As Cntnap2 KOs are learning the 
platform locations, they struggling learning which arms were already visited during the testing 
session. Furthermore, Cntnap2 KO mice and WT mice displayed similar turn angles throughout 
testing, suggesting they used similar strategies to complete the maze. That is, as testing 
proceeded, wider turn angles were noted, indicating subjects used more of a spatial strategy and 
less chaining to find a platform. These findings were likely due to the difficulty of the task used 
in this study, based on prior findings that failed to show a Cntnap2 deficit when compared to 
WTs on a simple MWM learning task (Peñagarikano et al., 2011). 
Current findings are consistent with deficits in executive learning as demonstrated in 
ASD (Ozonoff, Pennington & Rogers, 1991; Rosenberg et al., 2009; Hill, 2004). Moreover, our 
findings may further explain the dyad of core symptoms, given the central role of executive 
processing in both higher and lower levels of processing. That is, the global connectivity 
deficiency seen in ASD could contribute to the spatial working memory and learning 
impairments observed here. This pattern has also been seen in neuroimaging studies with high 
functioning ASD participants (Di Martino et al., 2014). This disconnection may result in 
problems with sensory integration, and therefore thereby learning. This could explain why 
Cntnap2 KOs require more experience to effectively learn the maze, as compared to their WT 
controls. 
The impairments observed in the current study also may be explained by the abnormal 
myelin formation seen in this transgenic mouse model, consistent with the hypo-connectivity 
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theory of the neurobiology of ASD, as well as the spatial learning deficits seen in ASD. Future 
studies are planned to look into neuroanatomical differences in white matter tracks spanning 
cortical regions, and correlate these measures to the cognitive differences seen here (using 
anatomy from these same subjects). Overall, these behavioral findings suggest that CNTNAP2 
plays a clear underlying role in the development of neural systems important to learning and 
cross-modal integration, and disruption of this function could be associated with delayed 
learning observed in individuals with ASD. Future studies should investigate heterozygous mice 
performance as well, since this would be relevant due to the presence of heterozygous mutations 
in the clinical population. 
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Figure 2.1. A schematic of the 4/8 radial arm maze and the categorization of memory 
















Figure 2.2. Water escape performance in Cntnap2 KO mice. Mean latency to platform in the 
water escape task (+SEM). There were no significant differences between Genotypes on latency 













Figure 2.3 4/8 radial arm maze performance in Cntnap2 KO mice. (A) Total number of 
errors in the 4/8 arm radial water maze task over 14 days of testing (+SEM). Analysis of the 
average number of total errors (working memory, initial reference, and repeated reference 
memory errors) revealed a significant difference between WT and Cntnap2 KO groups, with 
Cntnap2 KOs making more errors. (B) Total number of reference memory errors (+SEM) in the 
4/8 arm radial water maze task over 14 days of testing. Analyses revealed that Cntnap2 KOs did 
make significantly more errors than WT subjects. (C) Total number of initial reference memory 
errors (+SEM) in the 4/8 arm radial water maze task over 14 days of testing. Cntnap2 KOs made 
significantly more initial reference memory errors. (D) Total number of repeated reference 
memory errors (+SEM) in the 4/8 arm radial water maze task over 14 days of testing. Cntnap2 
KOs made more repeated reference memory errors across the 14 days of testing but overall 
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performance was comparable between KOs and WTs. (E) Total number of working memory 
errors (+SEM) in the 4/8 arm radial water maze task over 14 days of testing. Cntnap2 KOs made 
































Figure 2.4. Latency and turn angles on 4/8 radial arm maze in Cntnap2 KO mice. (A) Total 
latency (+SEM) over testing sessions in the 4/8 arm radial water maze task over 14 days of 
testing. There was no significant difference of total latency to the platform during testing 
sessions, when comparing Cntnap2 KOs and WTs. (B) Average turn angle (+SEM) over testing 
sessions in the 4/8 arm radial water maze task over 14 days of testing. There were no significant 
differences between Genotypes. (C) Examples of swimming tracks from a WT and Cntnap2 KO 












Chapter 2 Addendum 
 
As our initial aim, we sought to behaviorally characterize Cntnap2 KO mice on various tasks 
with a primary focus on learning and memory. Here, we present additional data that was not 
included in the manuscript. Cntnap2 KO mice were also evaluated on rotarod, novel object 
recognition, social dominance tube task as well as vocalizations during male-female interactions.  
A repeated measures ANOVA did not reveal a main effect of Genotype on rotarod [F(1,19) = 
2.141, p>.05], indicating that there was no overall difference in performance on the rotarod (and 
hence sensorimotor function) between the wild-type and mutant groups. Analysis of novel object 
recognition was conducted using a univariate ANOVA. This revealed no main effect of 
Genotype [F(1,19) = .269, p> .05] with exploratory preference and object recognition being 
comparable between Cntnap2 KOs and WTs. Social dominance (tube task) was conducted to 
evaluate social dominance. Number of wins was calculated as a percentage of the 4 trials. A 
univariate ANOVA revealed there was a main effect of Genotype [F(1,19) = 48.245, p<.01]. 
Cntnap2 KO mice had significantly more losses on this task compared to their wild-type 
controls, suggesting they are more passive. A univariate ANOVA was conducted to evaluate 
time spent vocalizing for each minute spent interacting with a female mouse and revealed no 
main effect of Genotype [F(1,14) = .409, p>.05]. We did not observe any differences on 
sensorimotor motor coordination as well as novel object recognition or vocalizations. We did, 
however, observe differences in a social dominance task where Cntnap2 KO mice expressed 
more passive behavior. This more extensive behavioral characterization increases the scope of 








Figure 2.1.Supplemental – Additional behavioral tasks evaluating Cntnap2 KO mice. (A) 
Rotarod performance across 5 days. (B) Percent wins on social dominance tube task across 4 
trials. (C) Novel object recognition after a 5-minute delay. (D) Total time spent vocalizing 
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3.1       Abstract 
Dyslexia is a learning disability characterized by difficulty learning to read and write. The 
underlying biological and genetic etiology remains poorly understood. One candidate gene, 
dyslexia susceptibility 1 candidate 1 (DYX1C1), has been shown to be associated with deficits in 
short-term memory in dyslexic populations. The purpose of the current study was to examine the 
behavioral phenotype of a mouse model with a homozygous conditional (forebrain) knockout of 
the rodent homolog Dyx1c1. Twelve Dyx1c1 conditional homozygous knockouts, 7 Dyx1c1 
conditional heterozygous knockouts and 6 wild-type controls were behaviorally assessed. Mice 
with the homozygous Dyx1c1 knockout showed deficits on memory and learning, but not on 
auditory or motor tasks. These findings affirm existing evidence that DYX1C1 may play an 
underlying role in the development of neural systems important to learning and memory, and 












3.2       Introduction 
Developmental dyslexia is a heritable learning disability defined by difficulties in learning to 
read and write that cannot be explained by factors such as intellectual impairment, lack of 
educational opportunity or other co-morbid neurological disorders (e.g., epilepsy, or primary 
sensory impairments (blindness, deafness)). Dyslexia can be deconstructed into underlying core 
components, known as “intermediate phenotypes”. These include deficits in phonological 
processing (Kovelman et al., 2012; Melby-Larvag, Lyster & Hulme, 2012; Peyrin et al., 2012), 
short-term and/or working memory (Beneventi et al., 2010; Gathercole et al., 2006; Menghini et 
al., 2010), visuospatial attention (Franceschini, 2012; Gabrieli & Norton, 2012), and rapid 
auditory processing (Cohen-Mimran & Sapir, 2007; Fitch & Szalkowski, 2012; Hamalainen, 
Salminen & Leppanen, 2013). Other behavioral deficits that have been specifically associated 
with dyslexia include naming speed, motor functioning and visual processing of motion 
(Denckla & Rudel, 1976; Liao et al., 2015; Capellini, Coppede & Valle, 2010; Olulade, 
Napeliello & Eden, 2013). Dyslexia is also encompassed by the term "specific developmental 
reading disability," although reading disability is generally regarded as a more inclusive term, 
capturing comprehension deficits that would not usually be classified as dyslexia (Snowling & 
Hulme, 2012). The symptomology for both dyslexia and reading disability is heterogeneous, and 
the biological mechanisms underlying associated intermediate phenotypes remain poorly 
understood. 
What we do know of the biological and genetic etiology of dyslexia/reading disability 
indicates strong but complex genetic and environmental influences, with heritability estimates 
ranging from 40% to as high as 80% (Schumacher, Hoffmann, Schmal, Schulte-Korne, & 
Nothen, 2007). Not surprisingly, multiple genes have been implicated as contributing to this 
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disorder, much as seen for other complex disorders such as autism and schizophrenia (Gelernter, 
2015). Although the neurobiological mechanisms underlying dyslexia/reading disability are not 
yet fully understood, most of the risk genes identified to date appear to be involved in 
surprisingly similar biological mechanisms (i.e., neuronal migration and cilia function; Kere, 
2014). These identified genetic and neurobiological mechanisms in turn contribute to 
establishing the complex neurocircuitry that may subserve abilities such as phonological and 
visual processing, as well as learning. Disruptions in this neurocircuitry could result in 
impairments that are associated disorders of language and reading functions. 
The first candidate risk gene to be reported was dyslexia susceptibility 1 candidate 1 
(DYX1C1), a gene identified in two Finnish families with a history of dyslexia (Nopola-Hemmi 
et al., 2000). DYX1C1 was further supported as a candidate risk gene in 2003 (Taipale et 
al.,2003), although there have been inconsistent findings in clinical populations (Cope et al., 
2005; Marino et al., 2005; and Meng et al., 2005). Importantly, some reports have shown that 
DYX1C1 variants are specifically associated with core component features of dyslexia, including 
deficits in verbal short-term memory (Marino et al. 2007), short-term memory (Dahdouh, 2009), 
and orthographic choice tasks and non-word reading (Bates, 2009). These previous studies have 
provided evidence of DYX1C1 variants being explicitly linked to memory deficits in some 
language-impaired populations. 
With regard to the biological role of DYX1C1, this gene has been shown to be active in 
neuronal migration in the developing cortex, as well as more generalized cilia function (Wang et 
al., 2006; Tarkar et al., 2013). These appear to be recurrent biological “themes” in the etiology 
of dyslexia. For example, animal models using in utero RNA interference (RNAi) against the rat 
homolog Dyx1c1 showed disruptions of neuronal migration in the developing neocortex, thus 
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supporting a role for DYX1C1 in neuronal migration (Wang et al., 2006). Migration anomalies 
in the neocortex have also been associated with dyslexia in clinical populations, as evidenced by 
cortical malformations indicative of early migration disturbances (Galaburda et al., 1985, Chang 
et al., 2005). Rodent models for these types of developmental cortical malformations have been 
used to evaluate rapid auditory processing and working memory, since these are considered 
intermediate phenotypes of developmental dyslexia, and yet are accessible to rodent evaluations. 
Researchers found deficits in both rats with induced cortical malformations, and also rats with 
knockdown of Dyx1c1, in complex acoustic processing (Threlkeld et al. 2007; Threlkeld et al., 
2009). Working memory abilities were also assessed in the Dyx1c1 RNAi model, and significant 
impairments were noted for this core phenotype as well (Szalkowski et al., 2011). More 
recently, a mouse knockout model of Dyx1c1 was generated that demonstrated cilia defects, as 
well as severe embryonic lethality of approximately two-thirds of homozygous mutants. 
Homozygous constitutive mutants that survived after birth developed severe hydrocephalus by 
postnatal day P16, and died by P21 (Tarkar et al., 2013). This mouse model obviously could not 
be used for extensive behavioral profiling, and a conditional forebrain Dyx1c1 knockout model 
was developed. 
The current study was designed to further examine the behavioral features of this 
conditional preparation, using male mice with both homozygous and heterozygous conditional 
(forebrain) knockout of rodent homolog Dyx1c1. A forebrain conditional knockout model was 
chosen in part based on evidence of malformations in neocortex as well as hippocampus in the 
RNAi Dyx1c1 model (Rosen et al., 2007). These abnormalities in the neocortical and 
hippocampal regions resulted from disruption of neuronal migration, and have been observed in 
individuals with dyslexia (Galaburda et al., 1985). We hypothesized these differences in 
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underlying neuroanatomy may contribute to deficits in learning and memory reported in 
individuals with dyslexia. A forebrain conditional was also selected to avoid the lethal 
hydrocephaly observed in the systemic KO. Adult male littermates (generated through het x het 
breedings) were assessed on various behavioral paradigms that have been validated in our lab as 
effectively tapping core functions implicated in language and reading impairments. These tasks 
include auditory processing, and working and reference memory. Based on previous research and 
clinical evidence, we hypothesized that animals with homozygous conditional knockout of 
Dyx1c1 would show specific acoustic processing and/or memory impairments, while 
performance on other behavioral assessments (e.g., gross motor learning, pre-pulse inhibition, 
water escape) would not differ from matched wild-types. 
3.3      Methods and Materials 
3.3.1    Subjects 
Mice carrying the loxP– exon 2–4–loxP conditional allele of Dyx1c1 (Dyx1c1flox) were generated 
by the University of Connecticut Health Center Gene Targeting and Transgenic Facility, as 
described previously (Tarkar et al., 2013). Briefly, embryonic stem cells harboring a loxP-
flanked allele of exons 2–4 of Dyx1c1 were produced by electroporating mouse embryonic stem 
(ES) cells (129S6) with a targeting construct designed to replace exons 2–4 and flanking intronic 
sequence through homologous recombination. After PCR screening of the ES cell clones for 
correctly targeted colonies, a single positive colony was expanded, and chimeric mice were 
generated by embryo reaggregation. The animals were crossed with C57BL/6J mice and 
transmitted the targeted allele to the offspring through germ line. These mice were subsequently 
crossed with 129S4/SvJaeSor-Gt(ROSA)26Sortm1(FLP1)Dym/J mice (The Jackson Laboratory) to 
remove the PGK-Neo cassette in the targeting construct and the offspring thus produced were 
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used to generate Dyx1c1flox/flox mice colony. These mice were genotyped by PCR using three 
pairs of primers (PL452F-5’-CGAAGTTATTAGGTCCCTCG-3’ and loxgtR 5’-
TGAGCACCCTGCTTCTACCT-3’; loxwtF 5’- AAAACCAACCATCCAACCAA-3’ and 
loxgtR 5’-TGAGCACCCTGCTTCTACCT-3’; FrtgtF 5’-TAGGGATTCACCGTCACACA-3’ 
and FrtgtR 5’-AACCAAGTCCAAGGCCTTCT-3’).  
To generate the conditional forebrain knockout (Dyx1c1flox/flox/Emx-Cre+/+), -- mice with 
a deletion of exons 2-4 only in the forebrain -- we crossed Dyx1c1flox/flox mice with Emx1-IRES-
Cre knockin mice, B6.129-Emx1tm1(cre)Krj/J (The Jackson Laboratory). ). Emx1-IRES-Cre strain 
expresses Cre recombinase enzyme from the endogenous Emx1 locus, and when crossed with 
loxP-site containing Dyx1c1 sequence, leads to recombination in approximately 88% of 
neocortical neurons as well as hippocampus. The heterozygous offspring (Dyx1c1flox/wt/Emx-
Cre+/-) generated from this cross were then inbred to create the experimental forebrain 
conditional knockout (Dyx1c1flox/flox/Emx-Cre+/+) mice and the control (Dyx1c1flox/wt/Emx-Cre+/-, 
Dyx1c1flox/wt/Emx-Cre+/+, Dyx1c1wt/wt/Emx-Cre+/+ and Dyx1c1wt/wt/Emx-Cre+/-) mice. The 
knockout (KO) group was comprised of 12 animals with the genotype Dyx1c1flox/flox/Emx-Cre,+/+ 
while the heterozygous (HT) group was comprised of 6 subjects with either Dyx1c1flox/wt/Emx-
Cre+/- or Dyx1c1flox/wt/Emx-Cre+/+genotypes.  Lastly, the wild type (WT) group consisted of 7 
subjects with Dyx1c1wt/wt/Emx-Cre+/+or Dyx1c1wt/wt/Emx-Cre+/- genotypes.  Genotyping was 
performed by PCR for Dyx1c1flox/flox using the primers described above. The mice were 
genotyped for EMX-Cre using two pairs of primers (oIMR1084 5’- GCG GTC TGG CAG TAA 
AAA CTA TC-3’and oIMR085 5’- GTG AAA CAG CAT TGC TGT CAC TT-3’; oIMR4170 
5’- AAG GTG TGG TTC CAG AAT CG-3’ and oIMR4171 5’- CTC TCC ACC AGA AGG 
CTG AG-3’).  
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All subjects were single-housed in standard mouse tubs (12 h/12 h light/dark cycle), with 
food and water ad libitum, and all behavioral testing occurred during the light cycle. At the start 
of testing, animals were between the ages of postnatal day (P) 61 - P75. Procedures were 
performed blind to Genotype (ascertained at weaning by tail-snip PCR), and in compliance with 
the National Institutes of Health and University of Connecticut’s Institutional Animal Care and 
Use Committee (IACUC).      
3.3.2    Anatomy 
Finally, it is important to note that in contrast to the systemic KO preparation that exhibited 
lethal hydrocephaly (Tarkar et al., 2013), the forebrain conditional preparation has been shown 
not to exhibit any gross neurologic abnormalities in the cortex or hippocampus (homozygous or 
heterozygous), nor to exhibit any gross behavioral anomalies. To confirm these and other prior 
characterizations of the conditional model, a western blot was performed to examine the Dyx1c1 
protein expression in the forebrain KO and the control conditions. Additionally, we included the 
constitutive KO and WT protein lysates as a control for the experiment. We further investigated 
the lamination of the cortex obtained from the forebrain knockout using the neocortical layer 
marker Ctip2 and Cux1. We measured the depth of each layer of the cortex marked by Ctip2 and 
Cux1, and we further normalized the measurement with the total cortical depth to compare the 
thickness of the Ctip2 and Cux1 positive neuron-containing cortex. 
3.3.3    Rotarod (P124 to P129) 
All subjects were assessed at age P124 for sensorimotor ability and motor learning using the 
rotarod task. Subjects were placed on a rotating cylindrical drum that gradually accelerated from 
4 to 40 rotations per minute across a span of 2 minutes. Four trials were administered per test 
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day, across four consecutive days. For analysis, latency to fall from the rotating drum was 
measured and averaged across the four trials for each day.    
3.3.4    Auditory Processing (P68 to P98) 
All subjects were assessed for auditory processing ability using a modified pre-pulse inhibition 
paradigm (see Fitch et al., 2008 for review). Subjects were placed on individual load-cell 
platforms (Med Associates, St. Albans, VT) and presented with auditory stimuli generated using 
RPvdsEx on a Dell Pentium D PC and RZ6 multifunction processor (Tucker Davis 
Technologies, Alachua, FL). Sounds were amplified using a Niles SI-1260 Integration Amplifier 
(Niles Audio Corp., Carlsbad, CA) and delivered through powered Yamaha YHT-M100 speakers 
(Buena Park, CA). The acoustic startle reflex (ASR; a reflexive response elicited by an 
unexpected, intense stimulus) was recorded by an iMac 7.1 running Acknowledge 4.1, and 
obtained via the voltage output from each load cell platform through a linear amplifier (PHM-
250U; Med Associates, St. Albans, VT) connected to a Biopac MP150 acquisition system 
(Biopac Systems, Goleta, CA). The modified pre-pulse inhibition paradigm measured differences 
in ASR to a loud startle-eliciting stimulus (SES; 105dB, 50 ms, broadband white noise burst 
(1kHz-10kHz)) when presented with or without a preceding acoustic cue. The ASR difference on 
cued versus uncued trials provided a measure of cue detection and/or discrimination. If the 
auditory cue was detected, a reduction (attenuation) in the ASR was expected relative to the ASR 
elicited when the auditory cue was not present (or not detected). This phenomenon was 
quantified using an “attenuation score” (ATT) that compared the average amplitude of the ASR 
from the cued trial to the average ASR of the uncued trial ([average cued ASR/average uncued 
ASR]*100). 
3.3.4.1            Normal Single Tone P68     
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Prior to more complex auditory testing, all animals were tested on a Normal Single Tone (NST) 
to measure baseline pre-pulse inhibition and auditory ability (P68). This auditory PPI control 
task was used to establish whether subjects exhibited hearing deficits and/or impaired gross 
motor reflexes that could confound other auditory PPI tests, and provided an index of baseline 
auditory pre-pulse inhibition ability across test groups. Testing sessions consisted of 104 
pseudorandomly presented cued and uncued trials at inter-trial intervals (ITI) of varying 
durations (16–24 s). The task comprised of a silent background and a simple single tone cue (50 
ms, 75 dB, 8,000 Hz tone) presented 50 ms prior to the 50 ms, 105 dB. All subjects were able to 
perform this task and therefore were used for further behavioral evaluation. 
3.3.4.2            Embedded Tone (P71 to P83) 
First, the variable duration Embedded Tone (EBT) task was administered (with 300 sequential 
pseudorandom trials). This task assessed ability to detect a change in tone frequency relative to a 
standard background tone (cue was a variable duration 5.6 kHz pure tone embedded in a 10.5 
kHz background pure tone). On cued trials, the cue was presented 100 ms before the SES, while 
uncued trials used a "cue" of 0 ms. Two EBT tasks were used in this study – a long-duration 
EBT (0 ms to 100 ms), and a short-duration EBT (0 ms to 10 ms). A range of cue durations were 
used to evaluate specific thresholds for performance differences between the various genotypes, 
based on a hypothesis that subjects may perform comparably on longer durations yet may differ 
on shorter durations (which are more difficult to detect). Using a range of cue durations enables 
ascertainment of stimulus features that all animals can discriminate (ceiling), that no animals can 
discriminate (basement), as well as any group differences in the mid-range. Both EBT tasks were 
administered for five consecutive days, starting at P71 until P83.  
3.3.4.3            Silent Gap (P86 to P98) 
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Next, a Silent Gap (SG) task was used to assess the ability to detect silent breaks in continuous 
white noise (P86 to P98). A session included 300 trials with a continuous 75 dB broadband white 
noise background. Cued and uncued trials occurred pseudorandomly. On cued trials, a silent gap 
of variable duration (0-100 ms) was presented 100 ms before the SES, with "0 ms" trials serving 
as the uncued condition. Subjects were tested on the Silent Gap task for five consecutive days, 
for each version of the task. 
3.3.5    Water Maze Assessment 
3.3.5.1           Water Escape (P132) 
Subjects were initially tested on a water escape task prior to the 4/8 arm radial water maze task, 
to evaluate the presence of any underlying impairments that might confound further maze testing 
(i.e., deficits in motivation, swimming, or visual acuity). Subjects were placed in the far end of 
an oval tub (103 cm x 55.5 cm) filled with room temperature water, and were given 45 seconds 
to swim to a visible escape platform (8.5 cm in diameter; 1 cm above water surface) located at 
the opposite end of the tub. Latencies to reach the visible platform were recorded for assessment. 
None of the subjects displayed any impairments on this task (the subject code was used to 
analyze this data by an investigator who was not conducting testing). Therefore, we proceeded to 
implement a water version of the 4/8 radial arm maze (adapted from Hyde, Hoplight & 
Denenberg, 1998).  
3.3.5.2             4/8-arm radial water maze (P133 to P148) 
This task was used to assess spatial reference and working memory ability simultaneously, using 
a standard 8 arm radial maze with 4 arms baited (i.e., containing a submerged goal platform), and 
4 arms open but never baited with a platform. Configuration of goal arms were counterbalanced 
between subjects but remained fixed per subject across all test sessions. Additionally, high 
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contrast extra-maze cues were present, and the locations of these remained static for the entire 
experiment. 
 The day prior to testing (Day 1), subjects were given a training session where all arms 
that would not contain a platform were blocked, forcing the animals to only enter arms 
containing a platform. Subjects were placed in the start arm and given 120 seconds to locate a 
platform. Every subject completed 4 training trials, and each time they found a platform, that 
platform was removed and the entrance to that arm was blocked. This ensured that the subject 
could no longer enter this arm for the remainder of the training session. If the subject failed to 
find a platform in this window, they were guided to the nearest available goal. Once on the 
platform, subjects remained for 20 seconds and then were removed from the maze to their home 
cage (30 second inter-trial interval; ITI). 
 Testing began on Day 2 and continued for an additional 14 consecutive days. Here, 
instead of blocking the goal arm of the most recently located platform, the platform was simply 
removed during the 30 second ITI, but the arm remained open and unbaited for the remainder of 
the test session. Animals were required to locate all 4 platforms, and thus received 4 test trials 
per day. Test sessions were recorded using a Sony camera integrated with the SMART video-
tracking program (Panlab, Barcelona, Spain). Latency and path distance were recorded and in 
addition, subjects were given a point for each completed trial (i.e., successful location of a 
platform in 120 sec), with a maximum of 4 points per test session. All scores were recorded and 
used for further analysis.  
3.3.6   Novel Object Recognition (P162) 
One day prior to testing, all subjects were habituated to the testing chamber (40 cm × 24 cm × 20 
cm plexiglas tub with opaque walls) for 10 minutes. On testing day, each subject underwent a 
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habituation phase of 5 minutes to reduce stress and the chance of a neophobic response, and to 
promote exploratory activity in the test phase. The subject was given a 1-minute resting period in 
their home cage, and was then exposed to two identical Lego configurations for 5 minutes. This 
constituted the “familiarization” session. Afterwards, the subjects were given a short delay 
period of 5 minutes (resting in their home cage). Then, they were introduced to the testing 
chamber containing a new object and one familiar object (different Lego configurations) for 3 
minutes (“test” session). Anytime a mouse sniffed the object or touched the object while looking 
at it (i.e., when the distance between the nose and the object was less than 2 cm) this behavior 
was scored as exploratory. Total time spent exploring, and percent time spent with the familiar 
vs. novel object, were evaluated and analyzed.  
3.3.7    Modified T-Maze (P225 to P268) 
Subjects were gradually food restricted to 80%-85% of their baseline body weight (3 weeks). 
During the last week before training, subjects were given a sample of the food reward in their 
home cage, to habituate them to its taste and eliminate hyponeophagia. Animals were then 
introduced to the modified T-maze (30 cm x 10 cm start arm; 30 cm x 10 cm goal arm). This 
configuration included curved arms, to eliminate visual or olfactory cues of the food reward at 
the end of the arm. The left and right arms were high contrast colors - - the left arm was black, 
and the right arm was white. Prior to rewarded alternation testing, animals were placed in the 
start arm with both arms opened and containing food wells (with food reward) for about 3 min. 
Any time an animal consumed the reward, a food well was replenished. This was performed four 
times, with intervals between exposures of at least 10 min. 
During the training period, a subject was placed in the start arm with one of the goal arms 
blocked while the other arm remained opened, forcing the subject to enter the open arm. Multiple 
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trials were administered in a daily session, with equal numbers of left and right arms serving as 
the open arm. When the animal completed a forced trial by entering the open arm and consuming 
the reward, the blocked arm’s door was removed, and the animal was placed back into the start 
arm. This process trained the animal to learn that once when it entered an arm and consumed the 
reward, there would no longer be a reward at that location, so they must visit a new arm for 
reward. Now the animal was placed again in the start arm facing away from the two goal arms, 
and was permitted to make a choice between the two opened arms.  If the animal chose correctly, 
they were allowed time to consume the reward. If the subject chose incorrectly, they were 
removed (after the experimenter ensured the subject adequately explored the empty well). 
Once the animals were habituated and trained, ten trials were given in a daily session. 
Each one of a squad of approximately 8 mice received a trial in succession before the first animal 
started its next trial. The identity of the sample goal arm for each trial was determined by random 
sequence. The maximum number of consecutive identical arms was three, as a precaution against 
development of temporary position habits or reinforced perservation. A percentage reflecting 
correct trials completed per animal was calculated and evaluated (Deacons & Rawlins, 2006).  
3.3.8    Statistical analysis 
All behavioral data was analyzed using a mixed factorial design. All subjects were used for 
analysis (WT, n = 7; HT, n = 6; KO, n = 12). Group differences in rotarod performance were 
analyzed using a repeated measures ANOVA with Genotype (3 levels: WT, HT and KO) as the 
between measure, and Day (4 levels) as the within measure. A one-way between subjects 
ANOVA was conducted to compare the effect of Genotype on average Attenuation Scores on all 
auditory processing tasks. This included: EBT 0-100 ms, EBT 0-10 ms, SG 0-300 ms and SG 0-
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100 ms. Total number of completed trials on the 4/8 radial arm maze were independently 
examined using a 3 x 14 repeated measures ANOVA, with Genotype (3 levels: WT, HT and KO) 
as the between measure, and Day (14 levels) as the within measure. Finally, a univariate 
ANOVA was performed to analyze group differences on total time of exploration on the novel 
object recognition task, as well as accuracy (% trials correct) on the modified T-maze task. All 
statistical analyses were conducted using SPSS 19 with an alpha criterion of 0.05, two-tailed.       
3.4      Results 
3.4.1   Anatomy 
Western blot results showed that Dyx1c1 protein expression was reduced by 77% in the forebrain 
KO condition as compared to the control condition (Fig. 3.1). Since we know that Emx1-IRES-
Cre strain expresses Cre recombinase enzyme from the endogenous Emx1 locus that (when 
crossed with loxP-site containing Dyx1c1 sequence) leads to recombination in approximately 
88% of neocortical neurons as well as hippocampus, the slightly higher Dyx1c1 expression 
observed in the forebrain knockout could be attributed to the other cell types in the neocortex and 
hippocampus (e.g. interneurons (20%)), as well as vasculature. We also investigated the motility 
of the cilia lining the lateral ventricles of the forebrain KO and the control using 
videomicroscopy, and found that the KO cilia were immotile -- consistent with the previously 
identified phenotype of ciliary immotility in the Dyx1c1 ubiquitous KO. Finally, we found no 
significant differences in the cortical lamination patterning, as evident from the Cux1 and Ctip2 
staining in the forebrain conditional knockout compared to controls.  We also found no 
observable anomalies in the cortex of the conditional forebrain knockout animals compared to 
controls (Fig. 3.2).  
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3.4.2    Auditory Processing 
All subjects were initially tested on a normal single tone (NST) task, to establish baseline hearing 
and PPI ability. None of the subjects showed impairments on NST, nor was there a main effect 
of Genotype [F(2,22) = 2.196, N.S.]. Therefore subjects were advanced to subsequent levels of 
more complex acoustic tasks. On the embedded tone (EBT) 0-100 ms task, we found no main 
effect of Genotype [F(1,22) = .419, N.S.]. Moreover, all subjects were able to discriminate the 
stimuli, based on cued/uncued amplitude comparisons. Subjects were then tested on a more 
difficult embedded tone task, using cue durations ranging from 0 to 10 ms (where 0 ms is the 
uncued condition). Again, we found no main effect of Genotype [F(1,22) = 3.110, N.S.], and all 
subjects showed significant discrimination of the cues (particularly longer gaps). Next, auditory 
processing ability was evaluated on a silent gap detection task. First, we administered the silent 
gap 0-300 ms task, and again saw no main effect of Genotype [F(1,22) = .532, N.S.]. Subjects 
overall performed well on the task, and therefore we advanced them to the more difficult version 
of the task with silent gap durations ranging from 0 to 100 ms. Overall performance was poor on 
the silent gap 0-100 ms task and there was again no main effect of Genotype [F(1,22) = .591, 
N.S.].  
Finally, for each of the auditory tasks, we found that all 3 groups of animals showed 
significant discrimination of the cue, based on t-test comparisons between mean cued and uncued 
values within groups. The exception was on the hardest task (silent gap 0-100 ms), where all 
animals performed poorly (mean attenuation scores approximately 85%, and as high as 100% for 
the 2 ms cue). Comparing across groups, we found no significant effects of Genotype on any 
task, confirming that subjects performed comparably on all tasks (Fig. 3.4). 
3.4.3    Water Maze Assessment 
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Prior to spatial water maze testing, a visible platform control task was conducted to assess for 
underlying impairments that could confound subsequent water maze performance (e.g., 
impairments in swimming ability, visual acuity, or motivation). A univariate ANOVA on 
latencies found no main effect of Genotype [F(2,22)=.126, N.S.], indicating that genetically 
modified groups had no impairments on underlying aspects of the water task (e.g., swimming) 
(Fig. 3.5). 
 The 4/8 radial-arm water maze was then used to assess spatial working and reference 
memory ability. Animals were scored on errors and latencies, as well as their ability to complete 
this task (i.e., successfully locate a platform). Thus for every trial successfully completed, 
subjects received a point. We did find a main effect of Genotype on the number of trials 
successfully completed [F(2,22)=7.518, p<.01]. We also found a significant Day by Genotype 
interaction [F(26,286)=4.887, p<.001], with KOs continuing to drop in number of trials 
successfully completed as testing progressed (Fig. 3.6). Specifically, KOs performed comparably 
to WTs and HTs during the first few days of testing, with significant differences emerging by 
Day 5 [F(2,22)=4.148, p<.05].  
3.4.4    Novel Object Recognition 
Subjects were tested on a novel object recognition task, to assess both exploration and short-term 
memory abilities. We found a main effect of Genotype on total time of exploration, with KO 
animals exploring substantially less [F(2,22) = 8.613, p<.01]. As a result, KO animals did not 
meet criteria to evaluate novel object recognition ability (Fig. 3.7). 
3.4.5    Modified T-maze 
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Lastly all subjects were evaluated on a modified T-maze involving a rewarded alternation task. 
However, 3 subjects were dropped from the analysis (1 WT, 1 HT and 1 KO) since they did not 
perform the task during the testing period. The percentage of correct responses as a function of 
total trials completed was calculated for each subject, and a univariate ANOVA did reveal 
significant group differences. There was a main effect of Genotype on this measure, [F(2,19) = 
5.453, p<.05] with KOs performing the worst (Fig 3.8). Furthermore, a t-test was performed 
specifically comparing KOs versus WTs performance, which confirmed this significant 
difference between the two groups on accuracy of an win-shift task using a T-maze [t(15) = -
2.229, p< .05].  
3.5     Discussion 
The purpose of this study was to evaluate conditional forebrain knockout mice on motor 
learning, auditory processing, and working and reference memory tasks. Results showed that 
disrupting the function of Dyx1c1 does impair memory performance, but does not negatively 
impact motor learning and auditory processing abilities. These results further validate a role for 
Dyx1c1 in learning and memory capabilities, and support prior animal model work with this 
gene. For example, research on the relative behavioral impact of embryonic transfection of RNAi 
for the dyslexia risk homologs Kiaa0319 versus Dyx1c1 in rats revealed: (1) deficits in the 
discrimination of rapidly changing acoustic stimuli but not working memory when Kiaa0319 
was knocked-down (Szalkowski et al., 2012); but (2) acoustic processing deficits for complex 
stimuli (e.g., FM sweeps) but not rapidly changing stimuli, coupled with robust deficits on a 
working memory task, when Dyx1c1 was knocked-down (Threkeld et al., 2007; Szalkowski et 
al., 2011; Szalkowski et al., 2013). Unfortunately, the current study was not able to dissociate 
potential complex acoustic processing deficits in the conditional Dyx1c1 KO model, because we 
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have found that mice are not capable of performing the same complex FM sweep and tone-pair 
discrimination tasks that can be effectively used in rats. Nonetheless, these cumulative results are 
intriguing in light of human evidence that has associated mutations in the KIAA0319/DCDC2 
region of chromosome 6 with anomalies in mismatch negativity (MMN) for acoustic phonologic 
stimuli (Czamara, 2011), while DYX1C1 has been more closely associated with deficits in 
working memory and visual attention (Wigg et al., 2004; Marino et al. 2007; Dahdough et al., 
2009; Bates et al., 2010; Lim et al., 2011; Mascheretti et al., 2013).  Taken together, these 
findings suggest that different dyslexia risk genes may contribute more or less to different 
underlying intermediate phenotypes of dyslexia. If true, then early screening could provide 
indications for optimal intervention strategies on an individual basis.  
Overall, our results add support to a putative role for DYX1C1 in learning/memory 
components of language, based on the clear inability of conditional KO Dyx1c1 mice to learn a 
radial arm maze. However, we acknowledge that the deficits seen in the current study could be 
interpreted as reflecting motivational or attentional problems. In fact, significant differences 
comparing the KO group to the WT and HT group emerged on day 5 of testing. Specifically, 
within the first few days of testing, all animals were learning the task and making a high number 
of errors. The KO animals continued to make a high number of errors, and then appeared to 
become unmotivated -- possibly due to the level of task difficulty. At this point, they simply 
stopped performing. At the same time, the WT and HT group continued to perform the task and 
make decreasing numbers of errors. Unfortunately, we could not quantify KO animals’ errors 
during this later portion of testing, since they "timed out" and did not successfully complete the 
testing trials. Another interpretation may be that KO subjects performed poorly on this task 
because they did not attend to the paradigm and constraints, and therefore, did not successfully 
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complete as many trials. This hypothesis is in fact consistent with a lack of initial exploration by 
KOs in the acclimation phase of the Novel Object task. In that paradigm, intact mice typically 
explore a novel object, and when presented with that same object and a similar but new one, 
attend more to the new as compared to the familiar object. In the current study, the KO mice did 
not attend to the initial novel object for an adequate duration to proceed with testing. This could 
reflect a lack of attention, which might also impact on the radial arm maze. (It is important to 
again emphasize that the failure to explore in the Novel Object task, and fewer trials successfully 
completed in the radial arm maze, are not likely a reflection of motor impairments in the KOs, 
given that our rotarod and visible platform water escape tasks showed no group differences). 
Importantly, a counter to this argument to the core "failure to perform" as an explanation for 
deficits is the significantly worse % correct scores seen on T-maze learning for KO mice. Here 
all the mice performed the task, yet KOs performed significantly more poorly than comparison 
wild-types.  
Finally, in interpreting these findings, it is important to note that the conditional forebrain 
Dyx1c1 KO model specifically targets gene function in the cortex and hippocampus, but not 
subcortical structures. Specifically, Emx1- Cre recombinase activity is reported in neurons of the 
neocortex and hippocampus, and in the glial cells of the pallium. This conditional KO was 
created to avoid the lethal hydrocephalous observed with a systemic KO. While some very early 
physiology data could be obtained from the systemic KO preparation, subjects did not survive to 
an age that would allow behavioral testing. The forebrain conditional Dyx1c1 preparation, in 
contrast, has no associated lethality. It would be interesting to assess the effects of a KO 
preparation that extended into some of the sub-cortical structures not affected here (for example 
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the cochlear nucleus -- particularly with respect to our acoustic findings). This is an unfortunate 
limitation of the current model that may be overcome with future technologies. 
In closing, the conditional forebrain Dyx1c1 knockout mouse model examined here 
displayed learning and memory deficits, consistent with previous animal research using a 
Dyx1c1 RNAi knockdown model, and with human findings linking DYX1C1 to working memory 
performance. Future research, preferably using a larger sample size, will be needed to assess 
additional variables including effects in female mice, as well as relationships between aberrant 
behaviors and underlying changes in neural function and circuitry. 
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Figure 3.1. Western blot results of Dyx1c1 protein expression. This blot shows the Dyx1c1 
protein expression in the forebrain KO and the control conditions. We have also included the 
constitutive KO and WT protein lysates as a control for the experiment. Dyx1c1 protein 













Figure 3.2. Cortical lamination patterning in Dyx1c1 conditional KO mice. There were no 
significant differences in the cortical lamination patterning as evident from the Cux1 and Ctip2 
staining in the forebrain conditional knockout compared to the control. We found no observable 





Figure 3.3. Sensorimotor ability in Dyx1c1 conditional knockout mice. No differences in 
sensorimotor performance between Genotype were observed on the rotarod task. Both groups 












Figure 3.4. Auditory processing on Dyx1c1 conditional KO mice. Homozygous 
conditional Dyx1c1 knockout mice displayed comparable auditory processing abilities on the 
following tasks (a.) Embedded Tone 0-100 ms, (b.) Embedded Tone 0-10 ms, (c.) Silent Gap 0-








Figure 3.5. Water escape performance of Dyx1c1 conditional KO mice. No significant 








Figure 3.6. 4/8 radial arm maze performance of Dyx1c1 conditional KO mice. General 
learning and memory impairment in mice with homozygous conditional Dyx1c1 knockout mice 
on a 4/8 radial arm water maze. Analysis of total completed trials over 14 days reveal significant 
differences between Genotypes (*p <.05), as well as, significant Genotype x Day interaction 










Figure 3.7. Novel object performance of Dyx1c1 conditional KO mice. Lack of exploration 













Figure 3.8. T-maze performance of Dyx1c1 conditional KO mice. Accuracy on T-maze task. 
Homozygous conditional Dyx1c1 knockout mice exhibited significantly poorer performance on 
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4.1.      Abstract 
Timothy syndrome (TS) is a rare genetic disorder caused by a single de novo missense mutation 
to the 8A exon of CACNA1C gene, which codes for the voltage-gated L-type Ca2+ channel 
(Cav1.2). TS is strongly associated with cardiac arrthytmias, autism spectrum disorders (ASDs), 
and neurological dysfunction such as language impairments, seizures, and intellectual disability. 
A genetically engineered knock-in mouse with a heterogeneous TS2 (G406R) mutation in the L-
type calcium channel containing a neomycin resistance cassette was developed to study ASD-
like behaviors. This mouse model (TS2-neo) provides us with a platform to investigate the role 
of calcium channel inactivation and calcium signaling related to brain development and ASD. 
The purpose of the current study was to behaviorally characterize TS2-neo mice by assessing 
their performance on a wide variety of behavioral paradigms, including replication of findings 
that support the TS2-neo as a valid platform for studying ASD-like behavior. In addition to 
examining core social and repetitive anomalies, we sought to focus on basic perceptual 
processing in the auditory domain. Results indicate that the loss of Cav1.2 inactivation in this 
mouse model results in deviant social and repetitive behaviors as well as poor sensorimotor 
learning. TS2-neo mice display superior performance on both an embedded tone and silent gap 
discrimination task for short-duration acoustic stimuli. These findings parallel the low-level 
auditory enhancements observed within the ASD clinical population. Additionally, structural 
anomalies were seen for mutant mice in some white matter tracts and in the medial geniculate 
nucleus (MGN). Co-occurrence of these findings suggests that aberrant MGN morphology may 





4.2      Introduction 
Autism Spectrum Disorder (ASD) is a set of neurodevelopmental disorders characterized by a 
complex behavioral phenotype, encompassing deficits in both social and cognitive domains. The 
core symptoms are heterogeneous, and range from atypical social interactions and language 
impairments to repetitive behaviors (American Psychiatric Association, 2013). To date, causal 
mechanisms underlying ASD remain poorly understood, but likely include a complex 
combination of polygenic and environmental risk factors (Moreno-De-Luca, 2013). 
  There is a strong genetic influence in ASD, with heritability rates ranging from 70-90% 
(Bailey et al., 1995; Rosenberg et al., 2009; Steffenburg et al., 1989). However, much is still 
unknown about the genetic contribution. It is suggested that over a 1,000 genes are involved in 
ASD, reflecting a complex genetic architecture (DeRubeis et al., 2014). Notably, most of the 
genes identified have been shown to play a critical role in neurodevelopment, and in fact 
converge onto several core functional pathways. These can be roughly divided into two major 
categories: synaptic transmission and excitation/inhibition imbalance; and gene expression 
involved in transcription/translation (Bourgeron, 2015, for review; Ey, Leblond & Bourgeron, 
2011). This is consistent with evidence that genetic mutations associated with ASD influence the 
structure and the turnover of synapses at different levels, including increasing or decreasing 
synaptic strength or numbers. Disruption of synapses and signal transmission that alters neuronal 
connectivity in the brain could in turn mediate functional changes associated with ASD 
(Auerbach, Osterweil & Bear, 2011; Hahamy, Behrmann, & Malach, 2015). Recent pathway 
network analyses, coupled with genome-wide association studies of autism, reveal the calcium 
signaling pathway to be the most affected, suggesting that it is highly involved in the molecular 
basis of ASD (Skafidas et al., 2014; Wen, Alshikho & Herbert, 2016; Wittkoski et al., 2014). 
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Genes associated with calcium channels modulate neuronal function by mediating influx of 
calcium into neurons (and thus neurotransmitter release), intracellular signaling, and gene 
transcription. Disruption to any of these can interfere with the neurodevelopmental trajectory. 
 Among identified ASD risk genes, calcium voltage-gated channel subunit alpha1 C 
(CACNA1C) has been associated with disorders such as bipolar disorder, schizophrenia, major 
depression, and more recently ASD (Bhat et al., 2012, for review; Li et al., 2015). A single de 
novo missense mutation to the 8A exon of CACNA1C gene (which codes for the voltage-gated L-
type Ca2+ channel (Cav1.2)) results in a rare multisystem disorder known as Timothy syndrome 
(TS) (Splawski et al. 2004). This mutation sharply reduces calcium channel inactivation, which 
may lead to heightened Ca2+ influx (Barrett & Tsien, 2008; Splawski et al., 2004). TS is 
strongly associated with cardiac arrhythmias, ASD, and neurological dysfunctions that include 
language impairments, seizures and intellectual disability. All individuals with TS exhibit 
proarrhythmic prolongation of the cardiac action potential, which generally results in sudden 
cardiac death at a young age (Splawski et al. 2004). Therefore, it has been challenging to study 
the basic mechanism of TS in humans, including how this mutation leads to a high co-morbidity 
with ASD. A genetically engineered knock-in mouse with a heterogeneous TS2 (G406R) 
mutation in the L-type calcium channel containing a neomycin resistance cassette was developed 
to study this condition (Bader et al., 2011). The resulting mouse model (TS2-neo knock-in) 
provides a platform to investigate the role of calcium channel inactivation and calcium signaling 
in atypical brain development, and in the expression of ASD-like behaviors. Previous behavioral 
studies on TS2-neo mice found that these animals’ exhibit normal general health and anxiety 
levels, but display a strong autistic phenotype indicated by restricted and repetitive behaviors, 
altered social behavior, and decreased ultrasonic vocalizations (Bader et al., 2011; Bett et al., 
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2012).   
Understanding the causes of ASD will allow for earlier detection and more refined 
intervention. However, efforts have been hindered by the heterogeneity and complicated genetic 
and environmental influences implicated. The study of transgenic mouse models allows us to 
assess the role of individual genes in modulating biological and behaviorally phenotypes relevant 
to ASD. Numerous mouse models targeting ASD risk genes have been used to behaviorally 
phenotype core symptoms of ASD, and particularly repetitive and abnormal social behaviors. 
One area that has not been well explored involves “splinter skills,” or enhanced discrimination of 
local details within perceptual information among individuals with ASD (Bertone et al. 2005; 
Plaisted et al. 2003). Superior performance in ASD individuals has been shown in low-level 
visual perceptual tasks such as visual search (O’Riordan, Plaisted, Driver, & Baron-Cohen, 2001; 
Plaisted, O’Riordan, & BaronCohen, 1998) and discrimination tasks (Plaisted et al., 1998). Also 
seen are specific enhancements in pitch discrimination among those with ASD (Bonnel et al. 
2010, 2003; Eigsti & Fein, 2013; Heaton and Heaton 2003, 2005; Jones et al. 2009; O’Riordan & 
Plaisted 2001). A more recent study also found superior auditory performance on detecting 
perceptual features of pitch and timing in individuals with autistic traits (Stewart, Griffiths, 
Grube, 2015). These aberrant perceptual processing may relate to the core features of ASD, for 
example social and communication deficits. However, little animal research has focused on the 
low-level perceptual enhancements seen in ASD, even though they may impact higher-level 
cognition and behavior. 
The purpose of the current study was to behaviorally characterize TS2-neo mice by assessing 
their performance on a wide variety of behavioral paradigms, including replication of findings 
that support the TS2-neo as a valid platform for studying ASD-like behavior. In addition to 
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examining core social and repetitive anomalies, we sought to focus on basic perceptual 
processing in the auditory domain. All subjects underwent various tasks evaluating their motor 
coordination, auditory processing, social behaviors, and learning and memory. Following 
behavioral assessment subjects underwent neuroanatomical analysis of white matter tracts, as 
well as the medial geniculate nucleus (MGN), since these structures are known to be critical to 
many behaviors that are affected in ASD. 
4.3      Methods and Materials 
4.3.1     Subjects 
Twelve male TS2-neo mice (B6.Cg-Cacna1ctm2Itl/J; stock number 019547) and 12 matched male 
wild type (WT) controls (C57BL/6J; stock number 000664) were obtained from The Jackson 
Laboratory (Bar Harbor, ME). The TS2-neo mouse model has the G406R mutation associated 
with severe Timothy Syndrome (TS2) and an inverted neomycin resistance cassette, all inserted 
at the end of exon 8 of the CaV1.2 L-type calcium channel locus (Cacna1c) (for more detail on 
the development of the TS2-neo mouse model see Bader et al., 2011; Bett et al., 2012). The TS2-
neo mice do not display any gross behavioral abnormalities in vision, olfaction, or motor 
strength, thus replicating reports by Bett el al., (2012). Subjects were delivered to the University 
of Connecticut, Department of Psychology in two separate cohorts (Cohort 1: 6 TS2-neo, 6 WT 
mice; Cohort 2: 6 TS2-neo, 6 WT mice, all mice received at 7 weeks). All subjects were single-
housed in standard mouse tubs (12 h/12 h light/dark cycle), with food and water ad libitum. All 
behavioral testing occurred during the light cycle. At the start of testing, animals were between 
the ages of postnatal day (P) 55 – P57. Procedures were performed blind to Genotype, and in 
compliance with the National Institutes of Health and University of Connecticut’s Institutional 
Animal Care and Use Committee (IACUC).      
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4.3.2    Rotarod P57-P61 
Subjects were assessed at age P57 for sensorimotor ability and motor learning using 
a rotarod task. All mice were habituated to the rotarod a day prior to testing, where they were 
placed on a rotating cylindrical drum that was held at a constant speed of 4 rotations per minute. 
Subjects underwent 4 trials that maxed out at 2 minutes. Testing began the following day with 
subjects placed on a rotating cylindrical drum that accelerated from 4 to 40 rotations per minute 
across 2 minutes. Four trials were administered per day, across five consecutive days. Latency to 
fall from the rotating drum was averaged across the four trials for each day.    
4.3.3    Auditory Processing P70-P105 
Subjects then advanced to auditory processing testing, which utilizes a modified pre-pulse 
inhibition paradigm (see Fitch et al., 2008 for review). Subjects were placed on individual load-
cell platforms (Med Associates, St. Albans, VT) and presented with auditory stimuli generated 
using RPvdsEx on a Dell Pentium D PC and RZ6 multifunction processor (Tucker Davis 
Technologies, Alachua, FL). Sounds were amplified using a Niles SI-1260 Integration Amplifier 
(Niles Audio Corp., Carlsbad, CA) and delivered through powered Yamaha YHT-M100 speakers 
(Buena Park, CA). The acoustic startle reflex (ASR; a reflexive response elicited by an 
unexpected, intense stimulus) was recorded by an iMac 7.1 running Acknowledge 4.1, and 
obtained via the voltage output from each load cell platform through a linear amplifier (PHM-
250U; Med Associates, St. Albans, VT) connected to a Biopac MP150 acquisition system 
(Biopac Systems, Goleta, CA). The modified pre-pulse inhibition paradigm measured differences 
in ASR to a loud startle-eliciting stimulus (SES; 105dB, 50 ms, broadband white 
noise burst (1kHz-10kHz)) when presented with or without a preceding acoustic cue. The ASR 
difference on cued versus uncued trials provided a measure of cue detection and/or 
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discrimination. If the auditory cue was detected, a reduction (attenuation) in the ASR was 
expected relative to the ASR elicited when the auditory cue was not present (or not detected). 
This phenomenon was quantified using an “attenuation score” (ATT) that compared the average 
amplitude of the ASR from the cued trial to the average ASR of the uncued trial ([average cued 
ASR/average uncued ASR]*100). 
4.3.3.1             Normal Single Tone P70 
Animals were initially tested on Normal Single Tone (NST) to measure baseline pre-pulse 
inhibition and auditory ability (P70). This auditory PPI control task was used to 
establish whether subjects exhibited hearing deficits and/or impaired gross motor reflexes 
that could confound other auditory PPI tests, and provided an index of baseline auditory pre-
pulse inhibition ability across test groups. Testing sessions consisted of 
104 pseudorandomly presented cued and uncued trials at inter-trial intervals (ITI) of varying 
duration (16–24 s). The task comprised a silent background and a simple single tone cue (50 ms, 
75 dB, 8,000 Hz tone) presented 50 ms prior to the 50 ms, 105 dB SES. All subjects were able to 
perform this task, and therefore were used for further auditory processing evaluation.  
4.3.3.2             Embedded Tone P71-P83 
The variable duration Embedded Tone (EBT) task (300 sequential pseudorandom trials) assessed 
ability to detect a change in tone frequency relative to a standard background tone (cue was a 
variable duration 5.6 kHz pure tone embedded in a 10.5 kHz background pure tone). On cued 
trials, the cue was presented 100 ms before the SES, while uncued trials used a "cue" of 0 ms. 
Two EBT tasks were used in this study – a long-duration EBT (0 ms to 100 ms), and a short-
duration EBT (0 ms to 10 ms). A range of cue durations were used to evaluate specific thresholds 
for performance differences between the genotypes, since groups might perform comparably on 
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longer durations yet differ on shorter durations (which are more difficult to detect). Using a 
range of cue durations enables ascertainment of stimulus features that all animals can 
discriminate (ceiling), that no animals can discriminate (basement), as well as any group 
differences in the mid-range. Both EBT tasks were administered for five consecutive days (P71-
P83).   
4.3.3.3             Silent Gap P86-P98 
A Silent Gap (SG) task was used to assess ability to detect silent breaks in continuous white 
noise (P86 to P98). A session included 300 trials with a continuous 75 dB broadband white noise 
background, with pseudorandomized cued and uncued trials. On cued trials, a silent gap of 
variable duration (0-100 ms or 0-10 ms) was presented 100 ms before the SES, while a "0 ms" 
trial served as the uncued condition. Subjects were tested on the Silent Gap task for five 
consecutive days using both versions of the task. 
4.3.3.4             Pitch Discrimination P101-P105 
Pitch discrimination testing also took place across five consecutive days of testing (300 
trials/day). This task assessed ability to detect very small changes in pitch embedded in a 
background tone. A variable ITI (16–24s) was used, and the cue was a 300 ms, 75 dB tone of 
variable frequency embedded in a standard 75 dB, 10500 Hz background pure tone (2 ms 
up/down linear frequency ramp) prior to the SES. The experimental frequencies used for the 
pitch discrimination task deviated from the standard background frequency by as much as 75 Hz, 
to as little as 5 Hz. Uncued trials did not include a frequency deviant prior to the SES. 
4.3.4    Three-Chamber Social Interaction P107-P110 
The Three-Chamber test was used to assess general sociability as well as social recognition.  
This test derives from observations that healthy wild-type mice typically prefer to spend time 
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with a conspecific (social stimulus) rather than an object (non-social stimulus).  After a 5 min 
habituation period, the subjects were allowed to freely explore three chambers, with one 
containing another “stranger” mouse, and another chamber on the opposite side containing a 
novel object. The subject was placed into the middle (empty) chamber and was able to freely 
explore all the chambers for 10 min. Next we placed an unfamiliar conspecific mouse (“stranger 
2”) where the novel object was previously located, and subjects were given another 10 min to 
explore the chambers. The percent time spent interacting with the mouse during the social 
preference phase, and percent time spent interacting with the novel mouse during the social 
recognition phase, were recorded and analyzed. 
4.3.5    Social Dominance – Tube Test P113-P116 
The Tube Test was administered to evaluate social dominance/aggression. The tube used for this 
task was a clear plexiglas tube (length 30.5cm; outer diameter 4.5cm; inner diameter 3.5cm). 
This narrow space is just sufficient for a mouse to walk through without being able to reverse 
direction. Mice were trained to walk through the tube before testing. A WT and a mutant mouse 
were randomly paired on different sides of the tube (balanced), and released at the same time 
into the tube. The mouse that forced the other mouse to back out of the tube was considered the 
“winner” of the trial (recorded for analysis). Each mouse underwent 4 trials paired with a 
different randomly assigned subject and the percentage of wins was calculated and analyzed. 
Mice were not paired within Genotype since by definition this would yield a score of 50%. 
4.3.6    Marble Burying P115-P118 
Subjects were placed in a standard polycarbonate cage (26 cm x 48 cm x 20 cm) filled with fresh 
mouse bedding (5cm deep) for the marble burying test. Standard glass toy marbles (assorted 
styles and colors, 15 mm diameter, 5.2 g in weight) were placed on the surface of the bedding in 
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3 rows of 7 marbles. A marble was considered buried if at the end of the 45 minute session the 
marble was more than half-way covered by bedding. Subjects were given 45 minutes to explore 
the area; number of marbles buried were reported and used for analysis. 
4.3.7    Vocalizations during male-female interactions P122-P126 
Adult male vocalizations were recorded during individual male-female pair social interactions. 
Male mice produce ultrasonic vocalizations when they are in the presence of a female (and 
particularly during estrus), or when they detect a female’s urinary estrus pheromones. We 
measured the vocalization emission of all subjects when exposed to accumulated seven-day dirty 
bedding obtained from mature, age-matched C57 female. Bedding from seven-days was used to 
ensure inclusion of estrus phase (4 day cycle). That same female was free moving in the cage 
with the male subject during recording. On P122-126 male subjects were individually placed in a 
standard laboratory cage filled with bedding, dirty bedding and a freely moving female. Only 
WT females were used to avoid confounds. Vocalizations were recorded for 5 minutes using a 
1/4 inch condenser microphone (Brüel & Kjær type 4136, Nærum, Denmark) suspended 10 cm 
above the test subject. The microphone signal was preamplified with a Bru¨el & Kjær type 2619 
preamplifier and then amplified using a Brüel & Kjær type 2636 amplifier (Bru¨el & Kjær, 
Nærum, Denmark). The signal was digitized at a sampling rate of 200 kHz using a Tucker Davis 
Technologies (Alachua, FL) multifunction processor (RZ6) and saved as a .wav file using a 
custom MATLAB program (MathWorks, Natick, MA) on a Dell Pentium IV PC. Recorded 
sound waveforms were visualized and assessed using Adobe Audition (Adobe, San Jose, CA). 
Total time spent vocalizing was calculated by extracting vocalization intervals (continuous 
vocalization epochs, 200 ms apart) from periods of silence (no vocalizations). Time spent 
vocalizing was binned into minute periods across the 5 minute male-female interaction. Since 
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females vocalize little in the presence of males, all recorded vocalizations were presumed to 
reflect the male subject (D’Amato & Moles, 2001; Moles et al., 2007; Wang et al., 2008). 
4.3.6    Water Maze Assessment P127-P150 
Subjects were initially tested on a water escape to assess any underlying impairments that might 
confound further maze testing (i.e., deficits in motivation, swimming, or visual acuity). Subjects 
were placed in the far end of an oval tub (103 cm x 55.5 cm) filled with room temperature water, 
and given 45 seconds to swim to a visible escape platform (8.5 cm in diameter; 1 cm above water 
surface) at the opposite end of the tub. Latencies to reach the visible platform were recorded. 
None of the subjects displayed any impairment on this task, and thus all proceeded to Morris 
water maze testing. 
The Morris water maze is a behavioral task commonly used to assess spatial learning and 
memory, and specifically the ability to locate the position of a submerged escape platform using 
extra maze cues. Beginning on P129, subjects were tested on the Morris water maze over a span 
of five consecutive test days (sessions). During each test session, subjects were given four trials 
to locate the submerged platform. For each trial, the subject starting location was selected 
pseudorandomly at one of the four compass locations (i.e. north, south, east, and west), with each 
location used once per test session. Subjects were allowed 45 seconds to complete the trial and 
find the escape platform. If the platform was not located at 45-seconds, subjects were gently 
guided to the goal before removal from the maze. The position of the hidden platform remained 
static throughout all five test sessions. Latency to the escape platform was measured and 




Subjects then progressed to a water version of the 4/8 radial arm maze (adapted from Hyde, 
Hoplight & Denenberg, 1998). This task was used to assess spatial reference and working 
memory ability simultaneously, using a standard 8 arm radial maze with 4 arms baited (i.e., 
containing a submerged goal platform), and 4 arms open but never baited. Configuration of goal 
arms were counterbalanced between subjects but remained fixed per subject across all sessions. 
Additionally, high contrast extra-maze cues were present, and the locations of these remained 
static for the experiment. 
 The day prior to testing (Day 1), subjects were given a training session where all arms 
that would not contain a platform were blocked, forcing the animals to only enter arms 
containing a platform. Subjects were placed in the start arm and given 120 seconds to locate a 
platform. Every subject completed 4 training trials, and each time they found a platform, that 
platform was removed and the entrance to that arm was blocked. This ensured that the subject 
could no longer enter this arm for the remainder of the training session. If the subject failed to 
find a platform in this window, they were guided to the nearest available goal. Once on the 
platform, subjects remained for 20 seconds and then were removed from the maze to their home 
cage (30 second inter-trial interval; ITI). 
 Testing began on Day 2 and continued for an additional 14 consecutive days. Here, 
instead of blocking the goal arm of the most recently located platform, the platform was removed 
during the 30 second ITI. However, the arm remained open and unbaited for the remainder of the 
test session. Animals were required to locate all 4 platforms, and thus received 4 test trials per 
day. Test sessions were recorded using a Sony camera integrated with the SMART video-




4.3.7    Perfusion and histology P191 
At the completion of testing, all 24 subjects were weighed, anesthetized using ketamine 
(100mg/kg) and xylazine (15 mg/kg), and transcardially perfused using a .9% saline solution 
with formalin as the fixative. Brains were extracted and stored in formalin to postfix at 4°C. 
Sixteen tissue samples (8 TS2-neo, 8 WT) were stored long-term to await neuroanatomic 
assessment using a Nissl stain (with remaining tissue used in other immunohistochemical 
analyses). 
 Formalin-fixed brains were serially sectioned in the coronal plane at 60 μm using a 
vibratome (Leica VT1000 S). Every second section was mounted on gelatin-subbed slides and 
stained for Nissl bodies using cresyl violet (coverslipped with DPX mounting medium).  
Volumetric measures of white matter structures were assessed, including corpus callosum, 
cingulum, external and internal capsule, fornix, and anterior commissure.  All prepared samples 
were analyzed using the Stereo Investigator System (MBF Biosciences, Williston, VT, USA) 
integrated with a Zeiss Axio Imager A2 microscope (Carl Zeiss, Thornwood, NY). For all 
structures, volumes were reconstructed from serial area scores using the Cavalieri Estimator 
probe in StereoInvesigator. Neuronal cell populations were estimated using the Optical 
Fractionator probe, with cross sectional neuronal cell area estimated concurrently using the 
Nucleator probe. Neurons were only counted for analysis if the nucleolus was in focus and 
within the appropriate boundaries of the active counting frame and dissector depth. A standard 
stereotaxic atlas was used to determine the borders of the MGN for quantification (Lein et al., 
2007; Paxinos & Watson, 1986). An average of 8 to 10 sections per brain was used for white 
matter tract analysis while an average of 6 sections per brain was used for MGN analysis. 
Volumetric measurements as well as contours of the MGN were drawn at 2.5X magnification. 
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Cell size measurements and counts were assessed at 100X magnification. A sampling grid size of 
200 µm × 200 µm and a 30 µm × 30 µm counting frame were used for stereological 
examination. Estimates for both neuronal cell population and neuronal cell area were obtained 
for left MGN, right MGN, and total (left + right) MGN for each subject. All measurements were 
performed blind to genotype. 
4.3.8    Data Analyses 
All subjects were used for analysis (WT, n = 12; TS2-neo, n = 12). Group differences on rotarod 
performance were analyzed using a 2 (Genotype; TS2-neo and WT) x 5 (Day) repeated measures 
analysis of variance (ANOVA). Normal Single Tone (baseline control) data was examined using 
a univariate ANOVA comparing TS2-neo and WT attenuation scores. Although, there were no 
significant differences in performance on NST, NST attenuation scores were used as a covariate 
in subsequent statistical analysis to control for individual variations in baseline auditory prepulse 
inhibition (PPI). Differences in attenuation (ATT) scores during all auditory tasks (embedded 
tone, silent gap and pitch discrimination) were examined using a 2 × 5 × 9 repeated measures 
ANOVA with Genotype (2 levels: TS2-neo and WT) as the between-subjects variable, and Day 
(5 levels) and cue (9 levels) as the within-subjects variable. A univariate ANOVA was 
performed to analyze differences between Genotypes on the following tasks, social interaction, 
social dominance tube task, marble burying, vocalizations and water escape. A repeated 
measures ANOVA was performed to analyze latency to platform in the Morris water maze with 
Day (5 levels) being the within-subject variable and Genotype being the between subjects 
variable. Average total errors were examined for the 4/8 radial water maze, using a 2 x 14 
repeated measures ANOVA, with Genotype (2 levels: TS2-neo and WT) as the between measure 
and Days (14 levels) as the within measure. For neuroanatomical measures, subjects in the Nissl 
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stained group (n=16, 8 TS2-neo/8 WT) were used for analysis. Group differences in regional 
volume and cellular measurements (mean cell count and size within defined boundaries) were 
assessed using a univariate ANOVAs. Examination of cell size distribution was conducted using 
a cumulative percent distribution. To examine group differences in cell size distribution, non–
parametric analyses with Kolmogorov Smirnov (K-S) tests were conducted on the cumulative 
percent distributions of each Genotype. A bivariate correlation was used to examine the 
relationship between number of neurons and auditory processing performance. All statistical 
analyses were conducted using SPSS 19 with an alpha criterion of 0.05, two-tailed. 
4.4      Results 
4.4.1    Rotarod 
A repeated measures ANOVA examining average rotarod latency across 5 days of testing 
revealed a main effect of Genotype [F(1,22) = 14.037, p<.05], as well as a Genotype x Day 
interaction [F(4,88) = 8.251, p<.001]. TS2-neo mice showed impaired sensorimotor/motor 
ability, and the lack of improvement across days indicates they failed to show motor learning on 
this task (Fig. 4.2a).   
4.4.2    Auditory Processing 
All subjects were initially tested on a normal single tone (NST) task, to establish baseline hearing 
and PPI ability. None of the subjects showed impairments on NST, nor was there a main effect 
of Genotype [F(1,22) = .392, p>.05]. We did however controlled for individual variations in 
baseline auditory prepulse inhibition (PPI) performance using NST attenuation scores as a 
covariate. On the embedded tone (EBT) 0-100 ms task, we found no main effect of Genotype 
[F(1,21) =1.394, p>.05] (Fig 4.3a), and all subjects were able to discriminate the stimuli based on 
cued/uncued amplitude comparisons. On the more difficult embedded tone task (cue durations 
81 
 
ranging from 0 to 10 ms, where 0 ms is the uncued condition) we found a main effect of 
Genotype [F(1,21) = 5.388, p<.05], with TS2-neo mice showing enhanced detection of the 
embedded tone cue compared to WTs (Fig. 4.3b). For silent gap detection we assessed 
performance on the 0-300 ms task, and again saw no main effect of Genotype [F(1,21) = .004, 
p>.05] (Fig. 4.3c). On the silent gap 0-100 ms task, we found overall worse performance (since 
the task was harder), and also a main effect of Genotype [F(1,21) = 7.369, p<.05], with TS2-neo 
mice again demonstrating superior performance on gap detection (Fig. 4.3d). On the pitch 
discrimination task, we did not find a main effect of Genotype [F(1,21) = .731, p>.05]. 
4.4.3    Three-Chamber Social Interactions 
On the three-chamber social interaction tasks we did not find a main effect of Genotype, either in 
the social preference phase [F(1,22) = 1.426, p>.05], nor the social recognition phase [F(1,22) = 
.001, p>.05]. On all tasks, WTs and TS2-neo mice spent a comparable percentage of time 
exploring the social stimuli (Fig. 4.1d). 
4.4.4    Social Dominance 
On the social dominance (tube task) the number of wins was calculated as a percentage of the 4 
trials. We found a main effect of Genotype [F(1,22) = 12.138, p<.01], with TS2-neo mice 
showing more “wins” compared to WT controls. These findings indicate TS2-neo’s were more 
aggressive (Fig. 4.1a). 
4.4.5    Marble Burying 
A univariate ANOVA revealed a main effect of Genotype [F(1,220 = 10.662, p<.01] on the 
marble burying task with TS2-neo mice burying significantly more marbles compared to WTs. 
This indicates the mutants expressed more stereotyped and repetitive behaviors (Fig. 4.1c). 
4.4.6    Vocalizations 
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A univariate ANOVA was conducted to evaluate time spent vocalizing for each minute spent 
interacting with a female mouse. Analysis revealed that TS2-neo mice vocalized significantly 
less during male-female interactions after the initial two minutes, [Minute 1: F(1,22) = .187, 
p>.05; Minute 2: F(1,22) = .180, p>.05; Minute 3: F(1,22) = 4.803, p<.05; Minute 4: F(1,22) = 
4.058, p<.10; Minute 5: F(1,22) = 6.498, p<.05] (Fig. 4.1b). 
4.4.7    Water Maze Assessment 
Prior to spatial water maze testing, a visible platform control task was conducted to assess any 
underlying impairments that could confound subsequent water maze performance (e.g., 
impairments in swimming ability, visual acuity, or motivation). A univariate ANOVA on 
latencies found no main effect of Genotype [F(1,22)  = .037, p>.05] indicating that genetically 
modified groups had no impairments on underlying aspects of the water task (e.g., swimming) 
On the Morris Water Maze task we found no main effect of Genotype [F(1,22) = .013, p>.05], 
but did find a main effect of Day [F(4,88) = 6.313, p<.01], with all subjects showing decreased 
latencies as testing progressed (indicating learning; Fig. 4.2b). This indicated learning for all 
subjects. 
The 4/8 radial arm water maze was used to simultaneously measure spatial working and 
reference memory performance. A repeated-measures analysis of the average number of total 
errors (working memory, initial reference, and repeated reference memory errors) revealed no 
significant difference between WT and TS2-neo groups [F(1,22)=.016, p>.05] (Fig. 4.2c). A 
main effect of Day [F(13,286)=5.348, p<.01] was observed, confirming that both groups reduced 
errors across days (i.e., showed learning). We also examined group differences in error types 
including working memory, initial reference memory, and repeated reference memory. Again 
repeated measures ANOVA reveal no effect of Genotype on any error types (working memory 
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[F(1,22)=.098, p=.757], initial reference memory [Genotype: F(1,22)=.00, p>.05] and repeated 
reference memory  [Genotype: F(1,22)=.574  p>.05]). 
4.4.8    White Matter Tract Volumes 
Initial analysis of white matter tract volumes (Nissl stained samples, n=16 (8 TS2-neo/8 WT)), 
revealed a main effect of Genotype for volume of external capsule volume, with TS2-neo mice 
showing significantly smaller external capsule volumes compared to WTs[F(1,16)=6.417, 
p<.05]. A subsequent examination of hemisphere-dependent effects showed that this decrease 
was localized to the right external capsule [F(1,16)=10.737 p<.01]. Analysis of total fornix 
volume also showed a trend towards reduced volume in the TS2-neo group [F(1,16)=4.209, 
p<.1] (Fig. 4.4). No Genotype differences were seen for other white matter structures assessed. 
4.4.9    Medial Geniculate Nucleus  
A univariate ANOVA comparing MGN volume revealed a marginal main effect of Genotype, 
with a smaller MGN volume in TS2-neo mice compared to WTs [F(1,14) = 4.250, p=.058] (Fig. 
4.5a). Examination of mean cell size in the MGN found no main effect of Genotype [F(1,14) = 
.384, p>.05]. However, comparisons of cumulative percent distributions between TS2-neo and 
WT controls using a Kolmogorov Smirnov test revealed a significant K-S statistic (p<.05; Fig. 
4.5b). Analysis of cell size distribution in TS2-neo and WT brains revealed that TS2-neo brains 
contain more small and fewer large MGN cells than controls. A univariate ANOVA comparing 
MGN neuronal population revealed a main effect of Genotype, specifically for the right MGN, 
with TS2-neo mice exhibiting fewer neurons compared to WTs [total: F(1,14) = 2.489, p>.05; 
left: F(1,14) = .180, p>.05; right: F(1,14) = .045, p<.05] (Fig.4.5c). A bivariate correlation 
revealed a significant positive relationship between neuronal population in the MGN and average 
attenuation scores on EBT 0-10 in TS2-neo mice only (r = .792 n = 8, p<.05) (Fig. 4.5d). 
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Specifically, an increase in the number of neurons in the MGN was correlated with an increase in 
attenuation score (worse performance) on the EBT 0-10 task. This relationship was not seen in 
the WTs (r = -.269, n= 8, p>.05) or on any other auditory processing task. 
4.5      Discussion 
The purpose of this study was to behaviorally evaluate TS2-neo mice on motor learning, auditory 
processing, social and repetitive behaviors, as well as, on learning and memory tasks. Results 
showed that the loss of Ca.V1.2 inactivation in this mouse model significantly affected motor 
learning, auditory processing, and social and repetitive behaviors, but did not impact on spatial 
learning and memory. Additionally, structural anomalies were seen for mutant mice in some 
white matter tracts, and MGN. 
4.5.1    TS2-neo serves as a model of ASD 
 The results presented here reaffirm that when TS mutant channels are expressed at 
reduced levels (but low enough to avoid fatality), effects include behaviors consistent with 
symptoms observed in the clinical ASD population. Specifically, we found that the TS2-neo 
mice displayed deviant social behaviors, as well as repetitive behaviors replicating what has 
previously been reported in TS2-neo mice (Bader et al., 2011). Effects were also seen on a social 
dominance task, with mutants winning significantly more trials compared to their WT controls 
(thus showing more aggressive behavior). However, we did not observe any differences in social 
preference or recognition on the three-chamber task. This is actually consistent with Bader et al., 
(2011), where no differences in sociability measures were seen between TS2-neo and WT mice 
during the first 10 min of the task. In fact, Bader et al., (2011) only found differences in social 
behavior by testing over an unusually extensive period (a few hours, which is non-standard for 
the 3-chamber task). Also, our subjects were given the option to explore a novel inanimate 
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object, rather than an empty chamber (as used by Bader et al.). These discrepancies in protocols 
may explain why we did not observe Genotype differences in social behavior on this task. 
However, we found that TS2-neo subjects spent significantly less time vocalizing to a female in 
a vocalization task. Importantly, Bader et al., (2011) previously observed reduced vocalizations 
in pups, but not adults. Our findings show that aberrant social and communicative behaviors 
persist into adulthood, and across different types of social interactions. Lastly, subjects 
underwent a marble burying task, which we showed that TS2-neo mice buried twice as many 
marbles compared to their controls. This excessive burying is further indicative of repetitive, 
restricted and perseverative behavior -- another core symptom of ASD. Overall, these findings 
replicate prior reports on the TS2-neo model (Bader at al., 2011), and affirm that this mouse 
model exhibits core ASD-like traits such as repetitive behaviors and altered social behavior and 
ultrasonic vocalizations.  
4.5.2    Motor and Spatial Learning 
In addition to phenotyping core behavioral symptoms of ASD, we evaluated the TS2-neo mice 
on both motor and spatial learning. Although not a core criterion, motor and procedural learning 
deficits have been noted in individuals with ASD and it is thought that deficits in procedural 
learning may contribute to the cognitive and behavioral phenotype of autism. Here, the TS2-neo 
mice showed deficits in motor coordination and motor learning, as indicated by a lack of 
improvement across days on the Rotarod task. There have been parallel reports of impairments in 
motor coordination in ASD populations across a wide range of behaviors (Fournier et al., 2010). 
Furthermore, it has also been reported that children with ASD demonstrate diffusely decreased 
connectivity across the motor execution network relative to control children (Mostosky et al., 
2009). This cortico-cerebellar connectivity dysfunction is also considered a core characteristic of 
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ASD, and is thought to contribute to anomalies in both sensory-motor control, and higher 
function such as social cognition and emotion (Crippa et al., 2016).  
Finally, for spatial learning and memory in TS2-neo mice, we found no differences between 
Genotypes on either the Morris water maze or the 4/8 radial arm water maze. Similarly, Bader et 
al, (2011) evaluated TS2-neo mice on the Morris water maze and found no differences in 
learning. However, they did report that TS2-neo mice perseverated to the previous learned 
quadrant during a reversal task, suggesting that TS2-neo mice display comparable initial learning 
but are cognitively inflexible when given a reversal task. Our results here replicate initial 
findings as well as exemplify that TS2-neo mice can perform adequately on a complex spatial 
reference and working memory task as seen on the 4/8 radial arm water maze. 
4.5.3    Auditory Processing Enhancements 
 The current study revealed novel findings that TS2-neo mice displayed superior 
performance on both the embedded tone and silent gap task for short cue durations. Enhanced 
low-level perceptual discrimination has been reported in individuals with ASD for visual and 
auditory stimuli (Bertone et al., 2005; Mottron et al., 2006; Plaisted et al., 2003) , and this is the 
second ASD-like mouse model our lab has reported to display enhanced performance on an 
auditory processing task. Specifically, we previously found that Cntnap2 KO mice displayed 
superior discrimination on an embedded tone and pitch discrimination task (Truong et al., 2015). 
Interestingly, this type of superiority in auditory processing is not seen in other mutant rodent 
models, for example knock-outs using candidate susceptibility dyslexia risk genes (Rendall et al., 
2015; Truong et al., 2014; Szalkowksi et al., 2013; Szalkowksi et al., 2012). Thus although low-
level superiority in auditory processing may be related to language deficits seen in ASD (Eigsti 
& Fein, 2013), these same superiorities do not seem to occur in other language-specific 
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developmental disorders (e.g., dyslexia and specific language impairment). As such, low-level 
auditory enhancements form a particularly interesting aspect of the ASD-like animal model 
profile. An additional new finding --that better performance on the EBT 0-10 task (on which we 
have reported a similar atypical superiority in another ASD mouse model, Cntnap2; Truong et 
al., 2015) is actually correlated to fewer neurons in the MGN (which has generally been 
associated with deficits including language anomalies; Galaburda, Menard, & Rosen, 1994) – 
may further support the notion that low-level sensory enhancements are directly related to 
auditory-based language impairments in at least a subset of individuals with ASD. Further 
research should investigate other well-established mouse models of ASD by focusing on auditory 
processing patterns, to see if this trend of superior auditory processing is ubiquitous across 
multiple ASD mouse models beyond the TS2-neo and Cntnap2 KO mice, and whether the 
relationship with anomalous MGN cellular morphology can be replicated. 
Genetic, neurodevelopmental and behavioral exploration of these enhancements is important 
because low-level perceptual abilities are particularly important for the development of language, 
and differences in processing may be contributing to core features of autism such as language 
delay and aberrant social skills. In fact, atypical auditory processing in children with autism may 
be key to parsing different etiologies of autism, establishing interventions, and ameliorating 
overwhelming auditory sensory input to facilitate language development.  
4.5.4    Enhanced perceptual functioning and cortico-cortical disconnection theories 
The behavioral phenotype validated in the TS2-neo mouse model also aligns with the enhanced 
perceptual functioning theory of ASD put forth by Mottron et al. (2006). These authors contend 
that the paradoxical co-occurrence in ASD of enhanced sensory perceptual abilities and 
compromised global sensory integration (including social and language deficits) might be 
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explained by a developmental re-orientation of cortical functional patterns. Specifically, locally 
oriented “low-level” processing mechanisms may be enhanced and favored over more complex, 
integrative strategies that engage global and long-range processing mechanisms. This may 
further relate neurocognitively to regional hyper-connectivity and long-range hypo-connectivity 
(discussed further below).  
4.5.5    Atypical white matter development in the TS2-neo  
A growing body of neuroimaging studies identifies abnormal development of white matter tracts 
and organization of grey matter structures as markers of an ASD neurostructural phenotype, 
which we saw reflected in our own results. In the current study, we report reductions in volumes 
of the external capsule and fornix, two major white matter tracts. The external capsule contains 
cortico-cortical association fibers that form the basis of intercortical communication between the 
basal forebrain and other regions of the cerebral cortex, while the fornix is a bundle of 
commissural fibers connecting the hippocampus, mammillary bodies, and thalamus between the 
two hemispheres of the brain. Our findings of reductions in the fornix parallel reported results 
from neuroanatomical studies of the BTBR and NL3 mouse models of ASD, which showed 
decreases in fornix volume and integrity (Ellegood et al., 2015). Collectively, these results 
contribute to the larger body of work assessing ASD as a disorder of hypo-connectivity and 
disconnection between fronto-cortical and cortico-cortical networks. These pathways are critical 
for the integration of information that promotes normative socio-communicative development 
and deficits in connection integrity and structure are correlated with ASD symptom severity 
(Alexander et al., 2007; Poustka et al., 2012). This pattern of aberrant white matter development 
in ASD has become so consistent that some suggest that with further research it could become a 
unifying neuro-endophenotype for ASD. 
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4.5.6    TS2-neo mice display alterations within the MGN 
 Stereological analysis of the MGN revealed a reduction in MGN volume and number of 
neurons as well as neuronal size distribution shift toward more small neurons in TS2-neo mice 
relative to WTs. Furthermore, a significant correlation was observed between number of neurons 
and mean EBT10 performance in TS2-neo mice only. Co-occurrence of these findings suggests 
that aberrant MGN morphology is related to enhanced auditory processing phenotype, as 
observed in TS2-neo mice on EBT 0-10. These findings are consistent with in vivo 
neuroimaging studies showing fundamental differences in the thalamus of ASD individuals, 
including reduced volume (Tamura et al., 2010; Tsatsanis et al., 2003), altered neurochemical 
composition (Friedman et al., 2003), and abnormal thalamocortical connectivity (Chen et al., 
2016; Cheon et al., 2011; Chugani et al., 1997; Mizuno, Villalobos, Davies, Dahl, & Muller, 
2006; Muller et al., 1998; Nair et al., 2013). This collective evidence suggests that the thalamus 
may play a particular role in the etiology of ASD symptoms. TS2-neo neuroanatomical 
differences appear to be more robust within the right hemisphere, which corresponds to prior 
reports that TS2-neo brains are significantly more asymmetric than littermates (Bett et al., 2012). 
Further research is necessary to understand how alterations within the MGN may be contributing 
to the auditory enhancements observed, and in particular, why and how a reduction in the 
number of neurons and neuronal size could be advantageous to auditory processing but 
detrimental to language development. 
 Transgenic mouse models serve as a critical tool in evaluate the role of individual genes 
in the complex and polygenic cascade underlying neurodevelopment, and can further help to 
reveal how single-gene mutations can disrupt this process and result in neurodevelopment 
disorders (e.g., ASD). Among ASD genes identified, ~ 200 have been used to create engineered 
90 
 
mouse models, and associated phenotyping studies have revealed atypical social and 
perseverative/repetitive behaviors (3-chamber task, marble burying, alternating choice, task 
reversal) that can be linked to various disruptions in specific gene function (see Crawley, 2004 
for review). Although major strides have been made in mapping the genetic etiology of ASD-like 
deficits in the social and repetitive domains, few studies have used transgenic mice to delineate 
some of the low-level enhancements associated with ASD. Yet these features may prove to be 
critical in unravelling neurogenetic influences on the higher-order language and communication 
deficits associated with ASD. Indeed, while several prominent research groups in the field have 
successfully associated ASD risk gene mutations with decreases in vocal calls and/or atypical 
call acoustics (Ey et al., 2013, Lai et al., 2014, Michetti, Ricceri & Scattoni, 2012; Penagarikano 
et al., 2011; Penagarikano& Geschwind, 2012), little animal work has focused on core perceptual 
and sensory processing features that may contribute to higher order anomalies. Here we have 
demonstrated an association between enhancements in low-level acoustic processing and a TS2-
neo mutation associated with an ASD profile, bolstering prior data showing similar features in a 
Cntnap2 KO mouse model of ASD. Ongoing research to examine perceptual processing, 
including such enhancements, in ASD models will continue to benefit our understanding of the 
neurogenetic etiology of this complex disorder. 
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Figure 4.1 - TS2-neo mice display “ASD-like” behavioral profiles. (a.) Social Dominance: 
TS2-neo mice won significantly more trials on a tube test. (b.) Ultrasonic vocalizations during 
male-female interactions: TS2-neo mice vocalized significantly less during the last 3 minutes of 










Figure 4.2 - TS2-neo mice show deficits in motor learning but not spatial learning. (a.) 
Rotarod: TS2-neo mice displayed a lack of motor learning. (b.) Morris Water Maze: TS2-neo 
mice and WTs performed comparably. (c.) 4/8 Radial Arm Water Maze: TS2-neo mice and WTs 








Figure 4.3 - TS2-neo mice exhibit superior processing of short-duration acoustic stimuli. 
(a.) Embedded Tone 0-100 ms: TS2-neo mice and WTs showed comparable performance. (b.) 
Embedded Tone 0-10ms: TS2-neo mice had significantly lower (better) attenuation scores. (c.) 
Silent Gap 0-300 ms: TS2-neo mice and WTs had comparable performance. (d.) Silent Gap 0-








Figure 4.4 - TS2-neo mice show significant decrease in white matter structures. (a.) TS2-neo 
mice displayed a significant decrease in volume of the external capsule, specifically right 
external capsule, and a marginal decrease in the fornix. (b.) Location and size of external capsule 
(outlined in red) for representative TS2-neo and WT samples. (c.) Location and size of fornix 












Figure 4.5- TS2-neo mice display anomalies in the medial geniculate nucleus. (a.) TS2-neo 
mice exhibit a marginally significant reduction in MGN volume. (b.) TS2-neo display a 
significant shift in cumulative MGN cell size distribution, with mutants showing more small and 
fewer large MGN cells compared to WTs. (c.) TS2-neo display reductions in number of MGN 
neurons, specifically within the right MGN. (d.) A significant positive correlation was revealed 
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1 Department of Psychology/Behavioral Neuroscience and Institute for Systems Genomics, 
University of Connecticut, Storrs, CT 
 














Submitted: Genes, Brain and Behavior (2017) 
97 
 
5.1     Abstract 
Developmental dyslexia is a heritable disability characterized by difficulties in learning to read 
and write. The neurobiological and genetic mechanisms underlying dyslexia remain poorly 
understood; however, several dyslexia candidate risk genes have been identified. One of these 
candidate risk genes - doublecortin domain containing 2 (DCDC2) - has been shown to play a 
role in neuronal migration and cilia function.  At a behavioral level, variants of DCDC2 have 
been associated with impairments in phonological processing and working memory.  More 
recently, a specific mutation in DCDC2 has been strongly linked to deficits in motion perception 
- a skill subserving reading abilities. To further explore the relationship between DCDC2 and 
dyslexia, a genetic knockout (KO) of the rodent homolog of DCDC2 (Dcdc2) was created. Initial 
studies showed that Dcdc2 KOs display deficits in auditory processing and working memory. 
Since motion perception skills have not yet been assessed in the Dcdc2 KO mouse model, the 
current study was designed to evaluate the association between DCDC2 and motion perception. 
We developed a novel motion perception task, utilizing touchscreen technology and operant 
conditioning. Dcdc2 KOs displayed deficits on the Pairwise Discrimination task specifically as 
motion was added to visual stimuli. Following behavioral assessment, brains were histologically 
prepared for neuroanatomical analysis of the lateral geniculate nucleus (LGN). The cumulative 
distribution revealed that Dcdc2 KOs exhibited more small neurons and fewer larger neurons in 
the LGN. Results compliment findings that DCDC2 genetic alteration results in anomalies in 






5.2     Introduction 
Developmental dyslexia is a heritable disability characterized by difficulties in learning to read 
and write that cannot be explained by comorbid factors such as intellectual impairment, lack of 
educational opportunity, or other neurological disorders (e.g. epilepsy or primary sensory 
impairments (blindness, deafness)). Dyslexia is considered a common neurodevelopmental 
disorder, affecting 5%-12% of the population (Lyon, Shaywitz & Shaywitz, 2003; Peterson & 
Pennington, 2012). It is also a highly heterogeneous disorder, with varied intermediate 
phenotypes, that include visual and cross-modal integration deficits. Dyslexia can also be 
deconstructed into core impairments that include problems with phonological processing 
(Kovelman et al., 2012; Melby-Lervag, Lyster & Hulme, 2012; Peyrin et al., 2012), short-term 
and/or working memory (Beneventi et al., 2010; Gathercole et al., 2006; Menghini et al., 2010), 
rapid auditory processing (Cohen-Mimran & Sapir, 2007; Fitch & Szalkowski, 2012; 
Hamalainen, Salminen & Leppanen, 2013), visuospatial attention (Franceschini, 2012; Gabrieli 
& Norton, 2012), and/or visual attention/perception (Galaburda and Livingstone, 1993; Stein and 
Walsh, 1997; Vidyasagar and Pammer, 2010).  
 With regards to visual deficits associated with dyslexia, atypical or impaired visual 
perception of motion may be one factor underlying slow reading speed (Lyon et al., 2003; 
Nicholson and Fawcett, 2007). For example, children with dyslexia are reported to have some 
combination of spatial (Cornelissen et al., 1995; Hansen et al., 2001; Lawton, 2000, 2007, 2008, 
2011; Lovegrove et al., 1980; Stein, 2001; Stein and Walsh, 1997; Talcott et al., 2000) and/or 
temporal (Bradley and Bryant, 1983; Stanley and Hall, 1973; Tallal et al., 1993; Temple et al., 
2003) visual sequencing deficits. These impairments could relate to reports from dyslexics that 
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letters within words, and words on a page, often appear distorted, displaced, or crowded together 
(Atkinson, 1991). 
 The biological mechanisms underlying intermediate dyslexia phenotypes remain poorly 
understood. However, heritability rates ranging from 40% to as high as 80% indicate a strong 
genetic basis (Schumacher et al., 2007). To date, several dyslexia candidate risk genes have been 
identified, including DYX1C1, DCDC2, KIAA0319 and ROBO1. One of these candidate risk 
genes - doublecortin domain containing 2 (DCDC2) - has been shown to play a major role in 
neuronal migration during early development, as well as cilia function throughout life (Meng et 
al., 2005; Burbridge et al., 2008; Lee & Gleeson, 2010; Massinen et al., 2011; Szalkowski et al., 
2012). At a behavioral level, variants of DCDC2 have been associated not only with dyslexia per 
se, but also intermediate phenotypes such as impairments in phonological processing and 
working memory (Berninger et al., 2008; Marino et al., 2011). One specific mutation in DCDC2 
has been strongly linked to deficits in motion perception - a skill important to reading ability 
(Cicchini et al., 2015; Gori et al., 2015). This finding is consistent with evidence that visual 
processing deficits are more prominent in dyslexic samples when images are rapidly presented or 
moving, and associated theories of magnocellular neural timing deficits in dyslexia (Boets et al., 
2011; Lawton, 2000, 2007, 2008, 2011; Livingstone et al., 1991; Stein, 2001; Stein and Walsh, 
1997; Vidyasagar, 1999, 2001, 2012; Vidyasagar and Pammer, 2010;). Importantly, deficits in 
motion perception can be detected well before impairments in reading or even language, and 
visual motion thresholds are predictive of language outcome, making motion perception a useful 
intermediate phenotype for early diagnosis and intervention (Boets et al., 2011). 
 Motion processing deficits may reflect vulnerability of the magnocellular-dorsal system, 
which is a reoccurring biological theme in the study of dyslexia (Danelli et al., 2013; Gori et al., 
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2015; Schulte-Körne and Bruder, 2010; Stein 2001). In fact, early evidence pointed to a selective 
deficit of the magnocellular-dorsal system as measured both by atypical cellular morphology in 
thalamic nuclei (Galaburda and Kemper, 1979; Galaburda et al., 1985; Galaburda & Livingstone, 
1993; Livingstone et al., 1991), as well as electrophysiological profiles during motion-related 
magnocellular processing tasks (Cornelissen et al., 1995; Demb et al., 1998; Lovegrove et al., 
1980; Slaghuis and Ryan, 1999, 2006; Stein and Walsh, 1997)The most direct evidence of 
aberrations in the visual magnocellular system came from post mortem brains of dyslexics, 
where the magnocellular layers of the lateral geniculate nucleus (LGN) were found to be 
disordered, and the neurons were 30% smaller compared to control brains (Galaburda and 
Livingstone, 1993; Livingstone et al., 1991). 
 To further explore the relationship between DCDC2 and dyslexia, a genetic knockout 
(KO) of the rodent homolog of DCDC2 (Dcdc2) was created. Initial behavioral studies showed 
Dcdc2 KOs mice displayed persistent visuo-spatial memory deficits, as well as visual 
discrimination and long-term and working memory deficits on cognitively demanding tasks 
(Gabel et al., 2011; Truong et al., 2014). Further assessments revealed deficits in rapid auditory 
processing as well as disrupted ability to identify speech sounds in cortical knockdown (RNAi)  
Dcdc2 rats (Centanni et al., 2016; Truong et al., 2014). Electrophysiological studies found that 
cortical pyramidal neurons from Dcdc2 KO mice exhibited increased excitability and decreased 
temporal firing precision, which could explain a link between DCDC2 and motion perception 
deficits (Che et al., 2016). Since visual motion perception skills have not yet been assessed in the 
Dcdc2 KO mouse model, the current study was designed to evaluate this association. 
Specifically, we developed a novel motion perception task based on published human behavioral 
paradigms and stimuli used with dyslexic samples. To test our mice we used touchscreen 
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technology and operant conditioning in a modified Pairwise Discrimination task. Following 
shaping, subjects were exposed to visual stimuli known as Gabors (adjusted for mouse vision to 
provide higher contrast and longer display) adapted from those previously used to assess 
individuals with dyslexia (Cicchini et al., 2015). Following behavioral assessment, brains were 
histologically prepared for neuroanatomical analysis of the LGN. This was based on the 
relevance of the LGN in the magnocellular-dorsal system and evidence in dyslexic post mortem 
brains. Our overall goal was to replicate and extend the clinical finding that DCDC2 influences 
not only auditory processing and working memory, but also visual motion perception. 
5.3       Materials and Methods 
5.3.1    Subjects 
Dcdc2 knockout (KO) mice (Dcdc2del2/del2) carried a constitutive homozygous deletion of 
exon 2 (del2) within the Dcdc2 gene region of a 129SJ x C57BL/6J hybrid background 
backcrossed to C57BL/6J for 10 generations (see Wang et al., 2011 for details). Our subjects 
were generated from the Dcdc2 colony maintained by JJL at the University of Connecticut, using 
a heterozygous-heterozygous (Dcdc2wt/del2 × Dcdc2wt/del2) mating scheme, with resultant 
genotypes recovered in the expected mendelian ratios (1:2:1). Only male subjects were assessed 
on subsequent behavioral measures, 7 Dcdc2 KO mice and 7 wild-type littermate controls. All 
subjects were single-housed in standard mouse tubs (12 h/12 h light/dark cycle), with food and 
water ad lib, until the start of operant testing (when food restriction was implemented). Subjects 
were gradually food restricted to 80%-85% of their baseline body weight (3 weeks prior to 
operant testing). During the last week before training, subjects were given a sample of the food 
reward (Strawberry Ensure Plus, Abbott, IL, USA) in their home cage, to habituate them to its 
taste and eliminate hyponeophagia. All behavioral testing occurred during the light cycle. 
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Procedures were performed blind to genotype, and in compliance with the National Institutes of 
Health and University of Connecticut’s Institutional Animal Care and Use Committee (IACUC). 
5.3.2    Touch-screen Operant Conditioning 
Pairwise visual discrimination was tested in the automated Bussey-Saksida touchscreen 
apparatus for mice (Campden Instruments Ltd/Lafayette Instruments, Lafayette, IL, USA), using 
a procedure modified from methods described previously (Brigman and Rothblat, 2008; Brigman 
et al., 2013; Bussey et al., 2012; DePoy et al., 2013; Oomen et al., 2013; Silverman et al., 2013). 
The reinforcer was 20 μl of a palatable liquid nutritional supplement (Strawberry Ensure Plus). 
Each session was conducted under overhead lighting (∼60 lux). A standard tone cue was used to 
signal the delivery of the reinforcer during pre-training and acquisition. Prior to pre-training, 
subject mice were weighed, and placed on a restricted diet of 2–4 g of rodent chow per mouse 
per day, to induce a 15% weight loss. Body weight was carefully monitored throughout the 
experiment, to ensure that a minimum of 80% of free feeding age-corrected body weight was 
maintained for each mouse. 
5.3.3    Pairwise Discrimination (P100-340) 
Before subjects advanced to Pairwise Discrimination testing they underwent a series of 
'pretraining' sessions, in which they learned to make instrumental responses in the touchscreen 
apparatus. Pre-training consisted of Habituation, Initial Touch Training, Must Touch Stimuli, 
Must Initiate, Punish Incorrect (Horner et al., 2013). After completion of training, subjects 
progressed to Pairwise Discrimination Testing. At the start of the session a free delivery of food 
was made and the tray light was turned on. The mouse had to nose poke and exit the food-tray to 
begin the first trial. When a trial was initiated, two novel stimuli were presented on the screen -- 
one programmed as correct (S+), and the other incorrect (S-). S+ and S- were presented on the 
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left or right pseudo-randomly. Food delivery was accompanied by illumination of the tray light 
and a tone. Entry to collect the food turned off the tray light and started the intertrial interval 
(ITI). After the ITI, the tray light was illuminated and the mouse was required to nose poke and 
exit to initiate the next trial. If the mouse touched the incorrect stimulus, no reward was delivered 
and a timeout followed, which entailed illumination of the house light and an audible tone. 
Pairwise Discrimination was performed in 4 stages, using progressively more complex stimuli. 
The first stage of testing used stock black/white images, followed by static black/white Gabors, 
then moving Gabors, and finally moving dots (Fig. 5.1).  
5.3.4    Histology 
At P360 subjects were weighed, anesthetized (ketamine/xylazine (100/15 mg/kg)), and 
transcardially perfused with 0.9% saline followed by 10% formalin. Brains were extracted and 
post-fixed in 10% formalin. Brains were serially sectioned in the coronal plane (60 μm) using a 
vibratome (Leica VT1000 S). Every second section was mounted on gelatin-subbed slides and 
stained for Nissl bodies using cresyl violet (coverslipped with DPX mounting medium). 
5.3.5    Stereological Measures 
All prepared tissue was analyzed using Stereo Investigator (MBF Biosciences, Williston, VT, 
USA) integrated with a Zeiss Axio Imager A2 microscope (Carl Zeiss, Thornwood, NY). 
Experimenters were blind to subject genotype. Volumes were reconstructed from serial area 
scores using the Cavalieri Estimator probe in Stereo Invesigator. Neuronal cell populations were 
estimated using the Optical Fractionator probe, with cross sectional neuronal cell area estimated 
concurrently using the Nucleator probe. Measurements were made using a sampling frequency 
of every 2nd section, with the LGN appearing on 8-10 sections. Contours of the LGN for 
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volumetric measures were drawn at 2.5× magnification, and a standard stereotaxic atlas was used 
to determine borders (Paxinos & Franklin, 2004). All cell estimations were performed under 60× 
oil-immersion using the fractionator with a sampling grid of 250 × 250 µm and a counting box of 
30 × 30.  
5.3.6    Statistical Analysis 
All subjects were used for analysis (WT, n = 7; Dcdc2 KO, n = 7). Group differences on 
Pairwise Discrimination performance were analyzed using a 2 (Genotype; WT and Dcdc2 KO) x 
# (Weeks) repeated measures analysis of variance (ANOVA), where number of weeks varied by 
stimulus. All analyses used performance on the standard visual Pairwise Discrimination task as a 
covariate, to account for baseline differences between subjects. Group differences in volume and 
cellular measurements of the LGN (estimated neuron population and size within defined 
boundaries) were assessed using univariate ANOVAs. Examination of cell size distribution was 
conducted using a cumulative percent distribution. To examine group differences in cell size 
distribution, non–parametric analyses (Kolmogorov Smirnov; K-S) were conducted on the 
cumulative percent distributions of each Genotype. All statistical analyses were conducted using 
SPSS 19 with an alpha criterion of 0.05, two-tailed. 
5.4      Results 
5.4.1    Pairwise Discrimination 
A repeated measures ANOVA revealed no significant differences in Genotype on the standard 
Pairwise Discrimination task for percent correct across a 5 week period [F1,12 = .688, p>.05] 
(Fig. 5.2a). There was, however, a significant Week effect [F4,48 = 22.640, p<.01]. Both WT 
and Dcdc2 KOs scored progressively higher percent correct scores, indicative of learning. For 
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the next stage of testing (static Gabors), a repeated measure ANOVA was also performed on 
percent correct. This also revealed no significant differences in Genotype for percent correct 
across a 3 week period [F1,11 = 3.689, p>.05] (Fig. 5.2b). There was again, however, a 
significant Week effect [F2,22 = 6.683, p<.01] and a marginally significant Week x Genotype 
interaction [F2,22 = 3.356, p=.053], with WTs showing gradual improvement on this task while 
the Dcdc2 KOs did not (Fig. 5.2b). For the next stimulus (moving Gabors), repeated measures 
ANOVA revealed marginally significant differences in Genotype on the Pairwise Discrimination 
task (percent correct across a 6 week period, [F1,11 = 4.223, p=.064]; Fig. 5.2c). There was no 
significant effect of Week [F5,55 = .591, p>.05], with WTs showing only slight improvement 
over time (although they started at 84 percent correct). Lastly, a repeated measures ANOVA 
showed a significant Genotype effect [F4,44 = 1.752, p<.05] on the Pairwise Discrimination task 
when more difficult moving dots were used (percent correct across a 5 week period; Fig. 5.2d). 
WTs consistently scored higher compared to Dcdc2 KOs throughout this session, although we 
saw no Week effect [F4,44 = 1.752, p>.05] or interaction [F4,44 = .653, p>.05] (Fig. 5.2d). 
5.4.2    LGN Assessment 
A univariate ANOVA comparing LGN volumes revealed no main effect of Genotype [left: F1,12 
= .537, p>.05; right: F1,12 = .3.73, p>.05; total: F1,12 = .510, p>.05] (Fig 5.3a). Examination of 
LGN neuronal population also failed to show a significant effect of Genotype [left: F1,12 = .894, 
p>.05; right: F1,12 = .363, p>.05; total: F1,12 = 2.781, p>.05] (Fig. 5.3b), although results did 
trend for Dcdc2 KOs to exhibit fewer neurons than WTs. Comparisons of cumulative percent 
distributions between Dcdc2 KOs and WT controls using a Kolmogorov Smirnov test did reveal 
a significant K-S statistic (p<.05; Fig. 5.3c). Specifically, analysis of cell size distribution 
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revealed that Dcdc2 KO brains contain more small and fewer large LGN neurons compared to 
controls. 
5.5     Discussion 
The purpose of this study was to behaviorally and neuroanatomically evaluate Dcdc2 KO mice 
on motion perception, as well as visual thalamic (LGN) cellular composition. Dcdc2 KOs did in 
fact exhibit significant deficits on motion perception, especially as stimuli became more complex 
(i.e., moving dot patterns). We did not observe any significant learning impairments on the 
standard Pairwise Discrimination task, although learning and memory deficits have previously 
been observed in this mouse model on other more cognitive demanding tasks (Gabel et al., 2011; 
Truong et al., 2014). We did, however, observe deficits on the Pairwise Discrimination task 
specifically as motion was added to visual stimuli. Interestingly, both WTs and Dcdc2 KOs 
displayed better performance when motion was added to the stimuli, however, Dcdc2 KOs 
consistently scored lower on percent correct compared to WTs. After weeks of moving Gabor 
testing, subjects advanced to the most difficult task, moving dots. Here, Dcdc2 KOs showed 
percent correct means that hovered at chance levels while WTs consistently scored above chance 
after the first week of testing, and these scores showed a significant Genotype effect. 
Our findings are generally consistent with a “magnocellular” theory of dyslexia (Galaburda et 
al., 1994; Livingstone et al., 1991; Stein, 2001). This theory posits that both visual and auditory 
processing dysfunction associated with reading disability can be attributed to low-level 
processing deficits resulting from specific disruption to the magnocellular sub-systems of 
thalamic nuclei, and potentially elsewhere in sub-cortical sensory structures (Galaburda et al., 
1994; Livingstone et al., 1991; see Stein, 2001, for review). It is well established that the 
magnocellular component of the visual system is specialized for processing rapidly-changing 
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temporal information (e.g., motion). Although the literature surrounding this theory remains 
controversial, early studies conducted by Livingstone et al. (2001) and Galaburda et al. (2004), 
examining post mortem human brain tissue from dyslexic individuals revealed a reduction in the 
distribution of large cells (“magnocells”) versus small cells (“parvocells”) in both the lateral 
geniculate (visual) and medial geniculate (auditory) nuclei of the thalamus of these subjects 
(noting that a distinct magnocellular sub-system has not been identified in the human MGN). It is 
thought that a resulting disruption in temporal processing in both visual and auditory domains 
might make it difficult for individuals with dyslexia to process rapidly changing sensory input 
(Stein & Walsh, 1997). 
In the current study, all subjects underwent histological preparation and stereological evaluation 
and analysis of the cumulative distribution revealed that Dcdc2 KOs exhibited more small 
neurons and fewer larger neurons in the LGN. This is similar to what has been reported in 
dyslexic post mortem brains. Although, the mouse LGN does not contain the 6 layers of neurons 
as seen in cats and primates (Connolly and Van Essen, 1984; Dreher et al. 1976; Kaas et al., 
1972; Malpeli and Baker, 1975; Sherman et al., 1976), there has been evidence suggesting 
magno and parvo-like cells are scattered in “salt and pepper” fashion throughout the LGN in 
mouse (Piscopo et al., 2013). The findings of more small and fewer large LGN neurons observed 
in Dcdc2 KOs parallel clinical findings, and do support a magnocellular theory of dyslexia. 
It should be noted that the low sample size of 7 per genotype was a major limitation of this study. 
Additionally, the development and adaptation of the pairwise discrimination task to moving 
stimuli was another limitation. Future experiments should incorporate a larger n and may adjust 
the parameters of the stimuli (e.g., speed and contrast). The level of difficulty when transitioning 
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from moving Gabors to moving dots was greater than anticipated, and it would be ideal to insert 
an intermediate version of the task  in future studies. 
Overall, our results compliment findings that DCDC2 genetic alteration results in anomalies in 
visual motion pathways in a subpopulation of dyslexic patients (Cicchini et al., 2015; Gori et al., 
2015). DCDC2 appears to play a role in the development neural processes governing typical 
motion perception, and our results are the first to directly evaluate the association between 
DCDC2 and motion perception using transgenic mice. Through ongoing phenotyping of mouse 
models, we can continue to gain insight on the role of individual genes critical to the polygenic 
developmental cascade subserving language abilities, including reading. Continued research may 
support more advanced early screening, as well as genetically-driven individualized treatment 





















Figure 5.2. Pairwise discrimination performance of Dcdc2 KO mice across various stimuli. 
Overall percent correct was analyzed across weeks. (a) Static Images. (b) Static Gabors. (c) 
Moving Gabors. (d) Moving Dots.  Data shown are mean ±SEM for each group, n = 7 for each 










Figure 5.3. Lateral geniculate nucleus assessment of Dcdc2 KO mice. (a) LGN Volume. (b) 













Behavioral characterization of Shank3B knockout mice 
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6.1     Abstract 
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by a core set 
of atypical behaviors in social-communicative and repetitive-motor domains. Individual profiles 
are highly heterogeneous, and language abilities in ASD range from nonverbal to hyperlexic. To 
date, causal mechanisms underlying ASD remain poorly understood, but appear to include a 
complex combination of polygenic and environmental risk factors. Heritability rates vary from 
70-90% and up to 1,000 risk genes have been identified, pointing to a complex genetic 
architecture. SHANK3 (SH3 and multiple ankyrin repeat domains 3) is among a handful of 
highly-replicated ASD-risk genes, with haploinsufficiency of SHANK3 following deletion or de 
novo mutation seen in about 1% of non-syndromic ASD. SHANK3 is a synaptic scaffolding 
protein enriched in the postsynaptic density of excitatory synapses. In order to more closely 
evaluate the contribution of SHANK3 to neurodevelopmental expression of ASD, a knockout 
mouse model with a mutation in the PDZ domain was developed. Initial research showed 
compulsive/repetitive behaviors and impaired social interactions in these mice, replicating two 
core ASD features. The current study was designed to further examine Shank3B heterozygous 
and homozygous knockout mice for behaviors that might map onto atypical language in ASD 
(e.g., auditory processing, and learning/memory). We report findings of atypical sensorimotor 
and social behaviors (replicating prior reports), as well as new evidence that Shank3 KO mice 
have typical auditory processing abilities with specific low-level enhancements (mapping onto 





6.2     Introduction 
Autism Spectrum Disorders (ASDs) are a set of neurodevelopmental disorders characterized by a 
complex behavioral phenotype, encompassing deficits in both social and cognitive domains. The 
core symptoms range from atypical social interactions and language impairments to repetitive 
behaviors (American Psychiatric Association, 2013). Accordingly, individual cases range 
substantially in severity and presentation of symptoms. Currently, the estimated prevalence in the 
United States identifies 1 in 68 children as having ASD, with a strong male bias among those 
diagnosed (1 in 42 boys versus 1 in 189 girls) (Elsabbagh et al., 2012; Newschaffer et al., 2007). 
To date, causal mechanisms underlying ASD remain poorly understood, but likely include a 
complex combination of polygenic and environmental risk factors (Moreno-De-Luca, 2013). 
Ongoing ASD research has been focused on investigating the genetic and neurobiological 
mechanisms of ASD, based on the notion that characterization of the varied neurogenetic 
features of ASD could provide insight to the diverse behavioral symptoms and variability 
observed. Multiple lines of evidence suggest the genetic contribution in ASD appears to be 
strong.  For example, monozygotic twin studies estimate concordance rates as high as 70% - 
90%, which is greater than that of any other known cognitive and/or behavioral disorders (Bailey 
et al., 1995; Rosenberg et al., 2009; Steffenburg et al., 1989). Furthermore, the recurrence 
estimates of infants with at least 1 older sibling with ASD are more than tenfold higher 
(Constantino et al., 2010; Ozonoff et al., 2011). Additionally, there are documented familial 
patterns of inheritance for qualitatively similar phenotypes (albeit with less severe behavioral and 
cognitive deficits, but falling under the broader autism phenotype) in first-degree relatives of 
identified probands, further supporting heritability of ASD (Bolton et al., 1994;  
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Bishop et al., 2004). Besides the strong monogenic risk factors that underlie syndromes such as 
Fragile X and Rett, the relative proportion of ASD that can be accounted for by either rare or 
common genetic variation remains to be determined and no single gene has been identified as a 
major cause. In fact, it is suggested that over 1,000 genes are involved in ASD, reflecting a 
complex genetic architecture (De Rubeis & Buxbaum, 2015). Additionally, no one of these 
known genetic contributors accounts for more than 1-2% of the phenotypic variance seen in 
ASD, despite the strong inheritance pattern (Abrahams & Geschwind, 2008).  
One highly replicated ASD-risk gene is SHANK3 (SH3 and multiple ankyrin repeat 
domains 3), which is a synaptic scaffolding protein enriched in the postsynaptic density of 
excitatory synapses, and that plays a crucial role in synaptic plasticity Grabrucker et al., 2011; 
Naisbitt et al., 1999). Heterozygous deletions or point mutations of SHANK3 are thought to be 
the main cause of Phelan–McDermid Syndrome (PMS, also referred to as 22q13 Deletion 
Syndrome) -- a genetic disorder characterized by global developmental delays, delayed or absent 
speech, moderate to severe intellectual disability, dysmorphic features, neonatal hypotonia, 
seizures, and a strong co-morbidity with ASD (Bonaglia et al., 2001; Harony-Nicolas et al., 
2015; Phelan, 2008; Phelan and McDermid, 2012). Haploinsufficiency of SHANK3 due to 
deletion or de novo mutations is seen in approximately 1% of autism spectrum disorder (ASD) 
cases, making SHANK3 abnormalities one of the most common genetic causes of autism (Durand 
et al., 2007; Moessner et al., 2007; Buxbaum, 2009; Betancur and Buxbaum, 2013; Boccuto et 
al., 2013). Additionally, SHANK3 variants have been linked to other non-syndromic ASDs, as 
well as schizophrenia and intellectual disability (Gauthier et al., 2010; Gong et al., 2012). 
Abnormal dosage of SHANK3 shows particularly robust effects on cognitive and 
language development (Bonaglia et al., 2001; Durand et al., 2006). Language is the most 
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significantly affected developmental domain, although deficits are variable and unpredictable 
(Durand et al., 2006; Zwanenburg et al., 2016). Impairments are also more prevalent in 
expressive than receptive language, consistent with severely delayed or absent speech in 
individuals with PMS. For instance, in a study evaluating 32 participants with PMS, none used 
phrase speech on a daily basis, and 19% used only single words to communicate (Soorya et al., 
2013). Individuals with PMS also show deficits in using and understanding gestures and other 
forms of nonverbal communication, such as eye contact and facial expression. Therefore, it is 
thought that SHANK3 participates in the assembly of specialized postsynaptic structures and 
neural circuitry necessary for the development of language and social communication (Durand et 
al., 2007).  
There has been accumulating evidence suggesting that language impairments observed in 
ASD could be a consequence of atypical auditory processing. Whereas many studies have linked 
deficits in rapid acoustic processing with emergent language and reading disorders (e.g., SLI and 
dyslexia; Benasich ref here), there are also robust findings within ASD populations of specific 
enhancements in low-level acoustic tasks (e.g., pitch discrimination) (Bonnel et al. 2010, 2003; 
Eigsti & Fein, 2013; Heaton 2003, 2005; Jones et al. 2009). Increased sensitivity to pitch may be 
particularly associated with difficulties generalizing across simple acoustic information to form 
broader phonemic categories, which would negatively impact language development (Eigsti & 
Fein, 2013). These aberrant perceptual processing may also relate to the core features of ASD, 
for example social and communication deficits. However, little animal or genetic research has 
focused on the low-level perceptual superiorities seen in ASD, regardless of their implications 
for higher-level cognition and language. Therefore, it is difficult to associate particular 
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underlying genetic and neurobiological mechanisms to the auditory enhancements seen in 
individuals with ASD. 
 In order to more closely evaluate the contribution of SHANK3 in neurodevelopment and 
behavior, a knockout mouse model with a mutation within the PDZ domain was created by the 
Feng lab (Peca et al., 2011). This Shank3B line includes a neo-cassette which replaces exons 13–
16 of the Shank3 gene, resulting in a deficiency of isoforms Shank3α and Shank3β, and a 
reduction in expression of the Shank3γ isoform. Initial research found that genetic disruption of 
Shank3 in mice leads to compulsive/repetitive behavior and impaired social interactions, thus 
modeling two of the core features of ASD.  Biochemical and electrophysiological studies further 
revealed synaptic dysfunction at cortico-striatal synapses -- part of the atypical neural circuitry 
strongly implicated in ASD (Peca et al.,2011). More recent research revealed that Shank3B 
heterozygous mice were slower to reach criterion in a pairwise visual discrimination task, 
indicating a deficit in discrimination learning in the Shank3B model of PMS and ASD (Copping 
et al., 2016).  
The current study was designed to further examine the behavioral profile of Shank3B 
heterozygous and homozygous knockout mice, specifically with regard to features that might 
map onto atypical language. Measures included acoustic processing of rapid and complex 
stimuli, sensorimotor functions, and social/communicative interactions, as well as learning and 
working memory. Our findings provide additional insight on how disruption of SHANK3 may 
alter fundamental processes required to develop typical language abilities. Ongoing research may 
promote enhanced early screening of infants, as well as individualized early-intervention 
treatments for children with ASD risk factors that indicate high probability of subsequent 
language and communicative impairments. 
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6.3     Methods and Materials 
6.3.1    Subjects 
Heterozygous breeding pairs were purchased from The Jackson Laboratory (Bar Harbor, Maine, 
B6.129-Shank3tm2Gfng; stock #01768). Subjects were generated from Het × Het breedings. 
Genotypes were determined by PCR of mouse ear punch DNA using (GAGACTGATCAG 
CGCAGT TG) Common, (TGACATAATCGCTGGCAAAG) Wild type Reverse and 
(GCTATACGAAGTTATGTCGACTAGG) Mutant Reverse. Only male subjects were assessed 
on subsequent behavioral measures. All subjects were single-housed in standard mouse tubs (12 
h/12 h light/dark cycle), with food and water ad libitum. Procedures were performed blind to 
genotype, and in compliance with the National Institutes of Health and University of 
Connecticut’s Institutional Animal Care and Use Committee (IACUC). 
6.3.2     Rotarod P60 
Subjects were assessed at age P60 for sensorimotor ability and motor learning using 
a rotarod task. All mice were habituated to the rotarod a day prior to testing, where they were 
placed on a rotating cylindrical drum that was held at a constant speed of 4 rotations per minute. 
Subjects underwent 4 trials that maxed out at 2 minutes. Testing began the following day with 
subjects placed on a rotating cylindrical drum that accelerated from 4 to 40 rotations per minute 
across 2 minutes. Four trials were administered per day, across five consecutive days. Latency to 
fall from the rotating drum was averaged across the four trials for each day.    
6.3.3    Marble Burying P65 
Subjects were placed in a standard polycarbonate cage (26 cm × 48 cm × 20 cm) filled with fresh 
mouse bedding (5cm deep) for the marble burying test. Standard glass toy marbles (assorted 
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styles and colors, 15 mm diameter, 5.2 g in weight) were placed on the surface of the bedding in 
3 rows of 7 marbles. A marble was considered buried if at the end of the 45 minute session the 
marble was more than half-way covered by bedding. Subjects were given 45 minutes to explore 
the area; number of marbles buried and time spent grooming were reported and used for analysis. 
6.3.4    Social Dominance – Tube Task P67 
The Tube Test was administered to evaluate social dominance/aggression. The tube used for this 
task was a clear plexiglas tube (length 30.5cm; outer diameter 4.5cm; inner diameter 3.5cm). 
This narrow space is just sufficient for a mouse to walk through without being able to reverse 
direction. Mice were trained to walk through the tube before testing. A WT and a mutant mouse 
were randomly paired on different sides of the tube (balanced), and released at the same time 
into the tube. The mouse that forced the other mouse to back out of the tube was considered the 
“winner” of the trial (recorded for analysis). Each mouse underwent 4 trials paired with a 
different randomly assigned subject and the percentage of wins was calculated and analyzed. 
Mice were not paired within Genotype since by definition this would yield a score of 50%. 
6.3.5    Three Chamber Social Preference and Recognition P72 
The Three-Chamber test was used to assess general sociability as well as social recognition.  
This test derives from observations that healthy wild-type mice typically prefer to spend time 
with a conspecific (social stimulus) rather than an object (non-social stimulus).  After a 5 min 
habituation period, the subjects were allowed to freely explore three chambers, with one 
containing another “stranger” mouse, and another chamber on the opposite side containing a 
novel object. The subject was placed into the middle (empty) chamber and was able to freely 
explore all the chambers for 10 min. Next we placed an unfamiliar conspecific mouse (“stranger 
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2”) where the novel object was previously located, and subjects were given another 10 min to 
explore the chambers. The percent time spent interacting with the mouse during the social 
preference phase, and percent time spent interacting with the novel mouse during the social 
recognition phase, were recorded and analyzed. 
6.3.6    Auditory Processing P78 – P114. 
Subjects then advanced to auditory processing testing, which utilizes a modified pre-pulse 
inhibition paradigm (see Fitch et al., 2008 for review). Subjects were placed on individual load-
cell platforms (Med Associates, St. Albans, VT) and presented with auditory stimuli generated 
using RPvdsEx on a Dell Pentium D PC and RZ6 multifunction processor (Tucker Davis 
Technologies, Alachua, FL). Sounds were amplified using a Niles SI-1260 Integration Amplifier 
(Niles Audio Corp., Carlsbad, CA) and delivered through powered Yamaha YHT-M100 speakers 
(Buena Park, CA). The acoustic startle reflex (ASR; a reflexive response elicited by an 
unexpected, intense stimulus) was recorded by an iMac 7.1 running Acknowledge 4.1, and 
obtained via the voltage output from each load cell platform through a linear amplifier (PHM-
250U; Med Associates, St. Albans, VT) connected to a Biopac MP150 acquisition system 
(Biopac Systems, Goleta, CA). The modified pre-pulse inhibition paradigm measured differences 
in ASR to a loud startle-eliciting stimulus (SES; 105dB, 50 ms, broadband white noise burst 
(1kHz-10kHz)) when presented with or without a preceding acoustic cue. The ASR difference on 
cued versus uncued trials provided a measure of cue detection and/or discrimination. If the 
auditory cue was detected, a reduction (attenuation) in the ASR was expected relative to the ASR 
elicited when the auditory cue was not present (or not detected). This phenomenon was 
quantified using an “attenuation score” (ATT) that compared the average amplitude of the ASR 
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from the cued trial to the average ASR of the uncued trial ([average cued ASR/average uncued 
ASR]*100). 
6.3.6.1             Normal Single Tone P78 
Animals were initially tested on Normal Single Tone (NST) to measure baseline pre-pulse 
inhibition and auditory ability (P78). This auditory PPI control task was used to establish 
whether subjects exhibited hearing deficits and/or impaired gross motor reflexes that could 
confound other auditory PPI tests, and provided an index of baseline auditory pre-pulse 
inhibition ability across test groups. Testing sessions consisted of 104 pseudorandomly presented 
cued and uncued trials at inter-trial intervals (ITI) of varying duration (16–24 s). The task 
comprised a silent background and a simple single tone cue (50 ms, 75 dB, 8,000 Hz tone) 
presented 50 ms prior to the 50 ms, 105 dB SES. All subjects were able to perform this task, and 
therefore were used for further auditory processing evaluation.  
6.3.6.2             Embedded Tone P82-P93 
The variable duration Embedded Tone (EBT) task (300 sequential pseudorandom trials) assessed 
ability to detect a change in tone frequency relative to a standard background tone (cue was a 
variable duration 5.6 kHz pure tone embedded in a 10.5 kHz background pure tone). On cued 
trials, the cue was presented 100 ms before the SES, while uncued trials used a "cue" of 0 ms. 
Two EBT tasks were used in this study – a long-duration EBT (0 ms to 100 ms), and a short-
duration EBT (0 ms to 10 ms). A range of cue durations were used to evaluate specific thresholds 
for performance differences between the genotypes, since groups might perform comparably on 
longer durations yet differ on shorter durations (which are more difficult to detect). Using a 
range of cue durations enables ascertainment of stimulus features that all animals can 
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discriminate (ceiling), that no animals can discriminate (basement), as well as any group 
differences in the mid-range. Both EBT tasks were administered for five consecutive days (P82-
P93).   
6.3.6.3             Silent Gap P96-107 
A Silent Gap (SG) task was used to assess ability to detect silent breaks in continuous white 
noise (P96 to P107). A session included 300 trials with a continuous 75 dB broadband white 
noise background, with pseudorandomized cued and uncued trials. On cued trials, a silent gap of 
variable duration (0-100 ms or 0-10 ms) was presented 100 ms before the SES, while a "0 ms" 
trial served as the uncued condition. Subjects were tested on the Silent Gap task for five 
consecutive days using both versions of the task. 
6.3.6.4             Pitch Discrimination P110-P114 
Pitch discrimination testing also took place across five consecutive days of testing (300 
trials/day). This task assessed ability to detect very small changes in pitch embedded in a 
background tone. A variable ITI (16–24s) was used, and the cue was a 300 ms, 75 dB tone of 
variable frequency embedded in a standard 75 dB, 10500 Hz background pure tone (2 ms 
up/down linear frequency ramp) prior to the SES. The experimental frequencies used for the 
pitch discrimination task deviated from the standard background frequency by as much as 75 Hz, 
to as little as 5 Hz. Uncued trials did not include a frequency deviant prior to the SES. 
6.3.5    Water Maze Testing P120-135 
Subjects were initially tested on a water escape to assess any underlying impairments that might 
confound further maze testing (i.e., deficits in motivation, swimming, or visual acuity). Subjects 
were placed in the far end of an oval tub (103 cm × 55.5 cm) filled with room temperature water, 
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and given 45 seconds to swim to a visible escape platform (8.5 cm in diameter; 1 cm above water 
surface) at the opposite end of the tub. Latencies to reach the visible platform were recorded. 
None of the subjects displayed any impairment on this task, and thus all subjects then progressed 
to a water version of the 4/8 radial arm maze (adapted from Hyde, Hoplight & Denenberg, 
1998). 
This task was used to assess spatial reference and working memory ability 
simultaneously, using a standard 8 arm radial maze with 4 arms baited (i.e., containing a 
submerged goal platform), and 4 arms open but never baited. Configuration of goal arms were 
counterbalanced between subjects but remained fixed per subject across all sessions. 
Additionally, high contrast extra-maze cues were present, and the locations of these remained 
static for the experiment. 
The day prior to testing (Day 1), subjects were given a training session where all arms 
that would not contain a platform were blocked, forcing the animals to only enter arms 
containing a platform. Subjects were placed in the start arm and given 120 seconds to locate a 
platform. Every subject completed 4 training trials, and each time they found a platform, that 
platform was removed and the entrance to that arm was blocked. This ensured that the subject 
could no longer enter this arm for the remainder of the training session. If the subject failed to 
find a platform in this window, they were guided to the nearest available goal. Once on the 
platform, subjects remained for 20 seconds and then were removed from the maze to their home 
cage (30 second inter-trial interval; ITI). 
Testing began on Day 2 and continued for an additional 14 consecutive days. Here, 
instead of blocking the goal arm of the most recently located platform, the platform was removed 
during the 30 second ITI. However, the arm remained open and unbaited for the remainder of the 
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test session. Animals were required to locate all 4 platforms, and thus received 4 test trials per 
day. Test sessions were recorded using a Sony camera integrated with the SMART video-
tracking program (Panlab, Barcelona, Spain). Total number of errors were recorded and used for 
analysis. 
6.4      Results 
6.4.1   Rotarod 
A repeated measures ANOVA examining average rotarod latency across 5 days of testing 
showed no main effect of Genotype on rotarod [F2,25 = .148, p>.05], indicating no overall 
difference in performance on the rotarod (and hence sensorimotor function) between the 
wildtype and mutant groups.  There was, however, a significant Genotype × Day interaction 
[F8,100 = 2.130, p<.05], with WTs and HTs showing similar learning curves across days but 
Shank3B KOs exhibiting a delay in improvement (increasing latency) across days. This 
interaction indicates a motor learning impairment in the KO group. There was also a main effect 
of Day [F4,100 = 20.307, p<.01], with all Genotypes showing some increase in latency on the 
rotarod as testing progressed, indicative overall motor learning of varying degrees (Fig. 6.1a).  
6.4.2    Marble Burying 
A univariate ANOVA revealed a main effect of Genotype [F2,25 = 9.636, p<.01] on marble 
burying, with WTs burying significantly more marbles (Fig. 6.1b). However, further analysis 
revealed Shank3B KOs spent significantly more time grooming during the marble burying task 




6.4.3    Social Dominance 
Social dominance (tube task) was conducted to evaluate social dominance. Number of wins was 
calculated as a percentage of the 4 trials. A univariate ANOVA revealed a main effect of 
Genotype [F2,25 = 3.373, p=.05], with Shank3B  KOs winning significantly more trials compared 
to HTs and WTs (Fig. 6.1d). 
6.4.4    Three Chamber - Social Preference and Recognition 
On the three-chamber social interaction tasks we did not find a main effect of Genotype, either in 
the social preference phase [F2,25 = .151, p>.05] (Fig. 6.1e), or the social recognition phase [F2,25 
= .352, p>.05] (Fig. 6.1f). On all tasks, WTs, HTs and KOs mice spent a comparable percentage 
of time exploring the social stimuli (social preference - mouse; social recognition - novel 
mouse).  
6.4.5    Auditory Processing 
All subjects were initially tested on a normal single tone (NST) task, to establish baseline hearing 
and PPI ability. None of the subjects showed impairments on NST, nor was there a main effect 
of Genotype [F2,25 = 1.305, p>.05]. We did however control for individual variations in baseline 
auditory prepulse inhibition (PPI) performance by using NST attenuation scores as a covariate 
for analysis of additional tasks. On the embedded tone (EBT) 0-100 ms task, we found no main 
effect of Genotype [F2,25 = .171, p>.05], with all subjects able to discriminate the stimuli based 
on cued/uncued amplitude comparisons (Fig. 6.2a). On the more difficult embedded tone task 
(cue durations ranging from 0 to 10 ms, where 0 ms is the uncued condition) we also failed to 
find a main effect of Genotype [F2,25 = .379, p>.05] (Fig. 6.2b). For silent gap detection, we 
assessed performance on the 0-300 ms task and again saw no main effect of Genotype [F2,25 = 
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.041, p>.05] (Fig. 6.2c). On the silent gap 0-100 ms task we saw overall worse performance 
(attenuation scores hovering around 100 or chance levels), and again no main effect of Genotype 
[F2,25 = 1.667, p>.05] (Fig. 6.2d). On the pitch discrimination task, we also failed to find a main 
effect of Genotype when analyzing across all Days [F2,25 = .331, p>.05] (Fig. 6.2e). However, we 
did see a Day [F4,100 = 2.774, p<.05], and a Day x Genotype interaction [F8,216 =2.113, p<.05] 
reflecting the fact that Shank3b KOs exhibited significantly better discrimination of subtle 
differences in pitch during the initial testing sessions [Days 1-2; F1,13=5.132, p<.05] (Fig. 6.2f). 
6.4.6    Water Maze Testing 
Prior to spatial water maze testing, a visible platform control task was conducted to assess any 
underlying impairments that could confound subsequent water maze performance (e.g., 
impairments in swimming ability, visual acuity, or motivation). A univariate ANOVA on 
latencies found no main effect of Genotype [F2,25 = 1.060, p>.05] indicating that genetically 
modified groups had no impairments on underlying aspects of the water task (e.g., swimming). 
The 4/8 radial arm water maze was used to simultaneously measure spatial working and 
reference memory performance. A repeated-measures analysis of the average number of total 
errors (working memory, initial reference, and repeated reference memory errors) revealed 
significant effect of Genotype [F2,25 = 4.031, p<.05] (Fig. 6.3a). A main effect of Day 
[F13,325=5.611, p<.01] was observed, confirming that all groups reduced errors across days (i.e., 
showed learning). We also examined group differences in error types including total reference 
memory, initial reference memory, repeated reference memory, and working memory. Again 
repeated measures ANOVA revealed a significant main effect of Genotype on total reference 
memory [Genotype: F2,25 = 5.600, p<.05], initial reference memory [Genotype: F2,25 = 6.488, 
p<.05] and repeated reference memory errors [Genotype: F2,25 = 4.491  p<.05]) but not working 
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memory errors working memory [F2,25 =1.461, p>.05] (Fig. 6.3c). There were no significant 
differences in Genotype on latency to platform [F2,25 = .067, p>.05] (Fig. 6.3d).  
 
6.5      Discussion  
The current study was designed to further examine the behavioral profile of Shank3B 
heterozygous and homozygous mutant mice, specifically with regard to features that might map 
onto atypical language in ASD (e.g., auditory processing skills, learning and memory). Subjects’ 
sensorimotor ability and social behavior were also examined to confirm consistency with prior 
reports. Results showed that Shank3B KOs display particular enhancements in pitch 
discrimination, together with repetitive behaviors and learning impairments. 
6.5.1    Shank3B KOs exhibit ASD-like behaviors 
Previous studies  behavioral characterizing Shank3B KO mice found that genetic disruption of 
Shank3 leads to compulsive/repetitive behavior and impaired social interaction, which are two 
core symptoms of ASD (Peça et al., 2011). Here, we assessed Shank3B mutants on marble 
burying -- a task typically used to evaluate repetitive behaviors in transgenic mouse models of 
ASD. Shank3B KO mice did not show an increase in marble burying, however, when examining 
video recordings we found that Shank3B KOs spent significantly more time grooming compared 
to HTs and WTs, consistent with prior reports (Peça et al., 2011). Thus KOs did in fact exhibit 
enhanced repetitive behaviors, just not the behaviors we expected in that particular task. Related 
studies have shown that Shank3B KOs display early cortical hyperactivity, which triggers 
increased striatal spiny projection neurons excitatory synapse and corticostriatal 
hyperconnectivty. This tight functional coupling between cortex and striatum during early 
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postnatal development may explain the repetitive/perseverative behaviors seen in this mouse 
model (Peixoto et al., 2016).  
Our results also expanded the atypical social phenotype observed in Shank3B mutants 
with Shank3B KOs, specifically by showing that they display more dominant behaviors on the 
social dominance tube task. Although generally interpreted to reflect enhanced aggression, these 
results could also indicate a failure to perceive and process social cues when confronted with 
another mouse. Interestingly, we saw no significant differences on the three chamber task for 
both social preference and social recognition. This may reflect discrepancies in protocol across 
studies. Specifically, our subjects were given a choice to explore a mouse or a novel object, 
whereas other investigators have offered a choice between a caged cohort and an empty wired 
cage (Peça et al., 2011). Overall, our findings do replicate prior reports for the Shank3B mouse 
model, and affirm that this mouse model exhibits core ASD-like traits such as repetitive 
behaviors and altered social behavior. 
6.5.2    Shank3B KOs exhibit enhancements on pitch discrimination. 
Based on the language deficits observed in clinical patients with disruptions of SHANK3, and in 
ASD more generally, we explored auditory processing abilities in the Shank3B mutant mice. 
Enhanced low-level auditory processing has previously been associated with language deficits 
seen in ASD (Mottron et al., 2006). We found that Shank3B KO subjects performed equivalently 
to wild-types on all of the acoustic discrimination tasks, with the exception of a significant KO 
superiority observed on the pitch discrimination task. This is the most difficult of the tasks, since 
it requires detection of very small differences in frequency. Here, the Shank3B KOs were 
initially (Days 1 & 2) significantly better than wild types at the four conditions where any 
discrimination was seen: 10425 vs 10500 (△75 Hz), 10450 vs 10500 (△50 Hz), 10525 versus 
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10500 (△25 Hz) and 10550 vs 10500 (△50 Hz; F1,13=5.132, p<.05 for KO vs WT, with NST 
covariate). [The 5 more difficult PD conditions (from △5) failed to show discrimination by any 
group (ATT >95)]. This specific KO enhancement suggests an initial (intrinsic rather than 
learned) superiority among KOs on a fine-grained acoustic frequency discrimination (with HTs 
showing intermediate performance).  This is highly consistent with related studies showing 
robust local acoustic superiorities in other ASD mouse models. Specifically, Cntnap2 KOs 
showed superiority over matched wild-types on a fine-grained embedded frequency (EBT) and 
pitch discrimination (PD) task, while TS2-Neos showed acoustic superiority over matched wild-
types on virtually all ]acoustic discrimination tasks employed (Rendall et al., 2017; Truong et al., 
2015). Combined findings could reflect an interaction between intrinsic local acoustic 
superiorities in ASD models, and simultaneous learning deficits that degrade performance. In 
support of this view, TS2-Neo mice showed no learning deficits on a radial arm maze, coupled 
with significant superiority over wild-types on virtually all acoustic tasks employed (Rendall et 
al., 2017). Cntnap2s showed some mild (acquisition only) learning/memory deficits on a radial 
arm maze, coupled with significant acoustic superiorities on several (but not all) fine-grained 
acoustic tasks (EBT and PD; Truong et al., 2015). Here, Shank3Bs showed very robust 
(acquisition and retention) learning/memory deficits on a radial arm maze, along with more 
limited initial superiority on a PD task only. These results are important, since other investigators 
have shown that low-level acoustic enhancement in ASD may correlate with impaired language 
development, reflecting an initial failure to form distinct phonemic categories containing broadly 
generalized (e.g., co-articulated) variants of the core phoneme (Fein & Eigsti, xxxxx). Although, 
Shank3B KOs superiorities in auditory processing were not as prominent compared to the 
Cntnap2 and TS2-neo mouse model, our findings do parallel clinical evidence on sensory 
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sensitivity in children with PMS compared to children with idiopathic ASD (Mieses et al., 2016). 
Together this evidence suggests that language impairments seen in individuals with SHANK3 
mutations may be correlated to robust cognitive deficits as well as specific enhancements in pitch 
discrimination.  
6.5.3    Shank3B KOs demonstrated learning and memory impairments 
Investigators have previously assessed Shank3B on a Morris water maze task, and found KOs to 
performed comparably to WT controls in both learning and probe trials. There were also no 
differences found on reversal learning (Peça et al., 2011). However, another study showed 
Shank3B HTs were slower to reach criterion on a more difficult pairwise visual discrimination 
task (Copping et al., 2017). Here, we examined Shank3B HTs and KOs performance on a 
complex 4/8 radial arm water maze, and report that Shank3B KOs displayed robust deficits 
across different error types. Findings may relate to evidence that Shank3, KOs also exhibit a 
decrease in NMDA/AMPA excitatory postsynaptic current ratio in area CA1 of the 
hippocampus, as well as reduced long-term potentiation in area CA1, and deficits in 
hippocampus-dependent spatial learning and memory (Kouser et al., 2013). Both spatial learning 
deficits and decreased LTP in area CA1 of the hippocampus have also been reported in the 
Shank3e4–9 homozygous mutant mice (Bozdagi et al., 2010; Wang et al., 2011). Overall findings 
are consistent with SHANK3’s role in assembling postsynaptic structures and maturation of 
dendritic spines, which is altered in individuals with learning disabilities (Boeckers et al., 2002; 
Carlisle & Kennedy, 2005; Naisbitt et al., 1999). 
6.5.4    Conclusion 
The goal of the current study was to assess fundamental processes necessary to the 
development of typical language abilities in the Shank3B KO mouse model. We found that 
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Shank3B KOs exhibited normal sensorimotor learning, along with deficits in spatial learning. 
Interestingly, Shank3B KOs expressed some specifically enhanced pitch discrimination abilities 
compared to WT controls. These findings suggest that abnormal auditory processing as well as 
learning may contributing to language impairments seen in individuals with SHANK3 mutations. 
Both clinical studies and transgenic animal models provide us with indispensible tools in 
elucidating the underlying causes of neuromorphological, neurophysiological, and behavioral 
differences associated with language-related developmental disorders. Animal models can in 
particular be utilized to parse apart specific genetic contributions to the etiology/pathogenesis of 
core functional anomalies that underlie language-related disorders -- including some genetically 
mediated features that may be shared across clinically distinct disorders. Future studies of 
language-relevant processing skills in mouse ASD models will help to improve early screening, 
as well as the development of mechanism-based behavioral and possibly targeted 













Figure 6.1 – Shank3B KOs exhibit ASD-like behaviors. (A) Rotarod performance across 5 
days. (B) Number of marbles buried. (C) Grooming during Marble Burying. (D) Percent wins 
during Social Dominance Tube Test. (E) Social preference in 3 Chamber task. (D) Social 










Figure 6.2 - Shank3B KOs exhibit enhancements on pitch discrimination. (A) Embedded 
Tone 0-100 ms. (B) Embedded Tone 0-10 ms. (C) Silent Gap 0-300 ms. (D) Silent Gap 0-100 








Figure 6.3 - Shank3B KOs demonstrated learning and memory impairments. (A) Number of 
total errors. (B) Number of total reference memory errors. (C) Number of working memory 









Table 7.1 – Summary of behavioral data (Chapters 2 - 6) 
 
      ASD - like behaviors     Language intermediate phenotypes 





















KO - + = + - - N/A 
TS2-neo - + - = + = N/A 
Shank3b 
KO - + = + = - N/A 
Dyx1c1 co 
KO 
N/A N/A = = = - N/A 




















The collection of studies presented here provides important insight into the intricate 
relationship between genetic expression, neuroanatomical development, and behavioral 
outcomes in the context of language and reading related endophenotypes. To achieve our goal, 
we performed five experiments using transgenic mouse models. Each study was designed to 
examine loss or alteration of function of key genes highly associated with impaired 
language/communication and/or reading ability in clinical populations. Our findings provide 
valuable knowledge that may assist future development of personalized treatments targeted to 
underlying atypical neurobiology associated with language-related neurodevelopmental disorders 
(NDDs) (e.g., dyslexia and autism), including early behavioral interventions tailored to 
individual genetic risk factors. 
7.1     Summary of studies 
Acoustic processing ability, visual motion perception impairments, and working memory 
deficits all appear to contribute to emergent language problems. Here, we evaluated these 
behavioral disruptions across 5 models to understand how genetic and cellular mechanisms could 
influence behavioral impairments. A summary of all behavioral findings from the five models 
studied is displayed in Table 7.1. Overall, our data suggest that underlying disruptions in genetic 
factors crucial to neurodevelopment lead to subsequent deficits in fundamental processes, as well 
as anomalies of anatomic structure that underlie language related disorders. The present studies 
allow us to assess how these aberrant processes differ and overlap across varying targeted 
genetic and molecular mechanisms. This provides us with a foundational understanding of 
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behavioral and neuroanatomical vectors that could be involved in language disabilities, even 
though the biological etiology and neural substrates associated with language and reading related 
dysfunction in neurodevelopmental disorders such as dyslexia and autism remains unclear. 
Nonetheless, some major biological themes have emerged that pertain to our current results. 
These include genetic modulation of enhanced/diminished (maladaptive) synaptic plasticity; 
global disconnection disorders (i.e., hypo/hyper-connectivity, as observed in ASD); and/or 
developmental sub-cortical magnocellular defects as well as excitation/inhibition imbalance 
implicated in dyslexia. 
The enhanced acoustic processing observed in Cntnap2 KOs as well as Ts2-neo mice 
may be explained by enhanced synaptic plasticity, which is thought to be responsible for the 
superior perceptual processing observed in ASD (Mottron et al., 2014). A majority of the genes 
associated with ASD play a crucial role in the construction and maintenance of synapses, thus 
altering synaptic plasticity (Kelleher et al., 2008 and Baudouin et al., 2012; Bourgeron, 2015 for 
review). Furthermore, brain imaging studies have shown large-scale cortical reorganization in 
the autistic brain (Gillis and Rouleau, 2011 and Ronemus et al., 2014). Interestingly, the 
enhanced cross-modal plasticity observed in the ASD population is strikingly similar to that 
observed among individuals who are sensorially deprived (congenitally blind, congenitally deaf), 
wherein regional reorganization of brain functions also contributes to some modality-specific 
enhanced perceptual processing (Mottron, 2014). This superior perceptual processing could 
cause an inadvertent challenge for speech development (Heaton et al., 2008), since neural 
processes may shift to focus overly on irrelevant or low-level dimensions of language that are 
typically “ignored.” This theory of ASD is consistent with the “functional hypo-connectivity” 
and/or “weak central coherence” accounts (Happé and Frith, 2006). Weak central coherence 
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purports that individuals with ASD are biased towards local processing, at the expense of global 
processing crucial to language skills. It has been also been suggested that working memory may 
be specifically disrupted in ASD, also in association with a connectivity deficiency of 
corticocortical regions (Di Martino et al., 2014). Moreover, observed impairments in working 
memory in individuals with ASD seem be the result of a global disconnection rather than a 
focused deficit in the prefrontal cortex, as revealed in neuroimaging research (Barendse et al., 
2013). This disconnection may result in problems with sensory integration, and therefore disrupt 
learning, which could explain why Cntnap2 KOs exhibit delayed learning on a complex maze 
task. The magnocellular theory of dyslexia may further support the findings observed in the 
Dcdc2 KOs performance on a motion perception discrimination task (Galaburda et al., 1994; 
Livingstone et al., 1991; Stein, 2001). The magnocellular theory of dyslexia posits that both 
visual and auditory processing dysfunction associated with reading disability can be attributed to 
lower level processing deficits resulting from specific disruption to the magnocellular sub-
systems of thalamic nuclei, and potentially elsewhere in sub-cortical sensory structures 
(Galaburda et al., 1994; Livingstone et al., 1991; see Stein, 2001, for review). It is well 
established that the magnocellular component of the visual system is specialized for processing 
rapidly-changing temporal information (e.g., motion). Although the literature surrounding this 
theory remains controversial, early studies conducted by Livingstone et al. (2001) and Galaburda 
et al. (2004), examining post mortem human brain tissue from dyslexic individuals, revealed a 
reduction in the distribution of large cells (“magnocells”) versus small cells (“parvocells”) in 
both the lateral geniculate (visual) and medial geniculate (auditory) nuclei of the thalamus of 
these subjects (with disclaimer that a distinct magnocellular sub-system has not been identified 
in the MGN). It is thought that temporal imprecision in both visual and auditory domains might 
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lead to deficits for individuals with dyslexia in processing rapidly changing sensory input (Stein 
& Walsh, 1997).  
Future research should further investigate the above biological theories to aid in the 
understanding of the casual mechanisms underlying these disorders. Additionally, studies should 
incorporate female subjects into studies to gain a better understanding of the sex differences 
observed in neurodevelopmental disorders. Sexually dimorphic disease prevalence is well 
recognized but poorly understood. For instance, males are diagnosed with dyslexia much more 
frequently than females (Finucci &Childs, 1981; Vogel, 1990; Hawke et al., 2007; Olson, 2002), 
and autism also shows a strong male bias with approximately 4 affected males for every 1 
affected female. These sex differences currently remain unexplained. 
7.2     The Research Domain (RDoC) approach. 
It is essential to gain better understanding of the causes of NDDs because this will allow 
for earlier detection and more refined innervation that is mechanistically driven. By studying 
transgenic mouse models we are able to assess the role of individual genes in modulating 
biological and behaviorally phenotypes. Due to the heterogeneity and complexity of higher-order 
functions implicated in disorders of language and social communication, it is crucial to 
deconstruct diagnostic outcomes into simpler behavioral “intermediate phenotypes” to examine 
what fundamental processes are contributing to deficits. Thus behavioral phenotypes can more 
easily be associated with individual genetic mechanisms, and also can identify shared features 
across disorders. As we know, genes implicated in NDDs are overlapping for numerous complex 
disorders including autism, dyslexia, specific language impairment, intellectual disability, 
schizophrenia, and bipolar disorder. The use of more fine-grained functional measures will allow 
for a highly focused analysis of how genes are specifically contributing to behavioral and/or 
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functional components within a broader domain. This approach is parallel to the National 
Institute of Mental Health’s (NIMH) Research Domain Criteria (RDoC) project that aims to 
create a framework for research on pathophysiology, especially for genomics and neuroscience, 
which will ultimately influence future classification techniques of neuropsychiatric disorders, 
including neurodevelopmental disorders (Insel et al., 2010). 
 Current versions of the Diagnostic and Statistical Manual of Mental Disorders (DSM) 
and International Classification of Diseases (ICD) have historically facilitated reliable clinical 
diagnosis and research. However, recent evidence emerging from clinical neuroscience and 
genetics fail to support diagnostic categories based on these established clinical criteria. This 
suggests that the boundaries of these categories are not capturing fundamental underlying 
neurobiological and genetic mechanisms that are contributing to the disorder as a whole. A major 
consequence of these limitations is the slow development of novel mechanism-based treatments 
that appropriately target the pathophysiology of the disorder (Insel et al., 2010). Therefore, it is 
essential for research as well as application to move towards developing a classification system 
based upon dimensions of neuroscience, genetics, and observable behavior. 
7.3     Treatment of neurodevelopmental disorders 
Neurodevelopmental disorders first appear during early development and are indexed by 
atypical milestones that emerge from infancy to school age. NNDs are caused by a variety of 
genetic and environmental conditions (Ehninger et al., 2008). The molecular and neuronal 
mechanisms underlying the clinical phenotype of non-syndromic NNDs remain largely 
unknown. However, NDDs are relatively common, affecting ~1-2% of the population, yet 
clinicians possess limited options for intervention and treatment. Yet, there is a growing and 
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constant demand for effective services and treatments for NDDs due to the fact that symptoms 
persistent across an individual’s life span.  
Abnormal brain development in NDDs comprises a sequence of critical periods and 
abnormalities occurring during early development. Alterations in development, (i.e., disruptions 
in neurogenesis, cell migration, and neuronal connectivity) are all potential vectors responsible 
for the irreversible behavioral deficits that emerge in childhood and persist in adulthood. 
However, recent animal model studies of neurodevelopmental disorders show that targeting the 
underlying molecular and cellular dysfunction could substantially reduce symptoms and improve 
cognitive function, possibly even via treatments initiated in adulthood. For example, it is possible 
that biochemical amelioration of the underlying genetic deficits may promote plasticity in the 
adult brain to compensate for, or even correct, specific developmental pathologies (Ehninger et 
al., 2008). These findings suggest that pharmacological treatments in combination with 
rehabilitation might alleviate and possibly reverse the symptoms of NDDs even after the end of 
critical developmental periods. Although this field of research is in its infancy, cumulative 
findings provide a rational and promising basis for treatment of NDDs.  
7.3.1    Dyslexia 
Currently, treatment of dyslexia consists of defining the disorder and advising parents. 
Subsequent treatment depends on the severity of dyslexia and psychological symptoms or 
concurrent disorders. There are no current pharmacological treatments available for dyslexia 
since it is thought that drug treatments are not beneficial; however, this avenue has not been fully 
explored. Only if the individual has ADHD or another comorbid disorder they will receive drug 
treatment along with psychotherapy.  
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 Early studies focused on Piracetam, a nootropic compound known for its learning and 
memory enhancing properties. Specifically, Piracetam modulates neurotransmission of 
cholinergic and glutamatergic systems and exhibits neuroprotective and anticonvulsant 
properties while also improving neuroplasticity. Although findings have been inconsistent, most 
studies reported a significant effect of Piracetam relative to placebo for outcomes that include 
verbal learning, reading speed and/or accuracy (Di Ianni et al., 1985; Levi & Sechi, 1987; Tallal 
et al., 1986; Van Hout & Giurgea, 1990; Wilsher, Atkins &Manfield, 1978; Wilsher et al., 1987). 
Overall, the improvement of cognitive symptoms with Piracetam have been shown to be modest, 
however, outcomes took months to manifest and were optimized when combined with 
educational programs (Winbald, 2005). More recent studies also point to targeting the 
glutamergic system, which may have significant potential for treating dyslexia. 
 Although there are no current pharmacological agents available to treat dyslexia, there 
are some potential avenues that can be explored. For instance, there was inconsistent spike 
timing observed in Dcdc2 KO mice that may be due to an up-regulation in Grin2B expression (a 
gene that encodes the 2B subunit of NMDA receptors) observed in these animals (Che et al., 
2013). The NMDA receptor is an ionotropic glutamate receptor that plays a role in synaptic 
plasticity, as well as memory function. Further electrophysiological experiments found that 
treating affected mice with an NMDA receptor antagonist led to increased temporal precision, 
thus rescuing the noisy spike timing phenotype in Dcdc2 KOs. This is consistent with evidence 
that low-level sensory processing deficits that require precise timing mechanisms underlie 
phonological impairments seen in dyslexia (Hancock, Pugh & Hoeft, 2017).  Neural excitability 
and neural noise are crucial to these temporal processes and therefore, targeting these 
mechanisms may be beneficial to individuals with dyslexia. Studies of endogenous 
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neurochemistry in humans also point towards increased excitability. Specifically, an overall 
negative association between reading skill and levels of glutamate was observed in the visual 
cortex of children with dyslexia (Pugh et al., 2014). Moreover, this excitation-inhibition 
imbalance is also suggested to be an outcome of abnormal pyramidal cell migration, as well as 
abnormal GABergic interneuron localization that has been associated with dyslexia risk genes 
Kiaa0319 and Dyx1c1 (Currier et al., 2011; Peschansky et al., 2010).  Fortunately, Memantine is 
a FDA-approved drug on the market, which is an uncompetitive NMDA-receptor antagonist used 
to treat cognitive symptoms of Alzheimer’s disease and vascular dementia. Future research (both 
pre-clinical and clinical) should study new pharmacological and behavioral approaches aimed at 
potentiating glutamatergic neurotransmission, particularly at NMDAR-type glutamate receptors.  
7.3.2    ASD 
 There is a growing and constant demand for effective services and treatments for ASD, 
due to the fact that symptoms persistent across the life span. Currently, there are no FDA-
approved drugs available for the specific treatment of core symptoms of ASD 
(social/communication deficits and repetitive behaviors). Despite this lack of targeted treatment, 
it is believed that 75% of patients with ASD receive some kind of pharmacological treatment, 
usually directed to treat a non-core symptom such as hyperactivity, irritability or aggression 
(Esbensen et al., 2009). Moreover, other patients may receive off-label prescriptions on an 
experimental basis; in efforts to treat components of ASD. Since there are no specific biological 
targets, drug prescription has been limited to drugs that are approved for other disorders (e.g. 
ADHD). To date, the only drugs that are approved by the United States Food and Drug 
Administration (FDA) to treat symptoms of ASD are atypical antipsychotics, Risperidone 
(approved in 2006) and Aripiprazole (approved in 2009), which treat irritability, hyperactivity 
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and aggression (Penagarikano, 2015). These drugs usually have a secondary effect of improving 
overall social behavior by alleviating hyperactivity/aggression. However, atypical antipsychotics 
are prescribed on a limited basis, due to undesirable side effects (Miral et al., 2008). Current 
research is focused on understanding the neurobiological etiology to develop more specific and 
effective medicines. 
 Although, the identification of the underlying mechanisms of ASD has been challenging, 
common neurobiological themes have emerged. The prevalent neurobiological pathways 
identified in ASD are thought to be an avenue for developing pharmacological therapies aiming 
to restore or compensate neurochemical imbalances. Potential targets include synaptic 
transmission, and serotonin and oxytocin signaling (Penagarikano, 2015). There have been a 
number of pharmacological studies, both human and animal, investigating drug manipulations of 
these systems that have been successful. Moreover, animal studies have shown that certain 
behavioral and molecular defects can be reversed in mature mouse brain, making the outlook for 
potential pharmacological treatments in human patients positive. (Penagarikano, 2015, for 
review). 
 A reoccurring synaptic defect seen in ASD is alteration in dendritic spines, including 
spine density, morphology and or dynamics; this has been observed in both postmortem studies 
of ASD patients as well as animal models (De Rubeis et al., 2014). Therefore, drugs that could 
enhance spine maturation may serve as a therapeutic option. For instance, insulin-like growth 
factor 1 (IGF-1) may be a potential treatment since it regulates and promotes synapse formation. 
IGF-1 has been shown to promote the formation of mature excitatory synapses in neurons 
generated from induced pluriplotent stem cells from patients with Phelan-McDermid syndrome 
(PMS), a complex disorder that is considered to be a monogenic form of ASD due to disruptions 
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in the SHANK3 gene (Shcheglovitov et al., 2013). A mouse knockout of Shank3 was treated with 
daily IGF-1 injections over a 2-week period, resulting in the rescue of motor and long term 
potentiation deficits (Tavassoli & Buxbaum, 2013). In a pilot study, children with PMS received 
a 3-month treatment of IGF-1 and showed significant improvements in both social and restrictive 
behaviors without showing any adverse side effects (Kolevzon et al, 2014). To date, there have 
been no studies examining the differences in efficacy of IGF-1 between children and adults. IGF-
1 seems like a viable potential drug candidate, specifically for individuals who have a mutation 
in the SHANK3, which is responsible for at least 0.5% of ASD cases (Durand et al, 2007). These 
findings inform us that an imbalance between excitatory and inhibitory at the cellular level due 
to the failure to form the correct number of excitatory synapses and the reduction of glutamate 
receptors may be responsible for social deficits as well as repetitive behaviors seen in ASD. 
Disruption of synapses and signal transmission is thought to be a major cause of ASD and 
various types of drugs may be able to target these aberrations at different levels. Recent 
preclinical trials have been utilizing glutamergic and GABAergic agents with some success. 
 Memantine, a NMDA receptor antagonist of glutamate, has been used in several ASD 
studies, and has resulted in improvements in language and social behaviors (Chez et al., 2007; 
Erickson et al., 2007). Memantine has also been administered in adjunction of Risperidone and 
reported reduction in repetitive behaviors, hyperactivity and irritability in addition (Ghaleiha, 
2013). Memantine’s efficacy has been evaluated in open-label trials in adults and has resulted in 
improvement in social/communication skills and without any serious adverse events (Joshi et al., 
2016). However, when Memantine’s safety, tolerability, and efficacy was evaluated in children 
with ASD, the trial did not demonstrate clinical efficacy, but results indicated that short and long 
term treatments of Memantine was well tolerated and safe (Aman et al., 2016). Therefore, further 
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research is indicated for Memantine use in children, since it may represent a potential drug 
candidate for the treatment of core symptoms seen in ASD. 
 Dysfunction in the GABAergic system also fits into this prominent excitatory-inhibitory 
imbalance hypothesis of ASD. An imbalance of excitatory/inhibitory neurotransmission is 
further consistent with comorbid anxiety and seizures observed in ASD (Bourgeron, 2009; 
Geschwind and Levitt, 2007; Gogolla et al, 2009; LeBlanc and Fagiolini, 2011; Rubenstein and 
Merzenich, 2003). Furthermore, multiple transgenic mouse models associated with ASD (Fmr1, 
Cntnap2, Cadps2 and En2) have shown a reduction in the number of cortical GABAergic 
interneurons, as well as reduced GABAergic neurotransmission. Therefore, elevating 
GABAergic signaling might be a promising target for pharmacological treatments. In clinical 
trials for Fragile X syndrome, Fragile X with an autism diagnosis, and ASD, the selective 
GABA(B) enantiomer Arbaclofen was used as a therapeutic strategy. A phase 2 clinical trial 
detected improvements on Aberrant Behavior Checklist (ABC)-Social Avoidance scores (Berry-
Kravis et al., 2012) in Fragile X patients. Another open-label trial of Arbaclofen in patients with 
ASD not associated with Fragile X showed beneficial effects on ABC-irritability social 
withdrawal scale and on the social responsiveness scale (Erickson et al, 2014). When Arbaclofen 
and Racemic baclofen were administered to Fmr1 knockout mice, protein synthesis was restored, 
their increased dendritic spine density was reduced, and audiogenic seizures were reduced 
(Henderson et al, 2012). Additionally, R-baclofen was used to treat two other mouse models of 
ASD (BTBR and C58 mice), with low doses leading to a significant reduction in repetitive 
behaviors, as well as reversed social deficits, without any deleterious effects (Silverman et al., 
2015). In clinical trials, Abraclofen has been effective in both children and adults. The efficacy 
of R-baclofen could be the result of its ability to dampen hyperexcitability via both pre- and 
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postsynaptic mechanisms. These data support the hypothesis that enhancing inhibitory 
transmission improves ASD relevant deficits through targeting GABAergic mechanisms. 
 Another potential target for treatment is the serotonin system, which plays an important 
role in neurodevelopmental processes such as cell proliferation, migration and differentiation. 
Elevated whole blood serotonin, or hyperserotonemia, was the first biochemical change observed 
in individuals with ASD and 45% of patients see increased levels of serotonin (Schain & 
Freedman, 1961; Cook and Leventhal, 1996). Abnormal 5-HT synthesis and signaling, platelet 
hyperserotonemia, and amelioration of repetitive behaviors by selective serotonin reuptake 
inhibitors (SSRIs) are some of the key findings that contribute to the notion that the 
serotoninergic system may be involved in ASD. Furthermore, it has been hypothesized that 
serotonergic genes might act as ASD susceptible genes. Variants in genes involved in the 
serotonin system such as the serotonin transporter (SLC6A4) and the monoamine oxidase A gene 
(MAOA) involvement in the deamination of serotonin has been linked to ASD (Conroy et al, 
2004; Cohen et al, 2003). Animal studies looking at transgenic mice of these genes displayed 
altered serotonergic transmission along with social deficits (Lira et al., 2003; Bortolato et al., 
2013). Currently the only drugs used to target this system are SSRIs, which have not been 
consistent with treating the symptoms of ASD. SSRIs such as Fluoxetine and Citalopram have 
been used to treat repetitive behavior and impulsivity but tend to have adverse side effects. Adult 
studies suggested that SSRIs relieve symptoms of irritability and rigid-compulsive behavior in 
autism (Gordon et al., 1993, Hollander et al., 2005 and Hollander et al., 2012). However, studies 
in children have been less supportive, perhaps because of greater adverse events in children or 
methodological shortcomings (King et al., 2009 and King et al., 2013). More consistent data 
support the use of Risperidone and Aripiprazole (the two approved treatments for ASD) 
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(McCracken et al., 2002 and McDougle et al., 2005), which are antagonists at multiple 
monoamine receptors, including the serotonin receptor 5-HT2A. Drugs targeting serotonin 
receptors, particularly 5-HT1A and 5-HT2A, have shown promise for increasing social 
interaction or decreasing cognitive rigidity (File et al., 1996, Edwards et al., 2006, Boulougouris 
and Robbins, 2010, Gould et al., 2011 and Amodeo et al., 2014). Most of this work has been 
conducted in animal models with limited research in humans. There is potential for developing 
drugs that target different levels of the serotonin system (i.e., receptor, transport, and processing) 
that may target the core symptoms of ASD unlike the current SSRIs available (Muller, Anacker 
& Veenstra-VanderWeele, 2015). Future research should investigate ways on using serotonin as 
a potential biomarker for ASD to help aid treatment. 
 Oxytocin (OXT), a naturally occurring neuropeptide has received substantial attention for 
its potential therapeutic value for treating social deficits in ASD. OXT is produced in the 
hypothalamus and is involved in the modulation of a broad range of prosocial behaviors 
including maternal behavior, mother-infant bonding, pair bonding and social memory and 
recognition (Ross & Young, 2009). According to clinicaltrials.gov there is currently 21 total 
studies investigating the effects of oxytocin in individuals with ASD, 11 of which are pediatric. 
The results of the effectiveness of OXT have been promising, with 85% of controlled trials 
finding improvements in social behaviors such as eye gaze, facial emotion recognition (Preti et 
al., 2014). Recently studies have demonstrated neurobiological and behavioral changes to 
intranasal OXT including enhanced resting state functional connectivity between anterior 
cingulate cortex and dorso-medial prefrontal cortex and improvements in social reciprocity and 
interaction (Aoki et al., 2014; Tachibana et al, 2013; Watanbe et al., ). However, there have also 
been numerous studies with negative findings --to date, the results have been inconclusive. For 
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instance, two pediatric placebo-controlled oxytocin trials did not observe improvements in social 
function when compared to placebo (Dadds et al., 2014). As of now, OXT appears to be more 
effective as a treatment for adults compared to children. Animal models can be utilized to gain 
understanding on how OXT is acting on the system and influencing social behavior by targeting 
oxytocin at multiple levels including, gene, receptor, and release (Modi & Young, 2012). Future 
research is required to understand the best administration route, dosage, developmental time 
point, as well as duration of treatment for particular ASD subgroups.  
 In many neurodevelopmental disorders the exact underlying pathology of the disorder is 
unknown making it difficult to develop treatments based on biological mechanisms. However, 
there has been substantial progress in the development of targeted pharmacological treatments 
for the core symptoms of ASD. The main neurochemical correlates of ASD identified are a part 
of the following transmitter systems: glutamate, GABA, serotonin, and oxytocin. This means that 
there might be several different pathophysiological CNS differences that ultimately yield one 
generalized symptom or a group of symptoms of ASD. These widespread alternations in cell to 
cell communication appear to be contributing to deficits in social, as well as repetitive behavior 
and cognitive function including language. There is great potential for drugs to act on these 
systems to alleviate the core deficits of ASD.  
Overall, it appears adults respond better to treatment compared to children with NDDs. 
This may be a result to the fact that most pediatric drug studies include broad ranges of age, 
which is important to note since significant changes occur during development, meaning a year 
or two can make a substantial difference in response to treatment.  These changes in maturation 
can be influencing the clinical trials effects. Further work is necessary to establish biomarkers 
and development effective pharmacological interventions to treat NDDs.  Early discovery of 
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biomarkers in pediatric psychiatric and NDDs has been supported by NIH/foundation funding, 
although early studies focused on candidate genes; more recent studies are investigating CNS 
imaging biomarkers. Hopefully, with the push to establish early biomarkers this will accelerate 
the development of effective targeted pharmacological therapies. 
7.4    Final concluding remarks 
In summary, both clinical studies and transgenic animal models provide us with 
indispensible tools in elucidating the underlying causes of neuromorphological, 
neurophysiological, and behavioral differences associated with language-related developmental 
disorders. Animal models in particular are well suited to parse apart specific genetic 
contributions to the etiology/pathogenesis of core functional anomalies that underlie language-
related disorders, including some genetically mediated features that may be shared across 
clinically distinct disorders. Ongoing research will help to improve early screening, as well as 
promoting the development of mechanism-based behavioral therapies and targeted 
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